#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization
#Text=Understanding the fundamental alterations in brain functioning that lead to psychotic disorders remains a major challenge in clinical neuroscience.
1-1	0-26	Cerebello-thalamo-cortical	_	
1-2	27-44	hyperconnectivity	_	
1-3	45-47	as	_	
1-4	48-49	a	_	
1-5	50-67	state-independent	_	
1-6	68-78	functional	_	
1-7	79-85	neural	_	
1-8	86-95	signature	_	
1-9	96-99	for	_	
1-10	100-109	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
1-11	110-120	prediction	_	
1-12	121-124	and	_	
1-13	125-141	characterization	_	
1-14	142-155	Understanding	_	
1-15	156-159	the	_	
1-16	160-171	fundamental	_	
1-17	172-183	alterations	_	
1-18	184-186	in	_	
1-19	187-192	brain	_	
1-20	193-204	functioning	_	
1-21	205-209	that	_	
1-22	210-214	lead	_	
1-23	215-217	to	_	
1-24	218-227	psychotic	_	
1-25	228-237	disorders	_	
1-26	238-245	remains	_	
1-27	246-247	a	_	
1-28	248-253	major	_	
1-29	254-263	challenge	_	
1-30	264-266	in	_	
1-31	267-275	clinical	_	
1-32	276-288	neuroscience	_	
1-33	288-289	.	_	

#Text=In particular, it is unknown whether any state-independent biomarkers can potentially predict the onset of psychosis and distinguish patients from healthy controls, regardless of paradigm.
2-1	290-292	In	_	
2-2	293-303	particular	_	
2-3	303-304	,	_	
2-4	305-307	it	_	
2-5	308-310	is	_	
2-6	311-318	unknown	_	
2-7	319-326	whether	_	
2-8	327-330	any	_	
2-9	331-348	state-independent	_	
2-10	349-359	biomarkers	_	
2-11	360-363	can	_	
2-12	364-375	potentially	_	
2-13	376-383	predict	_	
2-14	384-387	the	_	
2-15	388-393	onset	_	
2-16	394-396	of	_	
2-17	397-406	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
2-18	407-410	and	_	
2-19	411-422	distinguish	_	
2-20	423-431	patients	_	
2-21	432-436	from	_	
2-22	437-444	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]	
2-23	445-453	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]	
2-24	453-454	,	_	
2-25	455-465	regardless	_	
2-26	466-468	of	_	
2-27	469-477	paradigm	_	
2-28	477-478	.	_	

#Text=Here, using multi-paradigm fMRI data from the North American Prodrome Longitudinal Study consortium, we show that individuals at clinical high risk for psychosis display an intrinsic “trait-like” abnormality in brain architecture characterized as increased connectivity in the cerebello–thalamo–cortical circuitry, a pattern that is significantly more pronounced among converters compared with non-converters.
3-1	479-483	Here	_	
3-2	483-484	,	_	
3-3	485-490	using	_	
3-4	491-505	multi-paradigm	_	
3-5	506-510	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging	
3-6	511-515	data	_	
3-7	516-520	from	_	
3-8	521-524	the	_	
3-9	525-530	North	_	
3-10	531-539	American	_	
3-11	540-548	Prodrome	_	
3-12	549-561	Longitudinal	_	
3-13	562-567	Study	_	
3-14	568-578	consortium	_	
3-15	578-579	,	_	
3-16	580-582	we	_	
3-17	583-587	show	_	
3-18	588-592	that	_	
3-19	593-604	individuals	_	
3-20	605-607	at	_	
3-21	608-616	clinical	_	
3-22	617-621	high	_	
3-23	622-626	risk	_	
3-24	627-630	for	_	
3-25	631-640	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
3-26	641-648	display	_	
3-27	649-651	an	_	
3-28	652-661	intrinsic	_	
3-29	662-663	“	_	
3-30	663-673	trait-like	_	
3-31	673-674	”	_	
3-32	675-686	abnormality	_	
3-33	687-689	in	_	
3-34	690-695	brain	_	
3-35	696-708	architecture	_	
3-36	709-722	characterized	_	
3-37	723-725	as	_	
3-38	726-735	increased	_	
3-39	736-748	connectivity	_	
3-40	749-751	in	_	
3-41	752-755	the	_	
3-42	756-782	cerebello–thalamo–cortical	_	
3-43	783-792	circuitry	_	
3-44	792-793	,	_	
3-45	794-795	a	_	
3-46	796-803	pattern	_	
3-47	804-808	that	_	
3-48	809-811	is	_	
3-49	812-825	significantly	_	
3-50	826-830	more	_	
3-51	831-841	pronounced	_	
3-52	842-847	among	_	
3-53	848-858	converters	_	
3-54	859-867	compared	_	
3-55	868-872	with	_	
3-56	873-887	non-converters	_	
3-57	887-888	.	_	

#Text=This alteration is significantly correlated with disorganization symptoms and predictive of time to conversion to psychosis.
4-1	889-893	This	_	
4-2	894-904	alteration	_	
4-3	905-907	is	_	
4-4	908-921	significantly	_	
4-5	922-932	correlated	_	
4-6	933-937	with	_	
4-7	938-953	disorganization	_	
4-8	954-962	symptoms	_	
4-9	963-966	and	_	
4-10	967-977	predictive	_	
4-11	978-980	of	_	
4-12	981-985	time	_	
4-13	986-988	to	_	
4-14	989-999	conversion	_	
4-15	1000-1002	to	_	
4-16	1003-1012	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
4-17	1012-1013	.	_	

#Text=Moreover, using an independent clinical sample, we demonstrate that this hyperconnectivity pattern is reliably detected and specifically present in patients with schizophrenia.
5-1	1014-1022	Moreover	_	
5-2	1022-1023	,	_	
5-3	1024-1029	using	_	
5-4	1030-1032	an	_	
5-5	1033-1044	independent	_	
5-6	1045-1053	clinical	_	
5-7	1054-1060	sample	_	
5-8	1060-1061	,	_	
5-9	1062-1064	we	_	
5-10	1065-1076	demonstrate	_	
5-11	1077-1081	that	_	
5-12	1082-1086	this	_	
5-13	1087-1104	hyperconnectivity	_	
5-14	1105-1112	pattern	_	
5-15	1113-1115	is	_	
5-16	1116-1124	reliably	_	
5-17	1125-1133	detected	_	
5-18	1134-1137	and	_	
5-19	1138-1150	specifically	_	
5-20	1151-1158	present	_	
5-21	1159-1161	in	_	
5-22	1162-1170	patients	_	
5-23	1171-1175	with	_	
5-24	1176-1189	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
5-25	1189-1190	.	_	

#Text=These findings implicate cerebello–thalamo–cortical hyperconnectivity as a robust state-independent neural signature for psychosis prediction and characterization.
6-1	1191-1196	These	_	
6-2	1197-1205	findings	_	
6-3	1206-1215	implicate	_	
6-4	1216-1242	cerebello–thalamo–cortical	_	
6-5	1243-1260	hyperconnectivity	_	
6-6	1261-1263	as	_	
6-7	1264-1265	a	_	
6-8	1266-1272	robust	_	
6-9	1273-1290	state-independent	_	
6-10	1291-1297	neural	_	
6-11	1298-1307	signature	_	
6-12	1308-1311	for	_	
6-13	1312-1321	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder	
6-14	1322-1332	prediction	_	
6-15	1333-1336	and	_	
6-16	1337-1353	characterization	_	
6-17	1353-1354	.	_	

#Text=Brain function alterations in schizophrenia and other psychotic disorders remain poorly understood.
7-1	1355-1360	Brain	_	
7-2	1361-1369	function	_	
7-3	1370-1381	alterations	_	
7-4	1382-1384	in	_	
7-5	1385-1398	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
7-6	1399-1402	and	_	
7-7	1403-1408	other	_	
7-8	1409-1418	psychotic	_	
7-9	1419-1428	disorders	_	
7-10	1429-1435	remain	_	
7-11	1436-1442	poorly	_	
7-12	1443-1453	understood	_	
7-13	1453-1454	.	_	

#Text=Here, the authors discover that increased neural connectivity in the cerebello-thalamo-cortical circuitry predicts psychosis in those at high risk, and is present in people with schizophrenia.
8-1	1455-1459	Here	_	
8-2	1459-1460	,	_	
8-3	1461-1464	the	_	
8-4	1465-1472	authors	_	
8-5	1473-1481	discover	_	
8-6	1482-1486	that	_	
8-7	1487-1496	increased	_	
8-8	1497-1503	neural	_	
8-9	1504-1516	connectivity	_	
8-10	1517-1519	in	_	
8-11	1520-1523	the	_	
8-12	1524-1550	cerebello-thalamo-cortical	_	
8-13	1551-1560	circuitry	_	
8-14	1561-1569	predicts	_	
8-15	1570-1579	psychosis	_	
8-16	1580-1582	in	_	
8-17	1583-1588	those	_	
8-18	1589-1591	at	_	
8-19	1592-1596	high	_	
8-20	1597-1601	risk	_	
8-21	1601-1602	,	_	
8-22	1603-1606	and	_	
8-23	1607-1609	is	_	
8-24	1610-1617	present	_	
8-25	1618-1620	in	_	
8-26	1621-1627	people	_	
8-27	1628-1632	with	_	
8-28	1633-1646	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
8-29	1646-1647	.	_	

#Text=Introduction
#Text=Understanding the fundamental alterations in brain functioning that underlie schizophrenia (SZ) and pinpointing potential neural markers predictive of psychosis in individuals at risk remain major challenges in clinical neuroscience.
9-1	1648-1660	Introduction	_	
9-2	1661-1674	Understanding	_	
9-3	1675-1678	the	_	
9-4	1679-1690	fundamental	_	
9-5	1691-1702	alterations	_	
9-6	1703-1705	in	_	
9-7	1706-1711	brain	_	
9-8	1712-1723	functioning	_	
9-9	1724-1728	that	_	
9-10	1729-1737	underlie	_	
9-11	1738-1751	schizophrenia	_	
9-12	1752-1753	(	_	
9-13	1753-1755	SZ	_	
9-14	1755-1756	)	_	
9-15	1757-1760	and	_	
9-16	1761-1772	pinpointing	_	
9-17	1773-1782	potential	_	
9-18	1783-1789	neural	_	
9-19	1790-1797	markers	_	
9-20	1798-1808	predictive	_	
9-21	1809-1811	of	_	
9-22	1812-1821	psychosis	_	
9-23	1822-1824	in	_	
9-24	1825-1836	individuals	_	
9-25	1837-1839	at	_	
9-26	1840-1844	risk	_	
9-27	1845-1851	remain	_	
9-28	1852-1857	major	_	
9-29	1858-1868	challenges	_	
9-30	1869-1871	in	_	
9-31	1872-1880	clinical	_	
9-32	1881-1893	neuroscience	_	
9-33	1893-1894	.	_	

#Text=The heterogeneity of clinical symptoms and associated cognitive and behavioral deficits in patients has motivated a broad search for neurobiological underpinnings across different functional domains.
10-1	1895-1898	The	_	
10-2	1899-1912	heterogeneity	_	
10-3	1913-1915	of	_	
10-4	1916-1924	clinical	_	
10-5	1925-1933	symptoms	_	
10-6	1934-1937	and	_	
10-7	1938-1948	associated	_	
10-8	1949-1958	cognitive	_	
10-9	1959-1962	and	_	
10-10	1963-1973	behavioral	_	
10-11	1974-1982	deficits	_	
10-12	1983-1985	in	_	
10-13	1986-1994	patients	_	
10-14	1995-1998	has	_	
10-15	1999-2008	motivated	_	
10-16	2009-2010	a	_	
10-17	2011-2016	broad	_	
10-18	2017-2023	search	_	
10-19	2024-2027	for	_	
10-20	2028-2043	neurobiological	_	
10-21	2044-2057	underpinnings	_	
10-22	2058-2064	across	_	
10-23	2065-2074	different	_	
10-24	2075-2085	functional	_	
10-25	2086-2093	domains	_	
10-26	2093-2094	.	_	

#Text=Accordingly, functional magnetic resonance imaging (fMRI) studies on psychosis have used an extensive repertoire of paradigms, including resting state, working memory, episodic memory, language processing, emotional processing, motor control, and response inhibition among others.
11-1	2095-2106	Accordingly	_	
11-2	2106-2107	,	_	
11-3	2108-2118	functional	_	
11-4	2119-2127	magnetic	_	
11-5	2128-2137	resonance	_	
11-6	2138-2145	imaging	_	
11-7	2146-2147	(	_	
11-8	2147-2151	fMRI	_	
11-9	2151-2152	)	_	
11-10	2153-2160	studies	_	
11-11	2161-2163	on	_	
11-12	2164-2173	psychosis	_	
11-13	2174-2178	have	_	
11-14	2179-2183	used	_	
11-15	2184-2186	an	_	
11-16	2187-2196	extensive	_	
11-17	2197-2207	repertoire	_	
11-18	2208-2210	of	_	
11-19	2211-2220	paradigms	_	
11-20	2220-2221	,	_	
11-21	2222-2231	including	_	
11-22	2232-2239	resting	_	
11-23	2240-2245	state	_	
11-24	2245-2246	,	_	
11-25	2247-2254	working	_	
11-26	2255-2261	memory	_	
11-27	2261-2262	,	_	
11-28	2263-2271	episodic	_	
11-29	2272-2278	memory	_	
11-30	2278-2279	,	_	
11-31	2280-2288	language	_	
11-32	2289-2299	processing	_	
11-33	2299-2300	,	_	
11-34	2301-2310	emotional	_	
11-35	2311-2321	processing	_	
11-36	2321-2322	,	_	
11-37	2323-2328	motor	_	
11-38	2329-2336	control	_	
11-39	2336-2337	,	_	
11-40	2338-2341	and	_	
11-41	2342-2350	response	_	
11-42	2351-2361	inhibition	_	
11-43	2362-2367	among	_	
11-44	2368-2374	others	_	
11-45	2374-2375	.	_	

#Text=These studies have provided evidence that dysfunction in several brain regions, including prefrontal cortex, parietal cortex, medial temporal cortex, cingulate cortex, thalamus, striatum, and cerebellum may in some way mark risk for and/or expression of psychosis.
12-1	2376-2381	These	_	
12-2	2382-2389	studies	_	
12-3	2390-2394	have	_	
12-4	2395-2403	provided	_	
12-5	2404-2412	evidence	_	
12-6	2413-2417	that	_	
12-7	2418-2429	dysfunction	_	
12-8	2430-2432	in	_	
12-9	2433-2440	several	_	
12-10	2441-2446	brain	_	
12-11	2447-2454	regions	_	
12-12	2454-2455	,	_	
12-13	2456-2465	including	_	
12-14	2466-2476	prefrontal	_	
12-15	2477-2483	cortex	_	
12-16	2483-2484	,	_	
12-17	2485-2493	parietal	_	
12-18	2494-2500	cortex	_	
12-19	2500-2501	,	_	
12-20	2502-2508	medial	_	
12-21	2509-2517	temporal	_	
12-22	2518-2524	cortex	_	
12-23	2524-2525	,	_	
12-24	2526-2535	cingulate	_	
12-25	2536-2542	cortex	_	
12-26	2542-2543	,	_	
12-27	2544-2552	thalamus	_	
12-28	2552-2553	,	_	
12-29	2554-2562	striatum	_	
12-30	2562-2563	,	_	
12-31	2564-2567	and	_	
12-32	2568-2578	cerebellum	_	
12-33	2579-2582	may	_	
12-34	2583-2585	in	_	
12-35	2586-2590	some	_	
12-36	2591-2594	way	_	
12-37	2595-2599	mark	_	
12-38	2600-2604	risk	_	
12-39	2605-2608	for	_	
12-40	2609-2612	and	_	
12-41	2612-2613	/	_	
12-42	2613-2615	or	_	
12-43	2616-2626	expression	_	
12-44	2627-2629	of	_	
12-45	2630-2639	psychosis	_	
12-46	2639-2640	.	_	

#Text=Nevertheless, the patterns of altered brain function associated with SZ are not entirely consistent across studies.
13-1	2641-2653	Nevertheless	_	
13-2	2653-2654	,	_	
13-3	2655-2658	the	_	
13-4	2659-2667	patterns	_	
13-5	2668-2670	of	_	
13-6	2671-2678	altered	_	
13-7	2679-2684	brain	_	
13-8	2685-2693	function	_	
13-9	2694-2704	associated	_	
13-10	2705-2709	with	_	
13-11	2710-2712	SZ	_	
13-12	2713-2716	are	_	
13-13	2717-2720	not	_	
13-14	2721-2729	entirely	_	
13-15	2730-2740	consistent	_	
13-16	2741-2747	across	_	
13-17	2748-2755	studies	_	
13-18	2755-2756	.	_	

#Text=In part, this inconsistency is likely to reflect the fact that each study is designed to probe particular brain systems based on particular task features.
14-1	2757-2759	In	_	
14-2	2760-2764	part	_	
14-3	2764-2765	,	_	
14-4	2766-2770	this	_	
14-5	2771-2784	inconsistency	_	
14-6	2785-2787	is	_	
14-7	2788-2794	likely	_	
14-8	2795-2797	to	_	
14-9	2798-2805	reflect	_	
14-10	2806-2809	the	_	
14-11	2810-2814	fact	_	
14-12	2815-2819	that	_	
14-13	2820-2824	each	_	
14-14	2825-2830	study	_	
14-15	2831-2833	is	_	
14-16	2834-2842	designed	_	
14-17	2843-2845	to	_	
14-18	2846-2851	probe	_	
14-19	2852-2862	particular	_	
14-20	2863-2868	brain	_	
14-21	2869-2876	systems	_	
14-22	2877-2882	based	_	
14-23	2883-2885	on	_	
14-24	2886-2896	particular	_	
14-25	2897-2901	task	_	
14-26	2902-2910	features	_	
14-27	2910-2911	.	_	

#Text=The goal of the present study was to determine whether a more consistent functional imaging biomarker of psychosis risk will emerge using a strategy that explicitly assesses patterns of brain functioning across paradigms.
15-1	2912-2915	The	_	
15-2	2916-2920	goal	_	
15-3	2921-2923	of	_	
15-4	2924-2927	the	_	
15-5	2928-2935	present	_	
15-6	2936-2941	study	_	
15-7	2942-2945	was	_	
15-8	2946-2948	to	_	
15-9	2949-2958	determine	_	
15-10	2959-2966	whether	_	
15-11	2967-2968	a	_	
15-12	2969-2973	more	_	
15-13	2974-2984	consistent	_	
15-14	2985-2995	functional	_	
15-15	2996-3003	imaging	_	
15-16	3004-3013	biomarker	_	
15-17	3014-3016	of	_	
15-18	3017-3026	psychosis	_	
15-19	3027-3031	risk	_	
15-20	3032-3036	will	_	
15-21	3037-3043	emerge	_	
15-22	3044-3049	using	_	
15-23	3050-3051	a	_	
15-24	3052-3060	strategy	_	
15-25	3061-3065	that	_	
15-26	3066-3076	explicitly	_	
15-27	3077-3085	assesses	_	
15-28	3086-3094	patterns	_	
15-29	3095-3097	of	_	
15-30	3098-3103	brain	_	
15-31	3104-3115	functioning	_	
15-32	3116-3122	across	_	
15-33	3123-3132	paradigms	_	
15-34	3132-3133	.	_	

#Text=Several lines of evidence make the exploration of such a neural signature plausible.
16-1	3134-3141	Several	_	
16-2	3142-3147	lines	_	
16-3	3148-3150	of	_	
16-4	3151-3159	evidence	_	
16-5	3160-3164	make	_	
16-6	3165-3168	the	_	
16-7	3169-3180	exploration	_	
16-8	3181-3183	of	_	
16-9	3184-3188	such	_	
16-10	3189-3190	a	_	
16-11	3191-3197	neural	_	
16-12	3198-3207	signature	_	
16-13	3208-3217	plausible	_	
16-14	3217-3218	.	_	

#Text=From a clinical perspective, although psychotic disorders present a diversity of phenotypes, similar symptoms such as hallucinations, delusions, and disorganized thought and behavior are the core features that distinguish psychosis from other mental disorders.
17-1	3219-3223	From	_	
17-2	3224-3225	a	_	
17-3	3226-3234	clinical	_	
17-4	3235-3246	perspective	_	
17-5	3246-3247	,	_	
17-6	3248-3256	although	_	
17-7	3257-3266	psychotic	_	
17-8	3267-3276	disorders	_	
17-9	3277-3284	present	_	
17-10	3285-3286	a	_	
17-11	3287-3296	diversity	_	
17-12	3297-3299	of	_	
17-13	3300-3310	phenotypes	_	
17-14	3310-3311	,	_	
17-15	3312-3319	similar	_	
17-16	3320-3328	symptoms	_	
17-17	3329-3333	such	_	
17-18	3334-3336	as	_	
17-19	3337-3351	hallucinations	_	
17-20	3351-3352	,	_	
17-21	3353-3362	delusions	_	
17-22	3362-3363	,	_	
17-23	3364-3367	and	_	
17-24	3368-3380	disorganized	_	
17-25	3381-3388	thought	_	
17-26	3389-3392	and	_	
17-27	3393-3401	behavior	_	
17-28	3402-3405	are	_	
17-29	3406-3409	the	_	
17-30	3410-3414	core	_	
17-31	3415-3423	features	_	
17-32	3424-3428	that	_	
17-33	3429-3440	distinguish	_	
17-34	3441-3450	psychosis	_	
17-35	3451-3455	from	_	
17-36	3456-3461	other	_	
17-37	3462-3468	mental	_	
17-38	3469-3478	disorders	_	
17-39	3478-3479	.	_	

#Text=Thus, an intrinsic neural deficit that is closely related to these features may typify individuals with psychosis and with higher vulnerability to psychosis.
18-1	3480-3484	Thus	_	
18-2	3484-3485	,	_	
18-3	3486-3488	an	_	
18-4	3489-3498	intrinsic	_	
18-5	3499-3505	neural	_	
18-6	3506-3513	deficit	_	
18-7	3514-3518	that	_	
18-8	3519-3521	is	_	
18-9	3522-3529	closely	_	
18-10	3530-3537	related	_	
18-11	3538-3540	to	_	
18-12	3541-3546	these	_	
18-13	3547-3555	features	_	
18-14	3556-3559	may	_	
18-15	3560-3566	typify	_	
18-16	3567-3578	individuals	_	
18-17	3579-3583	with	_	
18-18	3584-3593	psychosis	_	
18-19	3594-3597	and	_	
18-20	3598-3602	with	_	
18-21	3603-3609	higher	_	
18-22	3610-3623	vulnerability	_	
18-23	3624-3626	to	_	
18-24	3627-3636	psychosis	_	
18-25	3636-3637	.	_	

#Text=From a neurobiological perspective, recent work has suggested that the brain possesses an intrinsic and state-independent functional architecture, and functional networks during different paradigms are shaped primarily by this “standard” architecture and secondarily by paradigm-specific features.
19-1	3638-3642	From	_	
19-2	3643-3644	a	_	
19-3	3645-3660	neurobiological	_	
19-4	3661-3672	perspective	_	
19-5	3672-3673	,	_	
19-6	3674-3680	recent	_	
19-7	3681-3685	work	_	
19-8	3686-3689	has	_	
19-9	3690-3699	suggested	_	
19-10	3700-3704	that	_	
19-11	3705-3708	the	_	
19-12	3709-3714	brain	_	
19-13	3715-3724	possesses	_	
19-14	3725-3727	an	_	
19-15	3728-3737	intrinsic	_	
19-16	3738-3741	and	_	
19-17	3742-3759	state-independent	_	
19-18	3760-3770	functional	_	
19-19	3771-3783	architecture	_	
19-20	3783-3784	,	_	
19-21	3785-3788	and	_	
19-22	3789-3799	functional	_	
19-23	3800-3808	networks	_	
19-24	3809-3815	during	_	
19-25	3816-3825	different	_	
19-26	3826-3835	paradigms	_	
19-27	3836-3839	are	_	
19-28	3840-3846	shaped	_	
19-29	3847-3856	primarily	_	
19-30	3857-3859	by	_	
19-31	3860-3864	this	_	
19-32	3865-3866	“	_	
19-33	3866-3874	standard	_	
19-34	3874-3875	”	_	
19-35	3876-3888	architecture	_	
19-36	3889-3892	and	_	
19-37	3893-3904	secondarily	_	
19-38	3905-3907	by	_	
19-39	3908-3925	paradigm-specific	_	
19-40	3926-3934	features	_	
19-41	3934-3935	.	_	

#Text=These findings raise the possibility that the neural alterations associated with psychosis may occur in relation to the “standard” network architecture to a greater degree than the state-dependent networks.
20-1	3936-3941	These	_	
20-2	3942-3950	findings	_	
20-3	3951-3956	raise	_	
20-4	3957-3960	the	_	
20-5	3961-3972	possibility	_	
20-6	3973-3977	that	_	
20-7	3978-3981	the	_	
20-8	3982-3988	neural	_	
20-9	3989-4000	alterations	_	
20-10	4001-4011	associated	_	
20-11	4012-4016	with	_	
20-12	4017-4026	psychosis	_	
20-13	4027-4030	may	_	
20-14	4031-4036	occur	_	
20-15	4037-4039	in	_	
20-16	4040-4048	relation	_	
20-17	4049-4051	to	_	
20-18	4052-4055	the	_	
20-19	4056-4057	“	_	
20-20	4057-4065	standard	_	
20-21	4065-4066	”	_	
20-22	4067-4074	network	_	
20-23	4075-4087	architecture	_	
20-24	4088-4090	to	_	
20-25	4091-4092	a	_	
20-26	4093-4100	greater	_	
20-27	4101-4107	degree	_	
20-28	4108-4112	than	_	
20-29	4113-4116	the	_	
20-30	4117-4132	state-dependent	_	
20-31	4133-4141	networks	_	
20-32	4141-4142	.	_	

#Text=Further, despite the heterogeneity in results derived from different paradigms, the brain regions that are associated with psychosis highly overlap in the literature, suggesting the possibility that shared neural mechanisms underlie various functional states.
21-1	4143-4150	Further	_	
21-2	4150-4151	,	_	
21-3	4152-4159	despite	_	
21-4	4160-4163	the	_	
21-5	4164-4177	heterogeneity	_	
21-6	4178-4180	in	_	
21-7	4181-4188	results	_	
21-8	4189-4196	derived	_	
21-9	4197-4201	from	_	
21-10	4202-4211	different	_	
21-11	4212-4221	paradigms	_	
21-12	4221-4222	,	_	
21-13	4223-4226	the	_	
21-14	4227-4232	brain	_	
21-15	4233-4240	regions	_	
21-16	4241-4245	that	_	
21-17	4246-4249	are	_	
21-18	4250-4260	associated	_	
21-19	4261-4265	with	_	
21-20	4266-4275	psychosis	_	
21-21	4276-4282	highly	_	
21-22	4283-4290	overlap	_	
21-23	4291-4293	in	_	
21-24	4294-4297	the	_	
21-25	4298-4308	literature	_	
21-26	4308-4309	,	_	
21-27	4310-4320	suggesting	_	
21-28	4321-4324	the	_	
21-29	4325-4336	possibility	_	
21-30	4337-4341	that	_	
21-31	4342-4348	shared	_	
21-32	4349-4355	neural	_	
21-33	4356-4366	mechanisms	_	
21-34	4367-4375	underlie	_	
21-35	4376-4383	various	_	
21-36	4384-4394	functional	_	
21-37	4395-4401	states	_	
21-38	4401-4402	.	_	

#Text=However, such shared mechanisms may be masked by paradigm-specific effects on brain function and thus may be missed when studying each paradigm separately.
22-1	4403-4410	However	_	
22-2	4410-4411	,	_	
22-3	4412-4416	such	_	
22-4	4417-4423	shared	_	
22-5	4424-4434	mechanisms	_	
22-6	4435-4438	may	_	
22-7	4439-4441	be	_	
22-8	4442-4448	masked	_	
22-9	4449-4451	by	_	
22-10	4452-4469	paradigm-specific	_	
22-11	4470-4477	effects	_	
22-12	4478-4480	on	_	
22-13	4481-4486	brain	_	
22-14	4487-4495	function	_	
22-15	4496-4499	and	_	
22-16	4500-4504	thus	_	
22-17	4505-4508	may	_	
22-18	4509-4511	be	_	
22-19	4512-4518	missed	_	
22-20	4519-4523	when	_	
22-21	4524-4532	studying	_	
22-22	4533-4537	each	_	
22-23	4538-4546	paradigm	_	
22-24	4547-4557	separately	_	
22-25	4557-4558	.	_	

#Text=Here, using multi-paradigm fMRI data from two independent cohorts, we investigated whether common functional network abnormalities shared across different paradigms mark the risk for psychotic disorders and predict the onset of psychosis among those in a prodromal state.
23-1	4559-4563	Here	_	
23-2	4563-4564	,	_	
23-3	4565-4570	using	_	
23-4	4571-4585	multi-paradigm	_	
23-5	4586-4590	fMRI	_	
23-6	4591-4595	data	_	
23-7	4596-4600	from	_	
23-8	4601-4604	two	_	
23-9	4605-4616	independent	_	
23-10	4617-4624	cohorts	_	
23-11	4624-4625	,	_	
23-12	4626-4628	we	_	
23-13	4629-4641	investigated	_	
23-14	4642-4649	whether	_	
23-15	4650-4656	common	_	
23-16	4657-4667	functional	_	
23-17	4668-4675	network	_	
23-18	4676-4689	abnormalities	_	
23-19	4690-4696	shared	_	
23-20	4697-4703	across	_	
23-21	4704-4713	different	_	
23-22	4714-4723	paradigms	_	
23-23	4724-4728	mark	_	
23-24	4729-4732	the	_	
23-25	4733-4737	risk	_	
23-26	4738-4741	for	_	
23-27	4742-4751	psychotic	_	
23-28	4752-4761	disorders	_	
23-29	4762-4765	and	_	
23-30	4766-4773	predict	_	
23-31	4774-4777	the	_	
23-32	4778-4783	onset	_	
23-33	4784-4786	of	_	
23-34	4787-4796	psychosis	_	
23-35	4797-4802	among	_	
23-36	4803-4808	those	_	
23-37	4809-4811	in	_	
23-38	4812-4813	a	_	
23-39	4814-4823	prodromal	_	
23-40	4824-4829	state	_	
23-41	4829-4830	.	_	

#Text=We also examined whether the same network abnormalities are characteristic of patients with SZ.
24-1	4831-4833	We	_	
24-2	4834-4838	also	_	
24-3	4839-4847	examined	_	
24-4	4848-4855	whether	_	
24-5	4856-4859	the	_	
24-6	4860-4864	same	_	
24-7	4865-4872	network	_	
24-8	4873-4886	abnormalities	_	
24-9	4887-4890	are	_	
24-10	4891-4905	characteristic	_	
24-11	4906-4908	of	_	
24-12	4909-4917	patients	_	
24-13	4918-4922	with	_	
24-14	4923-4925	SZ	_	
24-15	4925-4926	.	_	

#Text=Using principal component analysis (PCA) combined with connectome-wide network-based statistics (NBS), we sought to delineate network-level changes in the human functional connectome that precede conversion to psychosis in a sample of 182 subjects at clinical high risk (CHR) for psychosis (among whom 19 cases later converted to full psychosis during follow-up) and 120 healthy controls drawn from the second phase of the North American Prodromal Longitudinal Study (NAPLS-2) consortium.
25-1	4927-4932	Using	_	
25-2	4933-4942	principal	_	
25-3	4943-4952	component	_	
25-4	4953-4961	analysis	_	
25-5	4962-4963	(	_	
25-6	4963-4966	PCA	_	
25-7	4966-4967	)	_	
25-8	4968-4976	combined	_	
25-9	4977-4981	with	_	
25-10	4982-4997	connectome-wide	_	
25-11	4998-5011	network-based	_	
25-12	5012-5022	statistics	_	
25-13	5023-5024	(	_	
25-14	5024-5027	NBS	_	
25-15	5027-5028	)	_	
25-16	5028-5029	,	_	
25-17	5030-5032	we	_	
25-18	5033-5039	sought	_	
25-19	5040-5042	to	_	
25-20	5043-5052	delineate	_	
25-21	5053-5066	network-level	_	
25-22	5067-5074	changes	_	
25-23	5075-5077	in	_	
25-24	5078-5081	the	_	
25-25	5082-5087	human	_	
25-26	5088-5098	functional	_	
25-27	5099-5109	connectome	_	
25-28	5110-5114	that	_	
25-29	5115-5122	precede	_	
25-30	5123-5133	conversion	_	
25-31	5134-5136	to	_	
25-32	5137-5146	psychosis	_	
25-33	5147-5149	in	_	
25-34	5150-5151	a	_	
25-35	5152-5158	sample	_	
25-36	5159-5161	of	_	
25-37	5162-5165	182	_	
25-38	5166-5174	subjects	_	
25-39	5175-5177	at	_	
25-40	5178-5186	clinical	_	
25-41	5187-5191	high	_	
25-42	5192-5196	risk	_	
25-43	5197-5198	(	_	
25-44	5198-5201	CHR	_	
25-45	5201-5202	)	_	
25-46	5203-5206	for	_	
25-47	5207-5216	psychosis	_	
25-48	5217-5218	(	_	
25-49	5218-5223	among	_	
25-50	5224-5228	whom	_	
25-51	5229-5231	19	_	
25-52	5232-5237	cases	_	
25-53	5238-5243	later	_	
25-54	5244-5253	converted	_	
25-55	5254-5256	to	_	
25-56	5257-5261	full	_	
25-57	5262-5271	psychosis	_	
25-58	5272-5278	during	_	
25-59	5279-5288	follow-up	_	
25-60	5288-5289	)	_	
25-61	5290-5293	and	_	
25-62	5294-5297	120	_	
25-63	5298-5305	healthy	_	
25-64	5306-5314	controls	_	
25-65	5315-5320	drawn	_	
25-66	5321-5325	from	_	
25-67	5326-5329	the	_	
25-68	5330-5336	second	_	
25-69	5337-5342	phase	_	
25-70	5343-5345	of	_	
25-71	5346-5349	the	_	
25-72	5350-5355	North	_	
25-73	5356-5364	American	_	
25-74	5365-5374	Prodromal	_	
25-75	5375-5387	Longitudinal	_	
25-76	5388-5393	Study	_	
25-77	5394-5395	(	_	
25-78	5395-5400	NAPLS	_	
25-79	5400-5401	-	_	
25-80	5401-5402	2	_	
25-81	5402-5403	)	_	
25-82	5404-5414	consortium	_	
25-83	5414-5415	.	_	

#Text=The observed network alterations in converters, by virtue of their temporal priority, are likely to reflect a state-independent neural trait that leads to the onset of psychosis.
26-1	5416-5419	The	_	
26-2	5420-5428	observed	_	
26-3	5429-5436	network	_	
26-4	5437-5448	alterations	_	
26-5	5449-5451	in	_	
26-6	5452-5462	converters	_	
26-7	5462-5463	,	_	
26-8	5464-5466	by	_	
26-9	5467-5473	virtue	_	
26-10	5474-5476	of	_	
26-11	5477-5482	their	_	
26-12	5483-5491	temporal	_	
26-13	5492-5500	priority	_	
26-14	5500-5501	,	_	
26-15	5502-5505	are	_	
26-16	5506-5512	likely	_	
26-17	5513-5515	to	_	
26-18	5516-5523	reflect	_	
26-19	5524-5525	a	_	
26-20	5526-5543	state-independent	_	
26-21	5544-5550	neural	_	
26-22	5551-5556	trait	_	
26-23	5557-5561	that	_	
26-24	5562-5567	leads	_	
26-25	5568-5570	to	_	
26-26	5571-5574	the	_	
26-27	5575-5580	onset	_	
26-28	5581-5583	of	_	
26-29	5584-5593	psychosis	_	
26-30	5593-5594	.	_	

#Text=As a test of the robustness of the resulting biomarker, we further examined the presence and specificity of the finding in a second cohort including 50 patients with SZ, 49 patients with bipolar disorder (BD), 40 patients with attention deficit hyperactivity disorder (ADHD), and 123 healthy controls drawn from the Consortium for Neuropsychiatric Phenomics (CNP) study.
27-1	5595-5597	As	_	
27-2	5598-5599	a	_	
27-3	5600-5604	test	_	
27-4	5605-5607	of	_	
27-5	5608-5611	the	_	
27-6	5612-5622	robustness	_	
27-7	5623-5625	of	_	
27-8	5626-5629	the	_	
27-9	5630-5639	resulting	_	
27-10	5640-5649	biomarker	_	
27-11	5649-5650	,	_	
27-12	5651-5653	we	_	
27-13	5654-5661	further	_	
27-14	5662-5670	examined	_	
27-15	5671-5674	the	_	
27-16	5675-5683	presence	_	
27-17	5684-5687	and	_	
27-18	5688-5699	specificity	_	
27-19	5700-5702	of	_	
27-20	5703-5706	the	_	
27-21	5707-5714	finding	_	
27-22	5715-5717	in	_	
27-23	5718-5719	a	_	
27-24	5720-5726	second	_	
27-25	5727-5733	cohort	_	
27-26	5734-5743	including	_	
27-27	5744-5746	50	_	
27-28	5747-5755	patients	_	
27-29	5756-5760	with	_	
27-30	5761-5763	SZ	_	
27-31	5763-5764	,	_	
27-32	5765-5767	49	_	
27-33	5768-5776	patients	_	
27-34	5777-5781	with	_	
27-35	5782-5789	bipolar	_	
27-36	5790-5798	disorder	_	
27-37	5799-5800	(	_	
27-38	5800-5802	BD	_	
27-39	5802-5803	)	_	
27-40	5803-5804	,	_	
27-41	5805-5807	40	_	
27-42	5808-5816	patients	_	
27-43	5817-5821	with	_	
27-44	5822-5831	attention	_	
27-45	5832-5839	deficit	_	
27-46	5840-5853	hyperactivity	_	
27-47	5854-5862	disorder	_	
27-48	5863-5864	(	_	
27-49	5864-5868	ADHD	_	
27-50	5868-5869	)	_	
27-51	5869-5870	,	_	
27-52	5871-5874	and	_	
27-53	5875-5878	123	_	
27-54	5879-5886	healthy	_	
27-55	5887-5895	controls	_	
27-56	5896-5901	drawn	_	
27-57	5902-5906	from	_	
27-58	5907-5910	the	_	
27-59	5911-5921	Consortium	_	
27-60	5922-5925	for	_	
27-61	5926-5942	Neuropsychiatric	_	
27-62	5943-5952	Phenomics	_	
27-63	5953-5954	(	_	
27-64	5954-5957	CNP	_	
27-65	5957-5958	)	_	
27-66	5959-5964	study	_	
27-67	5964-5965	.	_	

#Text=We hypothesized that (1) there would be a common connectomic signature of psychosis risk across different brain functional states and in particular those who later converted to psychosis; and (2) this state-independent connectomic profile related to psychosis risk would be specifically present in patients with SZ and not observed among patients with other forms of psychiatric illness.
28-1	5966-5968	We	_	
28-2	5969-5981	hypothesized	_	
28-3	5982-5986	that	_	
28-4	5987-5988	(	_	
28-5	5988-5989	1	_	
28-6	5989-5990	)	_	
28-7	5991-5996	there	_	
28-8	5997-6002	would	_	
28-9	6003-6005	be	_	
28-10	6006-6007	a	_	
28-11	6008-6014	common	_	
28-12	6015-6026	connectomic	_	
28-13	6027-6036	signature	_	
28-14	6037-6039	of	_	
28-15	6040-6049	psychosis	_	
28-16	6050-6054	risk	_	
28-17	6055-6061	across	_	
28-18	6062-6071	different	_	
28-19	6072-6077	brain	_	
28-20	6078-6088	functional	_	
28-21	6089-6095	states	_	
28-22	6096-6099	and	_	
28-23	6100-6102	in	_	
28-24	6103-6113	particular	_	
28-25	6114-6119	those	_	
28-26	6120-6123	who	_	
28-27	6124-6129	later	_	
28-28	6130-6139	converted	_	
28-29	6140-6142	to	_	
28-30	6143-6152	psychosis	_	
28-31	6152-6153	;	_	
28-32	6154-6157	and	_	
28-33	6158-6159	(	_	
28-34	6159-6160	2	_	
28-35	6160-6161	)	_	
28-36	6162-6166	this	_	
28-37	6167-6184	state-independent	_	
28-38	6185-6196	connectomic	_	
28-39	6197-6204	profile	_	
28-40	6205-6212	related	_	
28-41	6213-6215	to	_	
28-42	6216-6225	psychosis	_	
28-43	6226-6230	risk	_	
28-44	6231-6236	would	_	
28-45	6237-6239	be	_	
28-46	6240-6252	specifically	_	
28-47	6253-6260	present	_	
28-48	6261-6263	in	_	
28-49	6264-6272	patients	_	
28-50	6273-6277	with	_	
28-51	6278-6280	SZ	_	
28-52	6281-6284	and	_	
28-53	6285-6288	not	_	
28-54	6289-6297	observed	_	
28-55	6298-6303	among	_	
28-56	6304-6312	patients	_	
28-57	6313-6317	with	_	
28-58	6318-6323	other	_	
28-59	6324-6329	forms	_	
28-60	6330-6332	of	_	
28-61	6333-6344	psychiatric	_	
28-62	6345-6352	illness	_	
28-63	6352-6353	.	_	

#Text=Results
#Text=PCA for the NAPLS-2 data
#Text=Flowchart of the processing pipeline used in this study
#Text=All subjects in the NAPLS-2 sample (302 in total, including 19 converters, 163 non-converters, 120 controls) completed a battery of five fMRI paradigms at the point of recruitment: an eyes-open resting-state paradigm, a verbal working memory task, an episodic memory encoding task, an episodic memory retrieval task, and an emotional face matching task.
29-1	6354-6361	Results	_	
29-2	6362-6365	PCA	_	
29-3	6366-6369	for	_	
29-4	6370-6373	the	_	
29-5	6374-6379	NAPLS	_	
29-6	6379-6380	-	_	
29-7	6380-6381	2	_	
29-8	6382-6386	data	_	
29-9	6387-6396	Flowchart	_	
29-10	6397-6399	of	_	
29-11	6400-6403	the	_	
29-12	6404-6414	processing	_	
29-13	6415-6423	pipeline	_	
29-14	6424-6428	used	_	
29-15	6429-6431	in	_	
29-16	6432-6436	this	_	
29-17	6437-6442	study	_	
29-18	6443-6446	All	_	
29-19	6447-6455	subjects	_	
29-20	6456-6458	in	_	
29-21	6459-6462	the	_	
29-22	6463-6468	NAPLS	_	
29-23	6468-6469	-	_	
29-24	6469-6470	2	_	
29-25	6471-6477	sample	_	
29-26	6478-6479	(	_	
29-27	6479-6482	302	_	
29-28	6483-6485	in	_	
29-29	6486-6491	total	_	
29-30	6491-6492	,	_	
29-31	6493-6502	including	_	
29-32	6503-6505	19	_	
29-33	6506-6516	converters	_	
29-34	6516-6517	,	_	
29-35	6518-6521	163	_	
29-36	6522-6536	non-converters	_	
29-37	6536-6537	,	_	
29-38	6538-6541	120	_	
29-39	6542-6550	controls	_	
29-40	6550-6551	)	_	
29-41	6552-6561	completed	_	
29-42	6562-6563	a	_	
29-43	6564-6571	battery	_	
29-44	6572-6574	of	_	
29-45	6575-6579	five	_	
29-46	6580-6584	fMRI	_	
29-47	6585-6594	paradigms	_	
29-48	6595-6597	at	_	
29-49	6598-6601	the	_	
29-50	6602-6607	point	_	
29-51	6608-6610	of	_	
29-52	6611-6622	recruitment	_	
29-53	6622-6623	:	_	
29-54	6624-6626	an	_	
29-55	6627-6636	eyes-open	_	
29-56	6637-6650	resting-state	_	
29-57	6651-6659	paradigm	_	
29-58	6659-6660	,	_	
29-59	6661-6662	a	_	
29-60	6663-6669	verbal	_	
29-61	6670-6677	working	_	
29-62	6678-6684	memory	_	
29-63	6685-6689	task	_	
29-64	6689-6690	,	_	
29-65	6691-6693	an	_	
29-66	6694-6702	episodic	_	
29-67	6703-6709	memory	_	
29-68	6710-6718	encoding	_	
29-69	6719-6723	task	_	
29-70	6723-6724	,	_	
29-71	6725-6727	an	_	
29-72	6728-6736	episodic	_	
29-73	6737-6743	memory	_	
29-74	6744-6753	retrieval	_	
29-75	6754-6758	task	_	
29-76	6758-6759	,	_	
29-77	6760-6763	and	_	
29-78	6764-6766	an	_	
29-79	6767-6776	emotional	_	
29-80	6777-6781	face	_	
29-81	6782-6790	matching	_	
29-82	6791-6795	task	_	
29-83	6795-6796	.	_	

#Text=We used the expanded Power brain atlas with 270 regions to construct functional brain networks for each individual during each paradigm, thereby generating a total of 302 × 5 whole-brain connectivity matrices, each representing the pairwise connectivity between the 270 nodes for a given subject and paradigm.
30-1	6797-6799	We	_	
30-2	6800-6804	used	_	
30-3	6805-6808	the	_	
30-4	6809-6817	expanded	_	
30-5	6818-6823	Power	_	
30-6	6824-6829	brain	_	
30-7	6830-6835	atlas	_	
30-8	6836-6840	with	_	
30-9	6841-6844	270	_	
30-10	6845-6852	regions	_	
30-11	6853-6855	to	_	
30-12	6856-6865	construct	_	
30-13	6866-6876	functional	_	
30-14	6877-6882	brain	_	
30-15	6883-6891	networks	_	
30-16	6892-6895	for	_	
30-17	6896-6900	each	_	
30-18	6901-6911	individual	_	
30-19	6912-6918	during	_	
30-20	6919-6923	each	_	
30-21	6924-6932	paradigm	_	
30-22	6932-6933	,	_	
30-23	6934-6941	thereby	_	
30-24	6942-6952	generating	_	
30-25	6953-6954	a	_	
30-26	6955-6960	total	_	
30-27	6961-6963	of	_	
30-28	6964-6967	302	_	
30-29	6968-6969	×	_	
30-30	6970-6971	5	_	
30-31	6972-6983	whole-brain	_	
30-32	6984-6996	connectivity	_	
30-33	6997-7005	matrices	_	
30-34	7005-7006	,	_	
30-35	7007-7011	each	_	
30-36	7012-7024	representing	_	
30-37	7025-7028	the	_	
30-38	7029-7037	pairwise	_	
30-39	7038-7050	connectivity	_	
30-40	7051-7058	between	_	
30-41	7059-7062	the	_	
30-42	7063-7066	270	_	
30-43	7067-7072	nodes	_	
30-44	7073-7076	for	_	
30-45	7077-7078	a	_	
30-46	7079-7084	given	_	
30-47	7085-7092	subject	_	
30-48	7093-7096	and	_	
30-49	7097-7105	paradigm	_	
30-50	7105-7106	.	_	

#Text=To ascertain the existence of a common brain functional architecture independent of paradigm, we first performed a PCA analysis on the constructed connectivity matrices, aiming to extract the shared connectivity patterns that can explain the majority of variance across all paradigms for each individual (Fig. 1).
31-1	7107-7109	To	_	
31-2	7110-7119	ascertain	_	
31-3	7120-7123	the	_	
31-4	7124-7133	existence	_	
31-5	7134-7136	of	_	
31-6	7137-7138	a	_	
31-7	7139-7145	common	_	
31-8	7146-7151	brain	_	
31-9	7152-7162	functional	_	
31-10	7163-7175	architecture	_	
31-11	7176-7187	independent	_	
31-12	7188-7190	of	_	
31-13	7191-7199	paradigm	_	
31-14	7199-7200	,	_	
31-15	7201-7203	we	_	
31-16	7204-7209	first	_	
31-17	7210-7219	performed	_	
31-18	7220-7221	a	_	
31-19	7222-7225	PCA	_	
31-20	7226-7234	analysis	_	
31-21	7235-7237	on	_	
31-22	7238-7241	the	_	
31-23	7242-7253	constructed	_	
31-24	7254-7266	connectivity	_	
31-25	7267-7275	matrices	_	
31-26	7275-7276	,	_	
31-27	7277-7283	aiming	_	
31-28	7284-7286	to	_	
31-29	7287-7294	extract	_	
31-30	7295-7298	the	_	
31-31	7299-7305	shared	_	
31-32	7306-7318	connectivity	_	
31-33	7319-7327	patterns	_	
31-34	7328-7332	that	_	
31-35	7333-7336	can	_	
31-36	7337-7344	explain	_	
31-37	7345-7348	the	_	
31-38	7349-7357	majority	_	
31-39	7358-7360	of	_	
31-40	7361-7369	variance	_	
31-41	7370-7376	across	_	
31-42	7377-7380	all	_	
31-43	7381-7390	paradigms	_	
31-44	7391-7394	for	_	
31-45	7395-7399	each	_	
31-46	7400-7410	individual	_	
31-47	7411-7412	(	_	
31-48	7412-7415	Fig	_	
31-49	7415-7416	.	_	
31-50	7416-7417	 	_	
31-51	7417-7418	1	_	
31-52	7418-7419	)	_	
31-53	7419-7420	.	_	

#Text=We found that for all three studied groups, the first principal component (PC) scores explained ~70% of the total variance in the connectivity matrices across all five paradigms (Supplementary Fig 1A).
32-1	7421-7423	We	_	
32-2	7424-7429	found	_	
32-3	7430-7434	that	_	
32-4	7435-7438	for	_	
32-5	7439-7442	all	_	
32-6	7443-7448	three	_	
32-7	7449-7456	studied	_	
32-8	7457-7463	groups	_	
32-9	7463-7464	,	_	
32-10	7465-7468	the	_	
32-11	7469-7474	first	_	
32-12	7475-7484	principal	_	
32-13	7485-7494	component	_	
32-14	7495-7496	(	_	
32-15	7496-7498	PC	_	
32-16	7498-7499	)	_	
32-17	7500-7506	scores	_	
32-18	7507-7516	explained	_	
32-19	7517-7518	~	_	
32-20	7518-7521	70%	_	
32-21	7522-7524	of	_	
32-22	7525-7528	the	_	
32-23	7529-7534	total	_	
32-24	7535-7543	variance	_	
32-25	7544-7546	in	_	
32-26	7547-7550	the	_	
32-27	7551-7563	connectivity	_	
32-28	7564-7572	matrices	_	
32-29	7573-7579	across	_	
32-30	7580-7583	all	_	
32-31	7584-7588	five	_	
32-32	7589-7598	paradigms	_	
32-33	7599-7600	(	_	
32-34	7600-7613	Supplementary	_	
32-35	7614-7617	Fig	_	
32-36	7617-7618	 	_	
32-37	7618-7620	1A	_	
32-38	7620-7621	)	_	
32-39	7621-7622	.	_	

#Text=There were no significant differences in percent of variance explained between groups (P = 0.16, one-way ANOVA).
33-1	7623-7628	There	_	
33-2	7629-7633	were	_	
33-3	7634-7636	no	_	
33-4	7637-7648	significant	_	
33-5	7649-7660	differences	_	
33-6	7661-7663	in	_	
33-7	7664-7671	percent	_	
33-8	7672-7674	of	_	
33-9	7675-7683	variance	_	
33-10	7684-7693	explained	_	
33-11	7694-7701	between	_	
33-12	7702-7708	groups	_	
33-13	7709-7710	(	_	
33-14	7710-7711	P	_	
33-15	7712-7713	=	_	
33-16	7714-7718	0.16	_	
33-17	7718-7719	,	_	
33-18	7720-7727	one-way	_	
33-19	7728-7733	ANOVA	_	
33-20	7733-7734	)	_	
33-21	7734-7735	.	_	

#Text=In addition, when examining each paradigm separately, we found that the resting state, working memory, episodic memory encoding, and emotional face matching paradigms showed similar factor loadings on the first PCs, while the episodic memory retrieval paradigm had a slightly lower loading, suggesting a relatively smaller contribution of the memory retrieval paradigm to the first PCs compared with other paradigms.
34-1	7736-7738	In	_	
34-2	7739-7747	addition	_	
34-3	7747-7748	,	_	
34-4	7749-7753	when	_	
34-5	7754-7763	examining	_	
34-6	7764-7768	each	_	
34-7	7769-7777	paradigm	_	
34-8	7778-7788	separately	_	
34-9	7788-7789	,	_	
34-10	7790-7792	we	_	
34-11	7793-7798	found	_	
34-12	7799-7803	that	_	
34-13	7804-7807	the	_	
34-14	7808-7815	resting	_	
34-15	7816-7821	state	_	
34-16	7821-7822	,	_	
34-17	7823-7830	working	_	
34-18	7831-7837	memory	_	
34-19	7837-7838	,	_	
34-20	7839-7847	episodic	_	
34-21	7848-7854	memory	_	
34-22	7855-7863	encoding	_	
34-23	7863-7864	,	_	
34-24	7865-7868	and	_	
34-25	7869-7878	emotional	_	
34-26	7879-7883	face	_	
34-27	7884-7892	matching	_	
34-28	7893-7902	paradigms	_	
34-29	7903-7909	showed	_	
34-30	7910-7917	similar	_	
34-31	7918-7924	factor	_	
34-32	7925-7933	loadings	_	
34-33	7934-7936	on	_	
34-34	7937-7940	the	_	
34-35	7941-7946	first	_	
34-36	7947-7950	PCs	_	
34-37	7950-7951	,	_	
34-38	7952-7957	while	_	
34-39	7958-7961	the	_	
34-40	7962-7970	episodic	_	
34-41	7971-7977	memory	_	
34-42	7978-7987	retrieval	_	
34-43	7988-7996	paradigm	_	
34-44	7997-8000	had	_	
34-45	8001-8002	a	_	
34-46	8003-8011	slightly	_	
34-47	8012-8017	lower	_	
34-48	8018-8025	loading	_	
34-49	8025-8026	,	_	
34-50	8027-8037	suggesting	_	
34-51	8038-8039	a	_	
34-52	8040-8050	relatively	_	
34-53	8051-8058	smaller	_	
34-54	8059-8071	contribution	_	
34-55	8072-8074	of	_	
34-56	8075-8078	the	_	
34-57	8079-8085	memory	_	
34-58	8086-8095	retrieval	_	
34-59	8096-8104	paradigm	_	
34-60	8105-8107	to	_	
34-61	8108-8111	the	_	
34-62	8112-8117	first	_	
34-63	8118-8121	PCs	_	
34-64	8122-8130	compared	_	
34-65	8131-8135	with	_	
34-66	8136-8141	other	_	
34-67	8142-8151	paradigms	_	
34-68	8151-8152	.	_	

#Text=However, no significant group differences were found in factor loadings for each of the paradigms (P > 0.44, one-way ANOVA, Supplementary Fig 1B), suggesting that all three groups had paradigm-wise similar contributions to the first PC.
35-1	8153-8160	However	_	
35-2	8160-8161	,	_	
35-3	8162-8164	no	_	
35-4	8165-8176	significant	_	
35-5	8177-8182	group	_	
35-6	8183-8194	differences	_	
35-7	8195-8199	were	_	
35-8	8200-8205	found	_	
35-9	8206-8208	in	_	
35-10	8209-8215	factor	_	
35-11	8216-8224	loadings	_	
35-12	8225-8228	for	_	
35-13	8229-8233	each	_	
35-14	8234-8236	of	_	
35-15	8237-8240	the	_	
35-16	8241-8250	paradigms	_	
35-17	8251-8252	(	_	
35-18	8252-8253	P	_	
35-19	8254-8255	>	_	
35-20	8256-8260	0.44	_	
35-21	8260-8261	,	_	
35-22	8262-8269	one-way	_	
35-23	8270-8275	ANOVA	_	
35-24	8275-8276	,	_	
35-25	8277-8290	Supplementary	_	
35-26	8291-8294	Fig	_	
35-27	8294-8295	 	_	
35-28	8295-8297	1B	_	
35-29	8297-8298	)	_	
35-30	8298-8299	,	_	
35-31	8300-8310	suggesting	_	
35-32	8311-8315	that	_	
35-33	8316-8319	all	_	
35-34	8320-8325	three	_	
35-35	8326-8332	groups	_	
35-36	8333-8336	had	_	
35-37	8337-8350	paradigm-wise	_	
35-38	8351-8358	similar	_	
35-39	8359-8372	contributions	_	
35-40	8373-8375	to	_	
35-41	8376-8379	the	_	
35-42	8380-8385	first	_	
35-43	8386-8388	PC	_	
35-44	8388-8389	.	_	

#Text=NBS for the first PCs in the NAPLS-2 data
#Text=Network alteration observed in the NAPLS-2 data. a The identified network with higher connectivity in converters and non-converters compared with controls from the NBS analysis.
36-1	8390-8393	NBS	_	
36-2	8394-8397	for	_	
36-3	8398-8401	the	_	
36-4	8402-8407	first	_	
36-5	8408-8411	PCs	_	
36-6	8412-8414	in	_	
36-7	8415-8418	the	_	
36-8	8419-8424	NAPLS	_	
36-9	8424-8425	-	_	
36-10	8425-8426	2	_	
36-11	8427-8431	data	_	
36-12	8432-8439	Network	_	
36-13	8440-8450	alteration	_	
36-14	8451-8459	observed	_	
36-15	8460-8462	in	_	
36-16	8463-8466	the	_	
36-17	8467-8472	NAPLS	_	
36-18	8472-8473	-	_	
36-19	8473-8474	2	_	
36-20	8475-8479	data	_	
36-21	8479-8480	.	_	
36-22	8481-8482	a	_	
36-23	8483-8486	The	_	
36-24	8487-8497	identified	_	
36-25	8498-8505	network	_	
36-26	8506-8510	with	_	
36-27	8511-8517	higher	_	
36-28	8518-8530	connectivity	_	
36-29	8531-8533	in	_	
36-30	8534-8544	converters	_	
36-31	8545-8548	and	_	
36-32	8549-8563	non-converters	_	
36-33	8564-8572	compared	_	
36-34	8573-8577	with	_	
36-35	8578-8586	controls	_	
36-36	8587-8591	from	_	
36-37	8592-8595	the	_	
36-38	8596-8599	NBS	_	
36-39	8600-8608	analysis	_	
36-40	8608-8609	.	_	

#Text=The nodes in the network mapped to seven functional systems (SM sensorimotor, VIS visual, AUD auditory, DMN default-mode, FPN frontoparietal, ATT attentional, SC-CRB subcortical-cerebellar). b Significant linear relationship was shown for the mean cross-paradigm connectivity of the identified network between three groups, with the converter group having the highest value and the control group having the lowest.
37-1	8610-8613	The	_	
37-2	8614-8619	nodes	_	
37-3	8620-8622	in	_	
37-4	8623-8626	the	_	
37-5	8627-8634	network	_	
37-6	8635-8641	mapped	_	
37-7	8642-8644	to	_	
37-8	8645-8650	seven	_	
37-9	8651-8661	functional	_	
37-10	8662-8669	systems	_	
37-11	8670-8671	(	_	
37-12	8671-8673	SM	_	
37-13	8674-8686	sensorimotor	_	
37-14	8686-8687	,	_	
37-15	8688-8691	VIS	_	
37-16	8692-8698	visual	_	
37-17	8698-8699	,	_	
37-18	8700-8703	AUD	_	
37-19	8704-8712	auditory	_	
37-20	8712-8713	,	_	
37-21	8714-8717	DMN	_	
37-22	8718-8730	default-mode	_	
37-23	8730-8731	,	_	
37-24	8732-8735	FPN	_	
37-25	8736-8750	frontoparietal	_	
37-26	8750-8751	,	_	
37-27	8752-8755	ATT	_	
37-28	8756-8767	attentional	_	
37-29	8767-8768	,	_	
37-30	8769-8775	SC-CRB	_	
37-31	8776-8798	subcortical-cerebellar	_	
37-32	8798-8799	)	_	
37-33	8799-8800	.	_	
37-34	8801-8802	b	_	
37-35	8803-8814	Significant	_	
37-36	8815-8821	linear	_	
37-37	8822-8834	relationship	_	
37-38	8835-8838	was	_	
37-39	8839-8844	shown	_	
37-40	8845-8848	for	_	
37-41	8849-8852	the	_	
37-42	8853-8857	mean	_	
37-43	8858-8872	cross-paradigm	_	
37-44	8873-8885	connectivity	_	
37-45	8886-8888	of	_	
37-46	8889-8892	the	_	
37-47	8893-8903	identified	_	
37-48	8904-8911	network	_	
37-49	8912-8919	between	_	
37-50	8920-8925	three	_	
37-51	8926-8932	groups	_	
37-52	8932-8933	,	_	
37-53	8934-8938	with	_	
37-54	8939-8942	the	_	
37-55	8943-8952	converter	_	
37-56	8953-8958	group	_	
37-57	8959-8965	having	_	
37-58	8966-8969	the	_	
37-59	8970-8977	highest	_	
37-60	8978-8983	value	_	
37-61	8984-8987	and	_	
37-62	8988-8991	the	_	
37-63	8992-8999	control	_	
37-64	9000-9005	group	_	
37-65	9006-9012	having	_	
37-66	9013-9016	the	_	
37-67	9017-9023	lowest	_	
37-68	9023-9024	.	_	

#Text=Note that the cross-paradigm connectivity values were defined at the PCA space, which was rescaled to be mean centered at zero.
38-1	9025-9029	Note	_	
38-2	9030-9034	that	_	
38-3	9035-9038	the	_	
38-4	9039-9053	cross-paradigm	_	
38-5	9054-9066	connectivity	_	
38-6	9067-9073	values	_	
38-7	9074-9078	were	_	
38-8	9079-9086	defined	_	
38-9	9087-9089	at	_	
38-10	9090-9093	the	_	
38-11	9094-9097	PCA	_	
38-12	9098-9103	space	_	
38-13	9103-9104	,	_	
38-14	9105-9110	which	_	
38-15	9111-9114	was	_	
38-16	9115-9123	rescaled	_	
38-17	9124-9126	to	_	
38-18	9127-9129	be	_	
38-19	9130-9134	mean	_	
38-20	9135-9143	centered	_	
38-21	9144-9146	at	_	
38-22	9147-9151	zero	_	
38-23	9151-9152	.	_	

#Text=CHR-C converters, CHR-NC non-converters, HC healthy controls. c The functional connectivity strength of the identified network in the original connectivity matrices for three groups.
39-1	9153-9158	CHR-C	_	
39-2	9159-9169	converters	_	
39-3	9169-9170	,	_	
39-4	9171-9177	CHR-NC	_	
39-5	9178-9192	non-converters	_	
39-6	9192-9193	,	_	
39-7	9194-9196	HC	_	
39-8	9197-9204	healthy	_	
39-9	9205-9213	controls	_	
39-10	9213-9214	.	_	
39-11	9215-9216	c	_	
39-12	9217-9220	The	_	
39-13	9221-9231	functional	_	
39-14	9232-9244	connectivity	_	
39-15	9245-9253	strength	_	
39-16	9254-9256	of	_	
39-17	9257-9260	the	_	
39-18	9261-9271	identified	_	
39-19	9272-9279	network	_	
39-20	9280-9282	in	_	
39-21	9283-9286	the	_	
39-22	9287-9295	original	_	
39-23	9296-9308	connectivity	_	
39-24	9309-9317	matrices	_	
39-25	9318-9321	for	_	
39-26	9322-9327	three	_	
39-27	9328-9334	groups	_	
39-28	9334-9335	.	_	

#Text=Significant effects were shown for all five paradigms (RS resting state, WM working memory, EMenc episodic memory encoding, EMret episodic memory retrieval, FM emotional face matching). d The mean cross-paradigm connectivity of the network was significantly correlated with the SOPS disorganization scores in subjects at clinical high risk but not in healthy controls. e The mean cross-paradigm connectivity of the network significantly predicted time to conversion to psychosis among converters.
40-1	9336-9347	Significant	_	
40-2	9348-9355	effects	_	
40-3	9356-9360	were	_	
40-4	9361-9366	shown	_	
40-5	9367-9370	for	_	
40-6	9371-9374	all	_	
40-7	9375-9379	five	_	
40-8	9380-9389	paradigms	_	
40-9	9390-9391	(	_	
40-10	9391-9393	RS	_	
40-11	9394-9401	resting	_	
40-12	9402-9407	state	_	
40-13	9407-9408	,	_	
40-14	9409-9411	WM	_	
40-15	9412-9419	working	_	
40-16	9420-9426	memory	_	
40-17	9426-9427	,	_	
40-18	9428-9433	EMenc	_	
40-19	9434-9442	episodic	_	
40-20	9443-9449	memory	_	
40-21	9450-9458	encoding	_	
40-22	9458-9459	,	_	
40-23	9460-9465	EMret	_	
40-24	9466-9474	episodic	_	
40-25	9475-9481	memory	_	
40-26	9482-9491	retrieval	_	
40-27	9491-9492	,	_	
40-28	9493-9495	FM	_	
40-29	9496-9505	emotional	_	
40-30	9506-9510	face	_	
40-31	9511-9519	matching	_	
40-32	9519-9520	)	_	
40-33	9520-9521	.	_	
40-34	9522-9523	d	_	
40-35	9524-9527	The	_	
40-36	9528-9532	mean	_	
40-37	9533-9547	cross-paradigm	_	
40-38	9548-9560	connectivity	_	
40-39	9561-9563	of	_	
40-40	9564-9567	the	_	
40-41	9568-9575	network	_	
40-42	9576-9579	was	_	
40-43	9580-9593	significantly	_	
40-44	9594-9604	correlated	_	
40-45	9605-9609	with	_	
40-46	9610-9613	the	_	
40-47	9614-9618	SOPS	_	
40-48	9619-9634	disorganization	_	
40-49	9635-9641	scores	_	
40-50	9642-9644	in	_	
40-51	9645-9653	subjects	_	
40-52	9654-9656	at	_	
40-53	9657-9665	clinical	_	
40-54	9666-9670	high	_	
40-55	9671-9675	risk	_	
40-56	9676-9679	but	_	
40-57	9680-9683	not	_	
40-58	9684-9686	in	_	
40-59	9687-9694	healthy	_	
40-60	9695-9703	controls	_	
40-61	9703-9704	.	_	
40-62	9705-9706	e	_	
40-63	9707-9710	The	_	
40-64	9711-9715	mean	_	
40-65	9716-9730	cross-paradigm	_	
40-66	9731-9743	connectivity	_	
40-67	9744-9746	of	_	
40-68	9747-9750	the	_	
40-69	9751-9758	network	_	
40-70	9759-9772	significantly	_	
40-71	9773-9782	predicted	_	
40-72	9783-9787	time	_	
40-73	9788-9790	to	_	
40-74	9791-9801	conversion	_	
40-75	9802-9804	to	_	
40-76	9805-9814	psychosis	_	
40-77	9815-9820	among	_	
40-78	9821-9831	converters	_	
40-79	9831-9832	.	_	

#Text=Error bars indicate standard errors
#Text=After confirming that the first PC matrices can explain the majority of variance across paradigms and thus can serve as a “state-independent” trait matrix for each individual, we next considered whether there were any connectivity changes within these PC matrices between groups.
41-1	9833-9838	Error	_	
41-2	9839-9843	bars	_	
41-3	9844-9852	indicate	_	
41-4	9853-9861	standard	_	
41-5	9862-9868	errors	_	
41-6	9869-9874	After	_	
41-7	9875-9885	confirming	_	
41-8	9886-9890	that	_	
41-9	9891-9894	the	_	
41-10	9895-9900	first	_	
41-11	9901-9903	PC	_	
41-12	9904-9912	matrices	_	
41-13	9913-9916	can	_	
41-14	9917-9924	explain	_	
41-15	9925-9928	the	_	
41-16	9929-9937	majority	_	
41-17	9938-9940	of	_	
41-18	9941-9949	variance	_	
41-19	9950-9956	across	_	
41-20	9957-9966	paradigms	_	
41-21	9967-9970	and	_	
41-22	9971-9975	thus	_	
41-23	9976-9979	can	_	
41-24	9980-9985	serve	_	
41-25	9986-9988	as	_	
41-26	9989-9990	a	_	
41-27	9991-9992	“	_	
41-28	9992-10009	state-independent	_	
41-29	10009-10010	”	_	
41-30	10011-10016	trait	_	
41-31	10017-10023	matrix	_	
41-32	10024-10027	for	_	
41-33	10028-10032	each	_	
41-34	10033-10043	individual	_	
41-35	10043-10044	,	_	
41-36	10045-10047	we	_	
41-37	10048-10052	next	_	
41-38	10053-10063	considered	_	
41-39	10064-10071	whether	_	
41-40	10072-10077	there	_	
41-41	10078-10082	were	_	
41-42	10083-10086	any	_	
41-43	10087-10099	connectivity	_	
41-44	10100-10107	changes	_	
41-45	10108-10114	within	_	
41-46	10115-10120	these	_	
41-47	10121-10123	PC	_	
41-48	10124-10132	matrices	_	
41-49	10133-10140	between	_	
41-50	10141-10147	groups	_	
41-51	10147-10148	.	_	

#Text=Importantly, although not a direct measure of “functional connectivity” as defined traditionally using correlation-based methods, the values in a PC matrix do reflect the strength of functional connectivity shared across all paradigms for a given individual.
42-1	10149-10160	Importantly	_	
42-2	10160-10161	,	_	
42-3	10162-10170	although	_	
42-4	10171-10174	not	_	
42-5	10175-10176	a	_	
42-6	10177-10183	direct	_	
42-7	10184-10191	measure	_	
42-8	10192-10194	of	_	
42-9	10195-10196	“	_	
42-10	10196-10206	functional	_	
42-11	10207-10219	connectivity	_	
42-12	10219-10220	”	_	
42-13	10221-10223	as	_	
42-14	10224-10231	defined	_	
42-15	10232-10245	traditionally	_	
42-16	10246-10251	using	_	
42-17	10252-10269	correlation-based	_	
42-18	10270-10277	methods	_	
42-19	10277-10278	,	_	
42-20	10279-10282	the	_	
42-21	10283-10289	values	_	
42-22	10290-10292	in	_	
42-23	10293-10294	a	_	
42-24	10295-10297	PC	_	
42-25	10298-10304	matrix	_	
42-26	10305-10307	do	_	
42-27	10308-10315	reflect	_	
42-28	10316-10319	the	_	
42-29	10320-10328	strength	_	
42-30	10329-10331	of	_	
42-31	10332-10342	functional	_	
42-32	10343-10355	connectivity	_	
42-33	10356-10362	shared	_	
42-34	10363-10369	across	_	
42-35	10370-10373	all	_	
42-36	10374-10383	paradigms	_	
42-37	10384-10387	for	_	
42-38	10388-10389	a	_	
42-39	10390-10395	given	_	
42-40	10396-10406	individual	_	
42-41	10406-10407	.	_	

#Text=Here we termed these values as measures of “Cross-paradigm connectivity”, in order to differentiate them from “functional connectivity” in a more typical context.
43-1	10408-10412	Here	_	
43-2	10413-10415	we	_	
43-3	10416-10422	termed	_	
43-4	10423-10428	these	_	
43-5	10429-10435	values	_	
43-6	10436-10438	as	_	
43-7	10439-10447	measures	_	
43-8	10448-10450	of	_	
43-9	10451-10452	“	_	
43-10	10452-10466	Cross-paradigm	_	
43-11	10467-10479	connectivity	_	
43-12	10479-10480	”	_	
43-13	10480-10481	,	_	
43-14	10482-10484	in	_	
43-15	10485-10490	order	_	
43-16	10491-10493	to	_	
43-17	10494-10507	differentiate	_	
43-18	10508-10512	them	_	
43-19	10513-10517	from	_	
43-20	10518-10519	“	_	
43-21	10519-10529	functional	_	
43-22	10530-10542	connectivity	_	
43-23	10542-10543	”	_	
43-24	10544-10546	in	_	
43-25	10547-10548	a	_	
43-26	10549-10553	more	_	
43-27	10554-10561	typical	_	
43-28	10562-10569	context	_	
43-29	10569-10570	.	_	

#Text=Here, NBS was employed to examine this question following established procedures used in prior studies.
44-1	10571-10575	Here	_	
44-2	10575-10576	,	_	
44-3	10577-10580	NBS	_	
44-4	10581-10584	was	_	
44-5	10585-10593	employed	_	
44-6	10594-10596	to	_	
44-7	10597-10604	examine	_	
44-8	10605-10609	this	_	
44-9	10610-10618	question	_	
44-10	10619-10628	following	_	
44-11	10629-10640	established	_	
44-12	10641-10651	procedures	_	
44-13	10652-10656	used	_	
44-14	10657-10659	in	_	
44-15	10660-10665	prior	_	
44-16	10666-10673	studies	_	
44-17	10673-10674	.	_	

#Text=Notably, in addition to variance from neural signals, the first PC matrices derived from the PCA analysis could also capture signals associated with subjects’ demographic features, head motion, and/or medication status, since the variations related to these variables are also consistently present across paradigms.
45-1	10675-10682	Notably	_	
45-2	10682-10683	,	_	
45-3	10684-10686	in	_	
45-4	10687-10695	addition	_	
45-5	10696-10698	to	_	
45-6	10699-10707	variance	_	
45-7	10708-10712	from	_	
45-8	10713-10719	neural	_	
45-9	10720-10727	signals	_	
45-10	10727-10728	,	_	
45-11	10729-10732	the	_	
45-12	10733-10738	first	_	
45-13	10739-10741	PC	_	
45-14	10742-10750	matrices	_	
45-15	10751-10758	derived	_	
45-16	10759-10763	from	_	
45-17	10764-10767	the	_	
45-18	10768-10771	PCA	_	
45-19	10772-10780	analysis	_	
45-20	10781-10786	could	_	
45-21	10787-10791	also	_	
45-22	10792-10799	capture	_	
45-23	10800-10807	signals	_	
45-24	10808-10818	associated	_	
45-25	10819-10823	with	_	
45-26	10824-10832	subjects	_	
45-27	10832-10833	’	_	
45-28	10834-10845	demographic	_	
45-29	10846-10854	features	_	
45-30	10854-10855	,	_	
45-31	10856-10860	head	_	
45-32	10861-10867	motion	_	
45-33	10867-10868	,	_	
45-34	10869-10872	and	_	
45-35	10872-10873	/	_	
45-36	10873-10875	or	_	
45-37	10876-10886	medication	_	
45-38	10887-10893	status	_	
45-39	10893-10894	,	_	
45-40	10895-10900	since	_	
45-41	10901-10904	the	_	
45-42	10905-10915	variations	_	
45-43	10916-10923	related	_	
45-44	10924-10926	to	_	
45-45	10927-10932	these	_	
45-46	10933-10942	variables	_	
45-47	10943-10946	are	_	
45-48	10947-10951	also	_	
45-49	10952-10964	consistently	_	
45-50	10965-10972	present	_	
45-51	10973-10979	across	_	
45-52	10980-10989	paradigms	_	
45-53	10989-10990	.	_	

#Text=To mitigate these confounding influences, we included age, sex, IQ, site, mean frame-wise displacement (FD) across all paradigms, and antipsychotic dosage as nuisance regressors in the NBS analysis.
46-1	10991-10993	To	_	
46-2	10994-11002	mitigate	_	
46-3	11003-11008	these	_	
46-4	11009-11020	confounding	_	
46-5	11021-11031	influences	_	
46-6	11031-11032	,	_	
46-7	11033-11035	we	_	
46-8	11036-11044	included	_	
46-9	11045-11048	age	_	
46-10	11048-11049	,	_	
46-11	11050-11053	sex	_	
46-12	11053-11054	,	_	
46-13	11055-11057	IQ	_	
46-14	11057-11058	,	_	
46-15	11059-11063	site	_	
46-16	11063-11064	,	_	
46-17	11065-11069	mean	_	
46-18	11070-11080	frame-wise	_	
46-19	11081-11093	displacement	_	
46-20	11094-11095	(	_	
46-21	11095-11097	FD	_	
46-22	11097-11098	)	_	
46-23	11099-11105	across	_	
46-24	11106-11109	all	_	
46-25	11110-11119	paradigms	_	
46-26	11119-11120	,	_	
46-27	11121-11124	and	_	
46-28	11125-11138	antipsychotic	_	
46-29	11139-11145	dosage	_	
46-30	11146-11148	as	_	
46-31	11149-11157	nuisance	_	
46-32	11158-11168	regressors	_	
46-33	11169-11171	in	_	
46-34	11172-11175	the	_	
46-35	11176-11179	NBS	_	
46-36	11180-11188	analysis	_	
46-37	11188-11189	.	_	

#Text=After controlling for these variables, we observed a highly significant group effect on a connected network including a total of 84 edges linking pairs of 62 nodes covering multiple brain regions in the cerebellum, thalamus, and cerebral cortex (PFWE = 0.005 from 10,000 permutations, Fig. 2a).
47-1	11190-11195	After	_	
47-2	11196-11207	controlling	_	
47-3	11208-11211	for	_	
47-4	11212-11217	these	_	
47-5	11218-11227	variables	_	
47-6	11227-11228	,	_	
47-7	11229-11231	we	_	
47-8	11232-11240	observed	_	
47-9	11241-11242	a	_	
47-10	11243-11249	highly	_	
47-11	11250-11261	significant	_	
47-12	11262-11267	group	_	
47-13	11268-11274	effect	_	
47-14	11275-11277	on	_	
47-15	11278-11279	a	_	
47-16	11280-11289	connected	_	
47-17	11290-11297	network	_	
47-18	11298-11307	including	_	
47-19	11308-11309	a	_	
47-20	11310-11315	total	_	
47-21	11316-11318	of	_	
47-22	11319-11321	84	_	
47-23	11322-11327	edges	_	
47-24	11328-11335	linking	_	
47-25	11336-11341	pairs	_	
47-26	11342-11344	of	_	
47-27	11345-11347	62	_	
47-28	11348-11353	nodes	_	
47-29	11354-11362	covering	_	
47-30	11363-11371	multiple	_	
47-31	11372-11377	brain	_	
47-32	11378-11385	regions	_	
47-33	11386-11388	in	_	
47-34	11389-11392	the	_	
47-35	11393-11403	cerebellum	_	
47-36	11403-11404	,	_	
47-37	11405-11413	thalamus	_	
47-38	11413-11414	,	_	
47-39	11415-11418	and	_	
47-40	11419-11427	cerebral	_	
47-41	11428-11434	cortex	_	
47-42	11435-11436	(	_	
47-43	11436-11440	PFWE	_	
47-44	11441-11442	=	_	
47-45	11443-11448	0.005	_	
47-46	11449-11453	from	_	
47-47	11454-11460	10,000	_	
47-48	11461-11473	permutations	_	
47-49	11473-11474	,	_	
47-50	11475-11478	Fig	_	
47-51	11478-11479	.	_	
47-52	11479-11480	 	_	
47-53	11480-11482	2a	_	
47-54	11482-11483	)	_	
47-55	11483-11484	.	_	

#Text=In particular, the regions in the identified network belonged to seven functional systems as previously defined: subcortical-cerebellar (e.g., thalamus, putamen, cerebellum), sensorimotor (e.g., pre- and postcentral gyri, supplementary motor area), visual (e.g., middle and inferior occipital gyri, inferior temporal gyrus, lingual gyrus, fusiform gyrus), auditory (e.g., rolandic operculum), default-mode (e.g., medial prefrontal gyrus, angular gyrus, precuneous, middle temporal gyrus), frontoparietal (e.g., superior and middle frontal gyri), and attentional (e.g., superior and middle temporal gyri).
48-1	11485-11487	In	_	
48-2	11488-11498	particular	_	
48-3	11498-11499	,	_	
48-4	11500-11503	the	_	
48-5	11504-11511	regions	_	
48-6	11512-11514	in	_	
48-7	11515-11518	the	_	
48-8	11519-11529	identified	_	
48-9	11530-11537	network	_	
48-10	11538-11546	belonged	_	
48-11	11547-11549	to	_	
48-12	11550-11555	seven	_	
48-13	11556-11566	functional	_	
48-14	11567-11574	systems	_	
48-15	11575-11577	as	_	
48-16	11578-11588	previously	_	
48-17	11589-11596	defined	_	
48-18	11596-11597	:	_	
48-19	11598-11620	subcortical-cerebellar	_	
48-20	11621-11622	(	_	
48-21	11622-11625	e.g	_	
48-22	11625-11626	.	_	
48-23	11626-11627	,	_	
48-24	11628-11636	thalamus	_	
48-25	11636-11637	,	_	
48-26	11638-11645	putamen	_	
48-27	11645-11646	,	_	
48-28	11647-11657	cerebellum	_	
48-29	11657-11658	)	_	
48-30	11658-11659	,	_	
48-31	11660-11672	sensorimotor	_	
48-32	11673-11674	(	_	
48-33	11674-11677	e.g	_	
48-34	11677-11678	.	_	
48-35	11678-11679	,	_	
48-36	11680-11683	pre	_	
48-37	11683-11684	-	_	
48-38	11685-11688	and	_	
48-39	11689-11700	postcentral	_	
48-40	11701-11705	gyri	_	
48-41	11705-11706	,	_	
48-42	11707-11720	supplementary	_	
48-43	11721-11726	motor	_	
48-44	11727-11731	area	_	
48-45	11731-11732	)	_	
48-46	11732-11733	,	_	
48-47	11734-11740	visual	_	
48-48	11741-11742	(	_	
48-49	11742-11745	e.g	_	
48-50	11745-11746	.	_	
48-51	11746-11747	,	_	
48-52	11748-11754	middle	_	
48-53	11755-11758	and	_	
48-54	11759-11767	inferior	_	
48-55	11768-11777	occipital	_	
48-56	11778-11782	gyri	_	
48-57	11782-11783	,	_	
48-58	11784-11792	inferior	_	
48-59	11793-11801	temporal	_	
48-60	11802-11807	gyrus	_	
48-61	11807-11808	,	_	
48-62	11809-11816	lingual	_	
48-63	11817-11822	gyrus	_	
48-64	11822-11823	,	_	
48-65	11824-11832	fusiform	_	
48-66	11833-11838	gyrus	_	
48-67	11838-11839	)	_	
48-68	11839-11840	,	_	
48-69	11841-11849	auditory	_	
48-70	11850-11851	(	_	
48-71	11851-11854	e.g	_	
48-72	11854-11855	.	_	
48-73	11855-11856	,	_	
48-74	11857-11865	rolandic	_	
48-75	11866-11875	operculum	_	
48-76	11875-11876	)	_	
48-77	11876-11877	,	_	
48-78	11878-11890	default-mode	_	
48-79	11891-11892	(	_	
48-80	11892-11895	e.g	_	
48-81	11895-11896	.	_	
48-82	11896-11897	,	_	
48-83	11898-11904	medial	_	
48-84	11905-11915	prefrontal	_	
48-85	11916-11921	gyrus	_	
48-86	11921-11922	,	_	
48-87	11923-11930	angular	_	
48-88	11931-11936	gyrus	_	
48-89	11936-11937	,	_	
48-90	11938-11948	precuneous	_	
48-91	11948-11949	,	_	
48-92	11950-11956	middle	_	
48-93	11957-11965	temporal	_	
48-94	11966-11971	gyrus	_	
48-95	11971-11972	)	_	
48-96	11972-11973	,	_	
48-97	11974-11988	frontoparietal	_	
48-98	11989-11990	(	_	
48-99	11990-11993	e.g	_	
48-100	11993-11994	.	_	
48-101	11994-11995	,	_	
48-102	11996-12004	superior	_	
48-103	12005-12008	and	_	
48-104	12009-12015	middle	_	
48-105	12016-12023	frontal	_	
48-106	12024-12028	gyri	_	
48-107	12028-12029	)	_	
48-108	12029-12030	,	_	
48-109	12031-12034	and	_	
48-110	12035-12046	attentional	_	
48-111	12047-12048	(	_	
48-112	12048-12051	e.g	_	
48-113	12051-12052	.	_	
48-114	12052-12053	,	_	
48-115	12054-12062	superior	_	
48-116	12063-12066	and	_	
48-117	12067-12073	middle	_	
48-118	12074-12082	temporal	_	
48-119	12083-12087	gyri	_	
48-120	12087-12088	)	_	
48-121	12088-12089	.	_	

#Text=The PC scores representing the cross-paradigm connectivity between these regions were significantly higher in subjects at CHR compared with controls, an effect that was significantly more pronounced in those who later converted to psychosis than non-converters (Fig. 2b), suggesting a paradigm-independent connectivity alteration that precedes onset of psychosis.
49-1	12090-12093	The	_	
49-2	12094-12096	PC	_	
49-3	12097-12103	scores	_	
49-4	12104-12116	representing	_	
49-5	12117-12120	the	_	
49-6	12121-12135	cross-paradigm	_	
49-7	12136-12148	connectivity	_	
49-8	12149-12156	between	_	
49-9	12157-12162	these	_	
49-10	12163-12170	regions	_	
49-11	12171-12175	were	_	
49-12	12176-12189	significantly	_	
49-13	12190-12196	higher	_	
49-14	12197-12199	in	_	
49-15	12200-12208	subjects	_	
49-16	12209-12211	at	_	
49-17	12212-12215	CHR	_	
49-18	12216-12224	compared	_	
49-19	12225-12229	with	_	
49-20	12230-12238	controls	_	
49-21	12238-12239	,	_	
49-22	12240-12242	an	_	
49-23	12243-12249	effect	_	
49-24	12250-12254	that	_	
49-25	12255-12258	was	_	
49-26	12259-12272	significantly	_	
49-27	12273-12277	more	_	
49-28	12278-12288	pronounced	_	
49-29	12289-12291	in	_	
49-30	12292-12297	those	_	
49-31	12298-12301	who	_	
49-32	12302-12307	later	_	
49-33	12308-12317	converted	_	
49-34	12318-12320	to	_	
49-35	12321-12330	psychosis	_	
49-36	12331-12335	than	_	
49-37	12336-12350	non-converters	_	
49-38	12351-12352	(	_	
49-39	12352-12355	Fig	_	
49-40	12355-12356	.	_	
49-41	12356-12357	 	_	
49-42	12357-12359	2b	_	
49-43	12359-12360	)	_	
49-44	12360-12361	,	_	
49-45	12362-12372	suggesting	_	
49-46	12373-12374	a	_	
49-47	12375-12395	paradigm-independent	_	
49-48	12396-12408	connectivity	_	
49-49	12409-12419	alteration	_	
49-50	12420-12424	that	_	
49-51	12425-12433	precedes	_	
49-52	12434-12439	onset	_	
49-53	12440-12442	of	_	
49-54	12443-12452	psychosis	_	
49-55	12452-12453	.	_	

#Text=To better interpret the NBS findings, we further investigated two questions.
50-1	12454-12456	To	_	
50-2	12457-12463	better	_	
50-3	12464-12473	interpret	_	
50-4	12474-12477	the	_	
50-5	12478-12481	NBS	_	
50-6	12482-12490	findings	_	
50-7	12490-12491	,	_	
50-8	12492-12494	we	_	
50-9	12495-12502	further	_	
50-10	12503-12515	investigated	_	
50-11	12516-12519	two	_	
50-12	12520-12529	questions	_	
50-13	12529-12530	.	_	

#Text=First, since the signs of values in the PC matrices have been rescaled and might not be the same as in the original correlation matrices, whether the higher cross-paradigm connectivity observed in converters indeed reflected hyperconnectivity was unclear.
51-1	12531-12536	First	_	
51-2	12536-12537	,	_	
51-3	12538-12543	since	_	
51-4	12544-12547	the	_	
51-5	12548-12553	signs	_	
51-6	12554-12556	of	_	
51-7	12557-12563	values	_	
51-8	12564-12566	in	_	
51-9	12567-12570	the	_	
51-10	12571-12573	PC	_	
51-11	12574-12582	matrices	_	
51-12	12583-12587	have	_	
51-13	12588-12592	been	_	
51-14	12593-12601	rescaled	_	
51-15	12602-12605	and	_	
51-16	12606-12611	might	_	
51-17	12612-12615	not	_	
51-18	12616-12618	be	_	
51-19	12619-12622	the	_	
51-20	12623-12627	same	_	
51-21	12628-12630	as	_	
51-22	12631-12633	in	_	
51-23	12634-12637	the	_	
51-24	12638-12646	original	_	
51-25	12647-12658	correlation	_	
51-26	12659-12667	matrices	_	
51-27	12667-12668	,	_	
51-28	12669-12676	whether	_	
51-29	12677-12680	the	_	
51-30	12681-12687	higher	_	
51-31	12688-12702	cross-paradigm	_	
51-32	12703-12715	connectivity	_	
51-33	12716-12724	observed	_	
51-34	12725-12727	in	_	
51-35	12728-12738	converters	_	
51-36	12739-12745	indeed	_	
51-37	12746-12755	reflected	_	
51-38	12756-12773	hyperconnectivity	_	
51-39	12774-12777	was	_	
51-40	12778-12785	unclear	_	
51-41	12785-12786	.	_	

#Text=Second, it was unknown whether the detected effect was driven by any particular paradigms.
52-1	12787-12793	Second	_	
52-2	12793-12794	,	_	
52-3	12795-12797	it	_	
52-4	12798-12801	was	_	
52-5	12802-12809	unknown	_	
52-6	12810-12817	whether	_	
52-7	12818-12821	the	_	
52-8	12822-12830	detected	_	
52-9	12831-12837	effect	_	
52-10	12838-12841	was	_	
52-11	12842-12848	driven	_	
52-12	12849-12851	by	_	
52-13	12852-12855	any	_	
52-14	12856-12866	particular	_	
52-15	12867-12876	paradigms	_	
52-16	12876-12877	.	_	

#Text=To answer these questions, the entire identified network was extracted from the original connectivity matrices for each paradigm and averaged across all edges in this network.
53-1	12878-12880	To	_	
53-2	12881-12887	answer	_	
53-3	12888-12893	these	_	
53-4	12894-12903	questions	_	
53-5	12903-12904	,	_	
53-6	12905-12908	the	_	
53-7	12909-12915	entire	_	
53-8	12916-12926	identified	_	
53-9	12927-12934	network	_	
53-10	12935-12938	was	_	
53-11	12939-12948	extracted	_	
53-12	12949-12953	from	_	
53-13	12954-12957	the	_	
53-14	12958-12966	original	_	
53-15	12967-12979	connectivity	_	
53-16	12980-12988	matrices	_	
53-17	12989-12992	for	_	
53-18	12993-12997	each	_	
53-19	12998-13006	paradigm	_	
53-20	13007-13010	and	_	
53-21	13011-13019	averaged	_	
53-22	13020-13026	across	_	
53-23	13027-13030	all	_	
53-24	13031-13036	edges	_	
53-25	13037-13039	in	_	
53-26	13040-13044	this	_	
53-27	13045-13052	network	_	
53-28	13052-13053	.	_	

#Text=We found a significant group effect for all five paradigms on the mean functional connectivity of this network (PFWE < 0.04, one-way ANCOVA, Fig. 2c).
54-1	13054-13056	We	_	
54-2	13057-13062	found	_	
54-3	13063-13064	a	_	
54-4	13065-13076	significant	_	
54-5	13077-13082	group	_	
54-6	13083-13089	effect	_	
54-7	13090-13093	for	_	
54-8	13094-13097	all	_	
54-9	13098-13102	five	_	
54-10	13103-13112	paradigms	_	
54-11	13113-13115	on	_	
54-12	13116-13119	the	_	
54-13	13120-13124	mean	_	
54-14	13125-13135	functional	_	
54-15	13136-13148	connectivity	_	
54-16	13149-13151	of	_	
54-17	13152-13156	this	_	
54-18	13157-13164	network	_	
54-19	13165-13166	(	_	
54-20	13166-13170	PFWE	_	
54-21	13171-13172	<	_	
54-22	13173-13177	0.04	_	
54-23	13177-13178	,	_	
54-24	13179-13186	one-way	_	
54-25	13187-13193	ANCOVA	_	
54-26	13193-13194	,	_	
54-27	13195-13198	Fig	_	
54-28	13198-13199	.	_	
54-29	13199-13200	 	_	
54-30	13200-13202	2c	_	
54-31	13202-13203	)	_	
54-32	13203-13204	.	_	

#Text=Similarly, the converters showed the highest connectivity, followed by the non-converters, while the control subjects had the lowest connectivity.
55-1	13205-13214	Similarly	_	
55-2	13214-13215	,	_	
55-3	13216-13219	the	_	
55-4	13220-13230	converters	_	
55-5	13231-13237	showed	_	
55-6	13238-13241	the	_	
55-7	13242-13249	highest	_	
55-8	13250-13262	connectivity	_	
55-9	13262-13263	,	_	
55-10	13264-13272	followed	_	
55-11	13273-13275	by	_	
55-12	13276-13279	the	_	
55-13	13280-13294	non-converters	_	
55-14	13294-13295	,	_	
55-15	13296-13301	while	_	
55-16	13302-13305	the	_	
55-17	13306-13313	control	_	
55-18	13314-13322	subjects	_	
55-19	13323-13326	had	_	
55-20	13327-13330	the	_	
55-21	13331-13337	lowest	_	
55-22	13338-13350	connectivity	_	
55-23	13350-13351	.	_	

#Text=In addition, the functional connectivity measures in all three groups were positive.
56-1	13352-13354	In	_	
56-2	13355-13363	addition	_	
56-3	13363-13364	,	_	
56-4	13365-13368	the	_	
56-5	13369-13379	functional	_	
56-6	13380-13392	connectivity	_	
56-7	13393-13401	measures	_	
56-8	13402-13404	in	_	
56-9	13405-13408	all	_	
56-10	13409-13414	three	_	
56-11	13415-13421	groups	_	
56-12	13422-13426	were	_	
56-13	13427-13435	positive	_	
56-14	13435-13436	.	_	

#Text=These findings suggest a cerebello–thalamo–cortical hyperconnectivity in converters that is not driven by particular paradigms but rather, present in all paradigms used in the study.
57-1	13437-13442	These	_	
57-2	13443-13451	findings	_	
57-3	13452-13459	suggest	_	
57-4	13460-13461	a	_	
57-5	13462-13488	cerebello–thalamo–cortical	_	
57-6	13489-13506	hyperconnectivity	_	
57-7	13507-13509	in	_	
57-8	13510-13520	converters	_	
57-9	13521-13525	that	_	
57-10	13526-13528	is	_	
57-11	13529-13532	not	_	
57-12	13533-13539	driven	_	
57-13	13540-13542	by	_	
57-14	13543-13553	particular	_	
57-15	13554-13563	paradigms	_	
57-16	13564-13567	but	_	
57-17	13568-13574	rather	_	
57-18	13574-13575	,	_	
57-19	13576-13583	present	_	
57-20	13584-13586	in	_	
57-21	13587-13590	all	_	
57-22	13591-13600	paradigms	_	
57-23	13601-13605	used	_	
57-24	13606-13608	in	_	
57-25	13609-13612	the	_	
57-26	13613-13618	study	_	
57-27	13618-13619	.	_	

#Text=Association with psychosis severity
#Text=To examine potential associations between the identified network alteration and the severity of psychosis symptoms, we performed Spearman rank-order correlations between the mean network cross-paradigm connectivity and the positive and disorganization scores acquired from the Scale of Prodromal Symptoms (SOPS).
58-1	13620-13631	Association	_	
58-2	13632-13636	with	_	
58-3	13637-13646	psychosis	_	
58-4	13647-13655	severity	_	
58-5	13656-13658	To	_	
58-6	13659-13666	examine	_	
58-7	13667-13676	potential	_	
58-8	13677-13689	associations	_	
58-9	13690-13697	between	_	
58-10	13698-13701	the	_	
58-11	13702-13712	identified	_	
58-12	13713-13720	network	_	
58-13	13721-13731	alteration	_	
58-14	13732-13735	and	_	
58-15	13736-13739	the	_	
58-16	13740-13748	severity	_	
58-17	13749-13751	of	_	
58-18	13752-13761	psychosis	_	
58-19	13762-13770	symptoms	_	
58-20	13770-13771	,	_	
58-21	13772-13774	we	_	
58-22	13775-13784	performed	_	
58-23	13785-13793	Spearman	_	
58-24	13794-13804	rank-order	_	
58-25	13805-13817	correlations	_	
58-26	13818-13825	between	_	
58-27	13826-13829	the	_	
58-28	13830-13834	mean	_	
58-29	13835-13842	network	_	
58-30	13843-13857	cross-paradigm	_	
58-31	13858-13870	connectivity	_	
58-32	13871-13874	and	_	
58-33	13875-13878	the	_	
58-34	13879-13887	positive	_	
58-35	13888-13891	and	_	
58-36	13892-13907	disorganization	_	
58-37	13908-13914	scores	_	
58-38	13915-13923	acquired	_	
58-39	13924-13928	from	_	
58-40	13929-13932	the	_	
58-41	13933-13938	Scale	_	
58-42	13939-13941	of	_	
58-43	13942-13951	Prodromal	_	
58-44	13952-13960	Symptoms	_	
58-45	13961-13962	(	_	
58-46	13962-13966	SOPS	_	
58-47	13966-13967	)	_	
58-48	13967-13968	.	_	

#Text=Notably, positive and disorganization symptoms are diagnostically more specific to psychosis than negative and general symptoms.
59-1	13969-13976	Notably	_	
59-2	13976-13977	,	_	
59-3	13978-13986	positive	_	
59-4	13987-13990	and	_	
59-5	13991-14006	disorganization	_	
59-6	14007-14015	symptoms	_	
59-7	14016-14019	are	_	
59-8	14020-14034	diagnostically	_	
59-9	14035-14039	more	_	
59-10	14040-14048	specific	_	
59-11	14049-14051	to	_	
59-12	14052-14061	psychosis	_	
59-13	14062-14066	than	_	
59-14	14067-14075	negative	_	
59-15	14076-14079	and	_	
59-16	14080-14087	general	_	
59-17	14088-14096	symptoms	_	
59-18	14096-14097	.	_	

#Text=We observed a significant association of the network measure with the disorganization symptoms in subjects at CHR (R = 0.17, P = 0.02, Fig. 2d) but not in healthy controls (P = 0.41).
60-1	14098-14100	We	_	
60-2	14101-14109	observed	_	
60-3	14110-14111	a	_	
60-4	14112-14123	significant	_	
60-5	14124-14135	association	_	
60-6	14136-14138	of	_	
60-7	14139-14142	the	_	
60-8	14143-14150	network	_	
60-9	14151-14158	measure	_	
60-10	14159-14163	with	_	
60-11	14164-14167	the	_	
60-12	14168-14183	disorganization	_	
60-13	14184-14192	symptoms	_	
60-14	14193-14195	in	_	
60-15	14196-14204	subjects	_	
60-16	14205-14207	at	_	
60-17	14208-14211	CHR	_	
60-18	14212-14213	(	_	
60-19	14213-14214	R	_	
60-20	14215-14216	=	_	
60-21	14217-14221	0.17	_	
60-22	14221-14222	,	_	
60-23	14223-14224	P	_	
60-24	14225-14226	=	_	
60-25	14227-14231	0.02	_	
60-26	14231-14232	,	_	
60-27	14233-14236	Fig	_	
60-28	14236-14237	.	_	
60-29	14237-14238	 	_	
60-30	14238-14240	2d	_	
60-31	14240-14241	)	_	
60-32	14242-14245	but	_	
60-33	14246-14249	not	_	
60-34	14250-14252	in	_	
60-35	14253-14260	healthy	_	
60-36	14261-14269	controls	_	
60-37	14270-14271	(	_	
60-38	14271-14272	P	_	
60-39	14273-14274	=	_	
60-40	14275-14279	0.41	_	
60-41	14279-14280	)	_	
60-42	14280-14281	.	_	

#Text=The correlation between the network measure and positive symptoms did not reach significance in either group (P > 0.12).
61-1	14282-14285	The	_	
61-2	14286-14297	correlation	_	
61-3	14298-14305	between	_	
61-4	14306-14309	the	_	
61-5	14310-14317	network	_	
61-6	14318-14325	measure	_	
61-7	14326-14329	and	_	
61-8	14330-14338	positive	_	
61-9	14339-14347	symptoms	_	
61-10	14348-14351	did	_	
61-11	14352-14355	not	_	
61-12	14356-14361	reach	_	
61-13	14362-14374	significance	_	
61-14	14375-14377	in	_	
61-15	14378-14384	either	_	
61-16	14385-14390	group	_	
61-17	14391-14392	(	_	
61-18	14392-14393	P	_	
61-19	14394-14395	>	_	
61-20	14396-14400	0.12	_	
61-21	14400-14401	)	_	
61-22	14401-14402	.	_	

#Text=These findings suggest that the observed hyperconnectivity may be related to bizarre thought and behavior in individuals with prodromal symptoms.
62-1	14403-14408	These	_	
62-2	14409-14417	findings	_	
62-3	14418-14425	suggest	_	
62-4	14426-14430	that	_	
62-5	14431-14434	the	_	
62-6	14435-14443	observed	_	
62-7	14444-14461	hyperconnectivity	_	
62-8	14462-14465	may	_	
62-9	14466-14468	be	_	
62-10	14469-14476	related	_	
62-11	14477-14479	to	_	
62-12	14480-14487	bizarre	_	
62-13	14488-14495	thought	_	
62-14	14496-14499	and	_	
62-15	14500-14508	behavior	_	
62-16	14509-14511	in	_	
62-17	14512-14523	individuals	_	
62-18	14524-14528	with	_	
62-19	14529-14538	prodromal	_	
62-20	14539-14547	symptoms	_	
62-21	14547-14548	.	_	

#Text=Association with psychosis conversion speed
#Text=We then investigated whether the observed network alteration that preceded the onset of psychosis would predict the time to conversion in CHR converters.
63-1	14549-14560	Association	_	
63-2	14561-14565	with	_	
63-3	14566-14575	psychosis	_	
63-4	14576-14586	conversion	_	
63-5	14587-14592	speed	_	
63-6	14593-14595	We	_	
63-7	14596-14600	then	_	
63-8	14601-14613	investigated	_	
63-9	14614-14621	whether	_	
63-10	14622-14625	the	_	
63-11	14626-14634	observed	_	
63-12	14635-14642	network	_	
63-13	14643-14653	alteration	_	
63-14	14654-14658	that	_	
63-15	14659-14667	preceded	_	
63-16	14668-14671	the	_	
63-17	14672-14677	onset	_	
63-18	14678-14680	of	_	
63-19	14681-14690	psychosis	_	
63-20	14691-14696	would	_	
63-21	14697-14704	predict	_	
63-22	14705-14708	the	_	
63-23	14709-14713	time	_	
63-24	14714-14716	to	_	
63-25	14717-14727	conversion	_	
63-26	14728-14730	in	_	
63-27	14731-14734	CHR	_	
63-28	14735-14745	converters	_	
63-29	14745-14746	.	_	

#Text=To that end, Spearman rank-order correlation was performed between the mean network cross-paradigm connectivity and the number of months to conversion after the baseline scan.
64-1	14747-14749	To	_	
64-2	14750-14754	that	_	
64-3	14755-14758	end	_	
64-4	14758-14759	,	_	
64-5	14760-14768	Spearman	_	
64-6	14769-14779	rank-order	_	
64-7	14780-14791	correlation	_	
64-8	14792-14795	was	_	
64-9	14796-14805	performed	_	
64-10	14806-14813	between	_	
64-11	14814-14817	the	_	
64-12	14818-14822	mean	_	
64-13	14823-14830	network	_	
64-14	14831-14845	cross-paradigm	_	
64-15	14846-14858	connectivity	_	
64-16	14859-14862	and	_	
64-17	14863-14866	the	_	
64-18	14867-14873	number	_	
64-19	14874-14876	of	_	
64-20	14877-14883	months	_	
64-21	14884-14886	to	_	
64-22	14887-14897	conversion	_	
64-23	14898-14903	after	_	
64-24	14904-14907	the	_	
64-25	14908-14916	baseline	_	
64-26	14917-14921	scan	_	
64-27	14921-14922	.	_	

#Text=We observed a significant correlation between these two variables (R = −0.48, P = 0.04, Fig. 2e), suggesting that higher connenctivity in the cerebello–thalamo–cortical network predicts shorter conversion time.
65-1	14923-14925	We	_	
65-2	14926-14934	observed	_	
65-3	14935-14936	a	_	
65-4	14937-14948	significant	_	
65-5	14949-14960	correlation	_	
65-6	14961-14968	between	_	
65-7	14969-14974	these	_	
65-8	14975-14978	two	_	
65-9	14979-14988	variables	_	
65-10	14989-14990	(	_	
65-11	14990-14991	R	_	
65-12	14992-14993	=	_	
65-13	14994-14995	−	_	
65-14	14995-14999	0.48	_	
65-15	14999-15000	,	_	
65-16	15001-15002	P	_	
65-17	15003-15004	=	_	
65-18	15005-15009	0.04	_	
65-19	15009-15010	,	_	
65-20	15011-15014	Fig	_	
65-21	15014-15015	.	_	
65-22	15015-15016	 	_	
65-23	15016-15018	2e	_	
65-24	15018-15019	)	_	
65-25	15019-15020	,	_	
65-26	15021-15031	suggesting	_	
65-27	15032-15036	that	_	
65-28	15037-15043	higher	_	
65-29	15044-15057	connenctivity	_	
65-30	15058-15060	in	_	
65-31	15061-15064	the	_	
65-32	15065-15091	cerebello–thalamo–cortical	_	
65-33	15092-15099	network	_	
65-34	15100-15108	predicts	_	
65-35	15109-15116	shorter	_	
65-36	15117-15127	conversion	_	
65-37	15128-15132	time	_	
65-38	15132-15133	.	_	

#Text=Association with structural measures
#Text=Since the observed connectivity changes in the cerebello–thalamo–cortical circuit are robust across different paradigms, a question naturally arises as whether these changes relate to structural differences in identified nodes in this circuit, in which case the connectivity metrics may be redundant with anatomical measures in indexing risk for psychosis.
66-1	15134-15145	Association	_	
66-2	15146-15150	with	_	
66-3	15151-15161	structural	_	
66-4	15162-15170	measures	_	
66-5	15171-15176	Since	_	
66-6	15177-15180	the	_	
66-7	15181-15189	observed	_	
66-8	15190-15202	connectivity	_	
66-9	15203-15210	changes	_	
66-10	15211-15213	in	_	
66-11	15214-15217	the	_	
66-12	15218-15244	cerebello–thalamo–cortical	_	
66-13	15245-15252	circuit	_	
66-14	15253-15256	are	_	
66-15	15257-15263	robust	_	
66-16	15264-15270	across	_	
66-17	15271-15280	different	_	
66-18	15281-15290	paradigms	_	
66-19	15290-15291	,	_	
66-20	15292-15293	a	_	
66-21	15294-15302	question	_	
66-22	15303-15312	naturally	_	
66-23	15313-15319	arises	_	
66-24	15320-15322	as	_	
66-25	15323-15330	whether	_	
66-26	15331-15336	these	_	
66-27	15337-15344	changes	_	
66-28	15345-15351	relate	_	
66-29	15352-15354	to	_	
66-30	15355-15365	structural	_	
66-31	15366-15377	differences	_	
66-32	15378-15380	in	_	
66-33	15381-15391	identified	_	
66-34	15392-15397	nodes	_	
66-35	15398-15400	in	_	
66-36	15401-15405	this	_	
66-37	15406-15413	circuit	_	
66-38	15413-15414	,	_	
66-39	15415-15417	in	_	
66-40	15418-15423	which	_	
66-41	15424-15428	case	_	
66-42	15429-15432	the	_	
66-43	15433-15445	connectivity	_	
66-44	15446-15453	metrics	_	
66-45	15454-15457	may	_	
66-46	15458-15460	be	_	
66-47	15461-15470	redundant	_	
66-48	15471-15475	with	_	
66-49	15476-15486	anatomical	_	
66-50	15487-15495	measures	_	
66-51	15496-15498	in	_	
66-52	15499-15507	indexing	_	
66-53	15508-15512	risk	_	
66-54	15513-15516	for	_	
66-55	15517-15526	psychosis	_	
66-56	15526-15527	.	_	

#Text=To address this question, we extracted gray matter volumes of all identified cortical, subcortical, and cerebellar regions from subjects’ processed T1-weighted imaging data and correlated these measures with the mean PC scores of the identified network using Pearson Correlation.
67-1	15528-15530	To	_	
67-2	15531-15538	address	_	
67-3	15539-15543	this	_	
67-4	15544-15552	question	_	
67-5	15552-15553	,	_	
67-6	15554-15556	we	_	
67-7	15557-15566	extracted	_	
67-8	15567-15571	gray	_	
67-9	15572-15578	matter	_	
67-10	15579-15586	volumes	_	
67-11	15587-15589	of	_	
67-12	15590-15593	all	_	
67-13	15594-15604	identified	_	
67-14	15605-15613	cortical	_	
67-15	15613-15614	,	_	
67-16	15615-15626	subcortical	_	
67-17	15626-15627	,	_	
67-18	15628-15631	and	_	
67-19	15632-15642	cerebellar	_	
67-20	15643-15650	regions	_	
67-21	15651-15655	from	_	
67-22	15656-15664	subjects	_	
67-23	15664-15665	’	_	
67-24	15666-15675	processed	_	
67-25	15676-15678	T1	_	
67-26	15678-15679	-	_	
67-27	15679-15687	weighted	_	
67-28	15688-15695	imaging	_	
67-29	15696-15700	data	_	
67-30	15701-15704	and	_	
67-31	15705-15715	correlated	_	
67-32	15716-15721	these	_	
67-33	15722-15730	measures	_	
67-34	15731-15735	with	_	
67-35	15736-15739	the	_	
67-36	15740-15744	mean	_	
67-37	15745-15747	PC	_	
67-38	15748-15754	scores	_	
67-39	15755-15757	of	_	
67-40	15758-15761	the	_	
67-41	15762-15772	identified	_	
67-42	15773-15780	network	_	
67-43	15781-15786	using	_	
67-44	15787-15794	Pearson	_	
67-45	15795-15806	Correlation	_	
67-46	15806-15807	.	_	

#Text=Our analysis revealed no significant associations between the functional connectivity measures and the structural gray matter volumes after multiple correction (PFWE > 1).
68-1	15808-15811	Our	_	
68-2	15812-15820	analysis	_	
68-3	15821-15829	revealed	_	
68-4	15830-15832	no	_	
68-5	15833-15844	significant	_	
68-6	15845-15857	associations	_	
68-7	15858-15865	between	_	
68-8	15866-15869	the	_	
68-9	15870-15880	functional	_	
68-10	15881-15893	connectivity	_	
68-11	15894-15902	measures	_	
68-12	15903-15906	and	_	
68-13	15907-15910	the	_	
68-14	15911-15921	structural	_	
68-15	15922-15926	gray	_	
68-16	15927-15933	matter	_	
68-17	15934-15941	volumes	_	
68-18	15942-15947	after	_	
68-19	15948-15956	multiple	_	
68-20	15957-15967	correction	_	
68-21	15968-15969	(	_	
68-22	15969-15973	PFWE	_	
68-23	15974-15975	>	_	
68-24	15976-15977	1	_	
68-25	15977-15978	)	_	
68-26	15978-15979	.	_	

#Text=The only trend-level effects were shown in bilateral thalamus (R = −0.12, Puncorrected = 0.04), suggesting that the observed cerebello–thalamo–cortical hyperconnectivity conveys unique information on risk for psychosis that is not fully explained by anatomical changes associated with psychosis, and/or may occur at the time point before the most pronounced structural changes appear.
69-1	15980-15983	The	_	
69-2	15984-15988	only	_	
69-3	15989-16000	trend-level	_	
69-4	16001-16008	effects	_	
69-5	16009-16013	were	_	
69-6	16014-16019	shown	_	
69-7	16020-16022	in	_	
69-8	16023-16032	bilateral	_	
69-9	16033-16041	thalamus	_	
69-10	16042-16043	(	_	
69-11	16043-16044	R	_	
69-12	16045-16046	=	_	
69-13	16047-16048	−	_	
69-14	16048-16052	0.12	_	
69-15	16052-16053	,	_	
69-16	16054-16066	Puncorrected	_	
69-17	16067-16068	=	_	
69-18	16069-16073	0.04	_	
69-19	16073-16074	)	_	
69-20	16074-16075	,	_	
69-21	16076-16086	suggesting	_	
69-22	16087-16091	that	_	
69-23	16092-16095	the	_	
69-24	16096-16104	observed	_	
69-25	16105-16131	cerebello–thalamo–cortical	_	
69-26	16132-16149	hyperconnectivity	_	
69-27	16150-16157	conveys	_	
69-28	16158-16164	unique	_	
69-29	16165-16176	information	_	
69-30	16177-16179	on	_	
69-31	16180-16184	risk	_	
69-32	16185-16188	for	_	
69-33	16189-16198	psychosis	_	
69-34	16199-16203	that	_	
69-35	16204-16206	is	_	
69-36	16207-16210	not	_	
69-37	16211-16216	fully	_	
69-38	16217-16226	explained	_	
69-39	16227-16229	by	_	
69-40	16230-16240	anatomical	_	
69-41	16241-16248	changes	_	
69-42	16249-16259	associated	_	
69-43	16260-16264	with	_	
69-44	16265-16274	psychosis	_	
69-45	16274-16275	,	_	
69-46	16276-16279	and	_	
69-47	16279-16280	/	_	
69-48	16280-16282	or	_	
69-49	16283-16286	may	_	
69-50	16287-16292	occur	_	
69-51	16293-16295	at	_	
69-52	16296-16299	the	_	
69-53	16300-16304	time	_	
69-54	16305-16310	point	_	
69-55	16311-16317	before	_	
69-56	16318-16321	the	_	
69-57	16322-16326	most	_	
69-58	16327-16337	pronounced	_	
69-59	16338-16348	structural	_	
69-60	16349-16356	changes	_	
69-61	16357-16363	appear	_	
69-62	16363-16364	.	_	

#Text=Verification of results in a matched subsample
#Text=To confirm that the detected network change was not explained by demographic and/or clinical variables on which there were also significant group differences (Supplementary Table 1), we performed a supplementary analysis using a small subsample of subjects in the NAPLS-2 cohort that were unmedicated and well matched in terms of demographics across outcome groups (see Supplementary Table 2).
70-1	16365-16377	Verification	_	
70-2	16378-16380	of	_	
70-3	16381-16388	results	_	
70-4	16389-16391	in	_	
70-5	16392-16393	a	_	
70-6	16394-16401	matched	_	
70-7	16402-16411	subsample	_	
70-8	16412-16414	To	_	
70-9	16415-16422	confirm	_	
70-10	16423-16427	that	_	
70-11	16428-16431	the	_	
70-12	16432-16440	detected	_	
70-13	16441-16448	network	_	
70-14	16449-16455	change	_	
70-15	16456-16459	was	_	
70-16	16460-16463	not	_	
70-17	16464-16473	explained	_	
70-18	16474-16476	by	_	
70-19	16477-16488	demographic	_	
70-20	16489-16492	and	_	
70-21	16492-16493	/	_	
70-22	16493-16495	or	_	
70-23	16496-16504	clinical	_	
70-24	16505-16514	variables	_	
70-25	16515-16517	on	_	
70-26	16518-16523	which	_	
70-27	16524-16529	there	_	
70-28	16530-16534	were	_	
70-29	16535-16539	also	_	
70-30	16540-16551	significant	_	
70-31	16552-16557	group	_	
70-32	16558-16569	differences	_	
70-33	16570-16571	(	_	
70-34	16571-16584	Supplementary	_	
70-35	16585-16590	Table	_	
70-36	16590-16591	 	_	
70-37	16591-16592	1	_	
70-38	16592-16593	)	_	
70-39	16593-16594	,	_	
70-40	16595-16597	we	_	
70-41	16598-16607	performed	_	
70-42	16608-16609	a	_	
70-43	16610-16623	supplementary	_	
70-44	16624-16632	analysis	_	
70-45	16633-16638	using	_	
70-46	16639-16640	a	_	
70-47	16641-16646	small	_	
70-48	16647-16656	subsample	_	
70-49	16657-16659	of	_	
70-50	16660-16668	subjects	_	
70-51	16669-16671	in	_	
70-52	16672-16675	the	_	
70-53	16676-16681	NAPLS	_	
70-54	16681-16682	-	_	
70-55	16682-16683	2	_	
70-56	16684-16690	cohort	_	
70-57	16691-16695	that	_	
70-58	16696-16700	were	_	
70-59	16701-16712	unmedicated	_	
70-60	16713-16716	and	_	
70-61	16717-16721	well	_	
70-62	16722-16729	matched	_	
70-63	16730-16732	in	_	
70-64	16733-16738	terms	_	
70-65	16739-16741	of	_	
70-66	16742-16754	demographics	_	
70-67	16755-16761	across	_	
70-68	16762-16769	outcome	_	
70-69	16770-16776	groups	_	
70-70	16777-16778	(	_	
70-71	16778-16781	see	_	
70-72	16782-16795	Supplementary	_	
70-73	16796-16801	Table	_	
70-74	16801-16802	 	_	
70-75	16802-16803	2	_	
70-76	16803-16804	)	_	
70-77	16804-16805	.	_	

#Text=The subsample included a total of 11 converters, 40 non-converters, and 40 healthy controls drawn from the larger sample reported above.
71-1	16806-16809	The	_	
71-2	16810-16819	subsample	_	
71-3	16820-16828	included	_	
71-4	16829-16830	a	_	
71-5	16831-16836	total	_	
71-6	16837-16839	of	_	
71-7	16840-16842	11	_	
71-8	16843-16853	converters	_	
71-9	16853-16854	,	_	
71-10	16855-16857	40	_	
71-11	16858-16872	non-converters	_	
71-12	16872-16873	,	_	
71-13	16874-16877	and	_	
71-14	16878-16880	40	_	
71-15	16881-16888	healthy	_	
71-16	16889-16897	controls	_	
71-17	16898-16903	drawn	_	
71-18	16904-16908	from	_	
71-19	16909-16912	the	_	
71-20	16913-16919	larger	_	
71-21	16920-16926	sample	_	
71-22	16927-16935	reported	_	
71-23	16936-16941	above	_	
71-24	16941-16942	.	_	

#Text=Here, same as in the larger sample, we observed significant group differences in the cross-paradigm connectivity of the identified network (P < 0.001, one-way ANCOVA, Supplementary Fig 3A).
72-1	16943-16947	Here	_	
72-2	16947-16948	,	_	
72-3	16949-16953	same	_	
72-4	16954-16956	as	_	
72-5	16957-16959	in	_	
72-6	16960-16963	the	_	
72-7	16964-16970	larger	_	
72-8	16971-16977	sample	_	
72-9	16977-16978	,	_	
72-10	16979-16981	we	_	
72-11	16982-16990	observed	_	
72-12	16991-17002	significant	_	
72-13	17003-17008	group	_	
72-14	17009-17020	differences	_	
72-15	17021-17023	in	_	
72-16	17024-17027	the	_	
72-17	17028-17042	cross-paradigm	_	
72-18	17043-17055	connectivity	_	
72-19	17056-17058	of	_	
72-20	17059-17062	the	_	
72-21	17063-17073	identified	_	
72-22	17074-17081	network	_	
72-23	17082-17083	(	_	
72-24	17083-17084	P	_	
72-25	17085-17086	<	_	
72-26	17087-17092	0.001	_	
72-27	17092-17093	,	_	
72-28	17094-17101	one-way	_	
72-29	17102-17108	ANCOVA	_	
72-30	17108-17109	,	_	
72-31	17110-17123	Supplementary	_	
72-32	17124-17127	Fig	_	
72-33	17127-17128	 	_	
72-34	17128-17130	3A	_	
72-35	17130-17131	)	_	
72-36	17131-17132	.	_	

#Text=Again, the highest values were shown in converters, followed by non-converters and controls.
73-1	17133-17138	Again	_	
73-2	17138-17139	,	_	
73-3	17140-17143	the	_	
73-4	17144-17151	highest	_	
73-5	17152-17158	values	_	
73-6	17159-17163	were	_	
73-7	17164-17169	shown	_	
73-8	17170-17172	in	_	
73-9	17173-17183	converters	_	
73-10	17183-17184	,	_	
73-11	17185-17193	followed	_	
73-12	17194-17196	by	_	
73-13	17197-17211	non-converters	_	
73-14	17212-17215	and	_	
73-15	17216-17224	controls	_	
73-16	17224-17225	.	_	

#Text=These data further verify that the detected hyperconnectivity pattern in converters is not driven by group differences in demographics and medication.
74-1	17226-17231	These	_	
74-2	17232-17236	data	_	
74-3	17237-17244	further	_	
74-4	17245-17251	verify	_	
74-5	17252-17256	that	_	
74-6	17257-17260	the	_	
74-7	17261-17269	detected	_	
74-8	17270-17287	hyperconnectivity	_	
74-9	17288-17295	pattern	_	
74-10	17296-17298	in	_	
74-11	17299-17309	converters	_	
74-12	17310-17312	is	_	
74-13	17313-17316	not	_	
74-14	17317-17323	driven	_	
74-15	17324-17326	by	_	
74-16	17327-17332	group	_	
74-17	17333-17344	differences	_	
74-18	17345-17347	in	_	
74-19	17348-17360	demographics	_	
74-20	17361-17364	and	_	
74-21	17365-17375	medication	_	
74-22	17375-17376	.	_	

#Text=Comparison between subjects with 24-month clinical follow-up
#Text=Since clinical follow-up time in the NAPLS-2 sample varied between individuals, and those with relatively short duration of follow-ups were more likely to include persons who actually ended up converting, we compared the mean cross-paradigm connectivity of the identified network between CHR converters and CHR non-converters that had been followed-up for at least 24 months in a supplementary analysis (19 converters and 103 non-converters).
75-1	17377-17387	Comparison	_	
75-2	17388-17395	between	_	
75-3	17396-17404	subjects	_	
75-4	17405-17409	with	_	
75-5	17410-17412	24	_	
75-6	17412-17413	-	_	
75-7	17413-17418	month	_	
75-8	17419-17427	clinical	_	
75-9	17428-17437	follow-up	_	
75-10	17438-17443	Since	_	
75-11	17444-17452	clinical	_	
75-12	17453-17462	follow-up	_	
75-13	17463-17467	time	_	
75-14	17468-17470	in	_	
75-15	17471-17474	the	_	
75-16	17475-17480	NAPLS	_	
75-17	17480-17481	-	_	
75-18	17481-17482	2	_	
75-19	17483-17489	sample	_	
75-20	17490-17496	varied	_	
75-21	17497-17504	between	_	
75-22	17505-17516	individuals	_	
75-23	17516-17517	,	_	
75-24	17518-17521	and	_	
75-25	17522-17527	those	_	
75-26	17528-17532	with	_	
75-27	17533-17543	relatively	_	
75-28	17544-17549	short	_	
75-29	17550-17558	duration	_	
75-30	17559-17561	of	_	
75-31	17562-17572	follow-ups	_	
75-32	17573-17577	were	_	
75-33	17578-17582	more	_	
75-34	17583-17589	likely	_	
75-35	17590-17592	to	_	
75-36	17593-17600	include	_	
75-37	17601-17608	persons	_	
75-38	17609-17612	who	_	
75-39	17613-17621	actually	_	
75-40	17622-17627	ended	_	
75-41	17628-17630	up	_	
75-42	17631-17641	converting	_	
75-43	17641-17642	,	_	
75-44	17643-17645	we	_	
75-45	17646-17654	compared	_	
75-46	17655-17658	the	_	
75-47	17659-17663	mean	_	
75-48	17664-17678	cross-paradigm	_	
75-49	17679-17691	connectivity	_	
75-50	17692-17694	of	_	
75-51	17695-17698	the	_	
75-52	17699-17709	identified	_	
75-53	17710-17717	network	_	
75-54	17718-17725	between	_	
75-55	17726-17729	CHR	_	
75-56	17730-17740	converters	_	
75-57	17741-17744	and	_	
75-58	17745-17748	CHR	_	
75-59	17749-17763	non-converters	_	
75-60	17764-17768	that	_	
75-61	17769-17772	had	_	
75-62	17773-17777	been	_	
75-63	17778-17789	followed-up	_	
75-64	17790-17793	for	_	
75-65	17794-17796	at	_	
75-66	17797-17802	least	_	
75-67	17803-17805	24	_	
75-68	17806-17812	months	_	
75-69	17813-17815	in	_	
75-70	17816-17817	a	_	
75-71	17818-17831	supplementary	_	
75-72	17832-17840	analysis	_	
75-73	17841-17842	(	_	
75-74	17842-17844	19	_	
75-75	17845-17855	converters	_	
75-76	17856-17859	and	_	
75-77	17860-17863	103	_	
75-78	17864-17878	non-converters	_	
75-79	17878-17879	)	_	
75-80	17879-17880	.	_	

#Text=Similar to the result in the whole sample, this supplementary analysis showed a significant group difference between converters and non-converters (P = 0.004, one-way ANCOVA).
76-1	17881-17888	Similar	_	
76-2	17889-17891	to	_	
76-3	17892-17895	the	_	
76-4	17896-17902	result	_	
76-5	17903-17905	in	_	
76-6	17906-17909	the	_	
76-7	17910-17915	whole	_	
76-8	17916-17922	sample	_	
76-9	17922-17923	,	_	
76-10	17924-17928	this	_	
76-11	17929-17942	supplementary	_	
76-12	17943-17951	analysis	_	
76-13	17952-17958	showed	_	
76-14	17959-17960	a	_	
76-15	17961-17972	significant	_	
76-16	17973-17978	group	_	
76-17	17979-17989	difference	_	
76-18	17990-17997	between	_	
76-19	17998-18008	converters	_	
76-20	18009-18012	and	_	
76-21	18013-18027	non-converters	_	
76-22	18028-18029	(	_	
76-23	18029-18030	P	_	
76-24	18031-18032	=	_	
76-25	18033-18038	0.004	_	
76-26	18038-18039	,	_	
76-27	18040-18047	one-way	_	
76-28	18048-18054	ANCOVA	_	
76-29	18054-18055	)	_	
76-30	18055-18056	.	_	

#Text=Moreover, larger effect size (Cohen’s d = 0.76) was observed in this subsample compared with that in the whole sample (Cohen’s d = 0.68), suggesting that the observed hyperconnectivity in the NAPLS-2 sample may actually be underestimated.
77-1	18057-18065	Moreover	_	
77-2	18065-18066	,	_	
77-3	18067-18073	larger	_	
77-4	18074-18080	effect	_	
77-5	18081-18085	size	_	
77-6	18086-18087	(	_	
77-7	18087-18092	Cohen	_	
77-8	18092-18093	’	_	
77-9	18093-18094	s	_	
77-10	18095-18096	d	_	
77-11	18097-18098	=	_	
77-12	18099-18103	0.76	_	
77-13	18103-18104	)	_	
77-14	18105-18108	was	_	
77-15	18109-18117	observed	_	
77-16	18118-18120	in	_	
77-17	18121-18125	this	_	
77-18	18126-18135	subsample	_	
77-19	18136-18144	compared	_	
77-20	18145-18149	with	_	
77-21	18150-18154	that	_	
77-22	18155-18157	in	_	
77-23	18158-18161	the	_	
77-24	18162-18167	whole	_	
77-25	18168-18174	sample	_	
77-26	18175-18176	(	_	
77-27	18176-18181	Cohen	_	
77-28	18181-18182	’	_	
77-29	18182-18183	s	_	
77-30	18184-18185	d	_	
77-31	18186-18187	=	_	
77-32	18188-18192	0.68	_	
77-33	18192-18193	)	_	
77-34	18193-18194	,	_	
77-35	18195-18205	suggesting	_	
77-36	18206-18210	that	_	
77-37	18211-18214	the	_	
77-38	18215-18223	observed	_	
77-39	18224-18241	hyperconnectivity	_	
77-40	18242-18244	in	_	
77-41	18245-18248	the	_	
77-42	18249-18254	NAPLS	_	
77-43	18254-18255	-	_	
77-44	18255-18256	2	_	
77-45	18257-18263	sample	_	
77-46	18264-18267	may	_	
77-47	18268-18276	actually	_	
77-48	18277-18279	be	_	
77-49	18280-18294	underestimated	_	
77-50	18294-18295	.	_	

#Text=Specificity of the observed network
#Text=Since the identified network included a total of 84 edges, the relatively large size of this network raises the question as whether such change was edge-specific or rather generic across the whole brain.
78-1	18296-18307	Specificity	_	
78-2	18308-18310	of	_	
78-3	18311-18314	the	_	
78-4	18315-18323	observed	_	
78-5	18324-18331	network	_	
78-6	18332-18337	Since	_	
78-7	18338-18341	the	_	
78-8	18342-18352	identified	_	
78-9	18353-18360	network	_	
78-10	18361-18369	included	_	
78-11	18370-18371	a	_	
78-12	18372-18377	total	_	
78-13	18378-18380	of	_	
78-14	18381-18383	84	_	
78-15	18384-18389	edges	_	
78-16	18389-18390	,	_	
78-17	18391-18394	the	_	
78-18	18395-18405	relatively	_	
78-19	18406-18411	large	_	
78-20	18412-18416	size	_	
78-21	18417-18419	of	_	
78-22	18420-18424	this	_	
78-23	18425-18432	network	_	
78-24	18433-18439	raises	_	
78-25	18440-18443	the	_	
78-26	18444-18452	question	_	
78-27	18453-18455	as	_	
78-28	18456-18463	whether	_	
78-29	18464-18468	such	_	
78-30	18469-18475	change	_	
78-31	18476-18479	was	_	
78-32	18480-18493	edge-specific	_	
78-33	18494-18496	or	_	
78-34	18497-18503	rather	_	
78-35	18504-18511	generic	_	
78-36	18512-18518	across	_	
78-37	18519-18522	the	_	
78-38	18523-18528	whole	_	
78-39	18529-18534	brain	_	
78-40	18534-18535	.	_	

#Text=Here, we performed an additional permutation test to examine the specificity of the identified network.
79-1	18536-18540	Here	_	
79-2	18540-18541	,	_	
79-3	18542-18544	we	_	
79-4	18545-18554	performed	_	
79-5	18555-18557	an	_	
79-6	18558-18568	additional	_	
79-7	18569-18580	permutation	_	
79-8	18581-18585	test	_	
79-9	18586-18588	to	_	
79-10	18589-18596	examine	_	
79-11	18597-18600	the	_	
79-12	18601-18612	specificity	_	
79-13	18613-18615	of	_	
79-14	18616-18619	the	_	
79-15	18620-18630	identified	_	
79-16	18631-18638	network	_	
79-17	18638-18639	.	_	

#Text=Specifically, during each permutation, we randomly selected 84 edges from the PC matrices and compared the group differences on the means of these selected edges.
80-1	18640-18652	Specifically	_	
80-2	18652-18653	,	_	
80-3	18654-18660	during	_	
80-4	18661-18665	each	_	
80-5	18666-18677	permutation	_	
80-6	18677-18678	,	_	
80-7	18679-18681	we	_	
80-8	18682-18690	randomly	_	
80-9	18691-18699	selected	_	
80-10	18700-18702	84	_	
80-11	18703-18708	edges	_	
80-12	18709-18713	from	_	
80-13	18714-18717	the	_	
80-14	18718-18720	PC	_	
80-15	18721-18729	matrices	_	
80-16	18730-18733	and	_	
80-17	18734-18742	compared	_	
80-18	18743-18746	the	_	
80-19	18747-18752	group	_	
80-20	18753-18764	differences	_	
80-21	18765-18767	on	_	
80-22	18768-18771	the	_	
80-23	18772-18777	means	_	
80-24	18778-18780	of	_	
80-25	18781-18786	these	_	
80-26	18787-18795	selected	_	
80-27	18796-18801	edges	_	
80-28	18801-18802	.	_	

#Text=The whole procedure was iterated 10,000 times.
81-1	18803-18806	The	_	
81-2	18807-18812	whole	_	
81-3	18813-18822	procedure	_	
81-4	18823-18826	was	_	
81-5	18827-18835	iterated	_	
81-6	18836-18842	10,000	_	
81-7	18843-18848	times	_	
81-8	18848-18849	.	_	

#Text=We found that none of the P values derived from the 10,000 permutations reached statistical significance after Bonferroni correction (Supplementary Fig. 4).
82-1	18850-18852	We	_	
82-2	18853-18858	found	_	
82-3	18859-18863	that	_	
82-4	18864-18868	none	_	
82-5	18869-18871	of	_	
82-6	18872-18875	the	_	
82-7	18876-18877	P	_	
82-8	18878-18884	values	_	
82-9	18885-18892	derived	_	
82-10	18893-18897	from	_	
82-11	18898-18901	the	_	
82-12	18902-18908	10,000	_	
82-13	18909-18921	permutations	_	
82-14	18922-18929	reached	_	
82-15	18930-18941	statistical	_	
82-16	18942-18954	significance	_	
82-17	18955-18960	after	_	
82-18	18961-18971	Bonferroni	_	
82-19	18972-18982	correction	_	
82-20	18983-18984	(	_	
82-21	18984-18997	Supplementary	_	
82-22	18998-19001	Fig	_	
82-23	19001-19002	.	_	
82-24	19002-19003	 	_	
82-25	19003-19004	4	_	
82-26	19004-19005	)	_	
82-27	19005-19006	.	_	

#Text=In stark contrast, the observed network was highly significant even after Bonferroni correction for the 10,000 permutations.
83-1	19007-19009	In	_	
83-2	19010-19015	stark	_	
83-3	19016-19024	contrast	_	
83-4	19024-19025	,	_	
83-5	19026-19029	the	_	
83-6	19030-19038	observed	_	
83-7	19039-19046	network	_	
83-8	19047-19050	was	_	
83-9	19051-19057	highly	_	
83-10	19058-19069	significant	_	
83-11	19070-19074	even	_	
83-12	19075-19080	after	_	
83-13	19081-19091	Bonferroni	_	
83-14	19092-19102	correction	_	
83-15	19103-19106	for	_	
83-16	19107-19110	the	_	
83-17	19111-19117	10,000	_	
83-18	19118-19130	permutations	_	
83-19	19130-19131	.	_	

#Text=This supplementary analysis supports the specificity of the identified network in psychosis prediction, demonstrating that it is not driven by effects at the global level.
84-1	19132-19136	This	_	
84-2	19137-19150	supplementary	_	
84-3	19151-19159	analysis	_	
84-4	19160-19168	supports	_	
84-5	19169-19172	the	_	
84-6	19173-19184	specificity	_	
84-7	19185-19187	of	_	
84-8	19188-19191	the	_	
84-9	19192-19202	identified	_	
84-10	19203-19210	network	_	
84-11	19211-19213	in	_	
84-12	19214-19223	psychosis	_	
84-13	19224-19234	prediction	_	
84-14	19234-19235	,	_	
84-15	19236-19249	demonstrating	_	
84-16	19250-19254	that	_	
84-17	19255-19257	it	_	
84-18	19258-19260	is	_	
84-19	19261-19264	not	_	
84-20	19265-19271	driven	_	
84-21	19272-19274	by	_	
84-22	19275-19282	effects	_	
84-23	19283-19285	at	_	
84-24	19286-19289	the	_	
84-25	19290-19296	global	_	
84-26	19297-19302	level	_	
84-27	19302-19303	.	_	

#Text=NBS analysis on the resting-state data
#Text=To assess whether the observed network hyperconnectivity was simply a reflective of resting-state abnormality (in which case the PCA analysis would be redundant), we performed an additional NBS analysis solely on the resting-state data.
85-1	19304-19307	NBS	_	
85-2	19308-19316	analysis	_	
85-3	19317-19319	on	_	
85-4	19320-19323	the	_	
85-5	19324-19337	resting-state	_	
85-6	19338-19342	data	_	
85-7	19343-19345	To	_	
85-8	19346-19352	assess	_	
85-9	19353-19360	whether	_	
85-10	19361-19364	the	_	
85-11	19365-19373	observed	_	
85-12	19374-19381	network	_	
85-13	19382-19399	hyperconnectivity	_	
85-14	19400-19403	was	_	
85-15	19404-19410	simply	_	
85-16	19411-19412	a	_	
85-17	19413-19423	reflective	_	
85-18	19424-19426	of	_	
85-19	19427-19440	resting-state	_	
85-20	19441-19452	abnormality	_	
85-21	19453-19454	(	_	
85-22	19454-19456	in	_	
85-23	19457-19462	which	_	
85-24	19463-19467	case	_	
85-25	19468-19471	the	_	
85-26	19472-19475	PCA	_	
85-27	19476-19484	analysis	_	
85-28	19485-19490	would	_	
85-29	19491-19493	be	_	
85-30	19494-19503	redundant	_	
85-31	19503-19504	)	_	
85-32	19504-19505	,	_	
85-33	19506-19508	we	_	
85-34	19509-19518	performed	_	
85-35	19519-19521	an	_	
85-36	19522-19532	additional	_	
85-37	19533-19536	NBS	_	
85-38	19537-19545	analysis	_	
85-39	19546-19552	solely	_	
85-40	19553-19555	on	_	
85-41	19556-19559	the	_	
85-42	19560-19573	resting-state	_	
85-43	19574-19578	data	_	
85-44	19578-19579	.	_	

#Text=This analysis revealed no significant differences between the outcome groups, suggesting that the observed network change is detectable only when collapsing across multiple paradigms rather than during rest .
86-1	19580-19584	This	_	
86-2	19585-19593	analysis	_	
86-3	19594-19602	revealed	_	
86-4	19603-19605	no	_	
86-5	19606-19617	significant	_	
86-6	19618-19629	differences	_	
86-7	19630-19637	between	_	
86-8	19638-19641	the	_	
86-9	19642-19649	outcome	_	
86-10	19650-19656	groups	_	
86-11	19656-19657	,	_	
86-12	19658-19668	suggesting	_	
86-13	19669-19673	that	_	
86-14	19674-19677	the	_	
86-15	19678-19686	observed	_	
86-16	19687-19694	network	_	
86-17	19695-19701	change	_	
86-18	19702-19704	is	_	
86-19	19705-19715	detectable	_	
86-20	19716-19720	only	_	
86-21	19721-19725	when	_	
86-22	19726-19736	collapsing	_	
86-23	19737-19743	across	_	
86-24	19744-19752	multiple	_	
86-25	19753-19762	paradigms	_	
86-26	19763-19769	rather	_	
86-27	19770-19774	than	_	
86-28	19775-19781	during	_	
86-29	19782-19786	rest	_	
86-30	19787-19788	.	_	

#Text=Association with head motion parameters
#Text=To further ensure that the detected network abnormality was not driven by head motion differences between groups, we performed an additional analysis to test the potential association between the observed network metrics and frame-wise displacement values across all individuals in the NAPLS-2 sample using Spearman rank-order correlation.
87-1	19789-19800	Association	_	
87-2	19801-19805	with	_	
87-3	19806-19810	head	_	
87-4	19811-19817	motion	_	
87-5	19818-19828	parameters	_	
87-6	19829-19831	To	_	
87-7	19832-19839	further	_	
87-8	19840-19846	ensure	_	
87-9	19847-19851	that	_	
87-10	19852-19855	the	_	
87-11	19856-19864	detected	_	
87-12	19865-19872	network	_	
87-13	19873-19884	abnormality	_	
87-14	19885-19888	was	_	
87-15	19889-19892	not	_	
87-16	19893-19899	driven	_	
87-17	19900-19902	by	_	
87-18	19903-19907	head	_	
87-19	19908-19914	motion	_	
87-20	19915-19926	differences	_	
87-21	19927-19934	between	_	
87-22	19935-19941	groups	_	
87-23	19941-19942	,	_	
87-24	19943-19945	we	_	
87-25	19946-19955	performed	_	
87-26	19956-19958	an	_	
87-27	19959-19969	additional	_	
87-28	19970-19978	analysis	_	
87-29	19979-19981	to	_	
87-30	19982-19986	test	_	
87-31	19987-19990	the	_	
87-32	19991-20000	potential	_	
87-33	20001-20012	association	_	
87-34	20013-20020	between	_	
87-35	20021-20024	the	_	
87-36	20025-20033	observed	_	
87-37	20034-20041	network	_	
87-38	20042-20049	metrics	_	
87-39	20050-20053	and	_	
87-40	20054-20064	frame-wise	_	
87-41	20065-20077	displacement	_	
87-42	20078-20084	values	_	
87-43	20085-20091	across	_	
87-44	20092-20095	all	_	
87-45	20096-20107	individuals	_	
87-46	20108-20110	in	_	
87-47	20111-20114	the	_	
87-48	20115-20120	NAPLS	_	
87-49	20120-20121	-	_	
87-50	20121-20122	2	_	
87-51	20123-20129	sample	_	
87-52	20130-20135	using	_	
87-53	20136-20144	Spearman	_	
87-54	20145-20155	rank-order	_	
87-55	20156-20167	correlation	_	
87-56	20167-20168	.	_	

#Text=This analysis revealed no significant correlation between the two variables (R = 0.08, P = 0.17), which supports the argument that the detected network abnormality is unlikely to be driven by head motion differences between groups.
88-1	20169-20173	This	_	
88-2	20174-20182	analysis	_	
88-3	20183-20191	revealed	_	
88-4	20192-20194	no	_	
88-5	20195-20206	significant	_	
88-6	20207-20218	correlation	_	
88-7	20219-20226	between	_	
88-8	20227-20230	the	_	
88-9	20231-20234	two	_	
88-10	20235-20244	variables	_	
88-11	20245-20246	(	_	
88-12	20246-20247	R	_	
88-13	20248-20249	=	_	
88-14	20250-20254	0.08	_	
88-15	20254-20255	,	_	
88-16	20256-20257	P	_	
88-17	20258-20259	=	_	
88-18	20260-20264	0.17	_	
88-19	20264-20265	)	_	
88-20	20265-20266	,	_	
88-21	20267-20272	which	_	
88-22	20273-20281	supports	_	
88-23	20282-20285	the	_	
88-24	20286-20294	argument	_	
88-25	20295-20299	that	_	
88-26	20300-20303	the	_	
88-27	20304-20312	detected	_	
88-28	20313-20320	network	_	
88-29	20321-20332	abnormality	_	
88-30	20333-20335	is	_	
88-31	20336-20344	unlikely	_	
88-32	20345-20347	to	_	
88-33	20348-20350	be	_	
88-34	20351-20357	driven	_	
88-35	20358-20360	by	_	
88-36	20361-20365	head	_	
88-37	20366-20372	motion	_	
88-38	20373-20384	differences	_	
88-39	20385-20392	between	_	
88-40	20393-20399	groups	_	
88-41	20399-20400	.	_	

#Text=Presence of network hyperconnectivity in the CNP data
#Text=The presence of the observed network alteration in the CNP data. a Significant group differences were shown for the mean cross-paradigm connectivity of the identified network, which was driven by the differences between schizophrenia and controls.
89-1	20401-20409	Presence	_	
89-2	20410-20412	of	_	
89-3	20413-20420	network	_	
89-4	20421-20438	hyperconnectivity	_	
89-5	20439-20441	in	_	
89-6	20442-20445	the	_	
89-7	20446-20449	CNP	_	
89-8	20450-20454	data	_	
89-9	20455-20458	The	_	
89-10	20459-20467	presence	_	
89-11	20468-20470	of	_	
89-12	20471-20474	the	_	
89-13	20475-20483	observed	_	
89-14	20484-20491	network	_	
89-15	20492-20502	alteration	_	
89-16	20503-20505	in	_	
89-17	20506-20509	the	_	
89-18	20510-20513	CNP	_	
89-19	20514-20518	data	_	
89-20	20518-20519	.	_	
89-21	20520-20521	a	_	
89-22	20522-20533	Significant	_	
89-23	20534-20539	group	_	
89-24	20540-20551	differences	_	
89-25	20552-20556	were	_	
89-26	20557-20562	shown	_	
89-27	20563-20566	for	_	
89-28	20567-20570	the	_	
89-29	20571-20575	mean	_	
89-30	20576-20590	cross-paradigm	_	
89-31	20591-20603	connectivity	_	
89-32	20604-20606	of	_	
89-33	20607-20610	the	_	
89-34	20611-20621	identified	_	
89-35	20622-20629	network	_	
89-36	20629-20630	,	_	
89-37	20631-20636	which	_	
89-38	20637-20640	was	_	
89-39	20641-20647	driven	_	
89-40	20648-20650	by	_	
89-41	20651-20654	the	_	
89-42	20655-20666	differences	_	
89-43	20667-20674	between	_	
89-44	20675-20688	schizophrenia	_	
89-45	20689-20692	and	_	
89-46	20693-20701	controls	_	
89-47	20701-20702	.	_	

#Text=SZ schizophrenia, BD bipolar disorder, ADHD attention deficit hyperactivity disorder, HC healthy control. b The network alteration was significantly correlated with scores of SAPS thought disorder subscale in patients with schizophrenia. c Receiver operating characteristic curve for distinguishing patients with schizophrenia from healthy controls.
90-1	20703-20705	SZ	_	
90-2	20706-20719	schizophrenia	_	
90-3	20719-20720	,	_	
90-4	20721-20723	BD	_	
90-5	20724-20731	bipolar	_	
90-6	20732-20740	disorder	_	
90-7	20740-20741	,	_	
90-8	20742-20746	ADHD	_	
90-9	20747-20756	attention	_	
90-10	20757-20764	deficit	_	
90-11	20765-20778	hyperactivity	_	
90-12	20779-20787	disorder	_	
90-13	20787-20788	,	_	
90-14	20789-20791	HC	_	
90-15	20792-20799	healthy	_	
90-16	20800-20807	control	_	
90-17	20807-20808	.	_	
90-18	20809-20810	b	_	
90-19	20811-20814	The	_	
90-20	20815-20822	network	_	
90-21	20823-20833	alteration	_	
90-22	20834-20837	was	_	
90-23	20838-20851	significantly	_	
90-24	20852-20862	correlated	_	
90-25	20863-20867	with	_	
90-26	20868-20874	scores	_	
90-27	20875-20877	of	_	
90-28	20878-20882	SAPS	_	
90-29	20883-20890	thought	_	
90-30	20891-20899	disorder	_	
90-31	20900-20908	subscale	_	
90-32	20909-20911	in	_	
90-33	20912-20920	patients	_	
90-34	20921-20925	with	_	
90-35	20926-20939	schizophrenia	_	
90-36	20939-20940	.	_	
90-37	20941-20942	c	_	
90-38	20943-20951	Receiver	_	
90-39	20952-20961	operating	_	
90-40	20962-20976	characteristic	_	
90-41	20977-20982	curve	_	
90-42	20983-20986	for	_	
90-43	20987-21001	distinguishing	_	
90-44	21002-21010	patients	_	
90-45	21011-21015	with	_	
90-46	21016-21029	schizophrenia	_	
90-47	21030-21034	from	_	
90-48	21035-21042	healthy	_	
90-49	21043-21051	controls	_	
90-50	21051-21052	.	_	

#Text=The area under curve was significantly higher than that can be achieved by chance, per permutation testing.
91-1	21053-21056	The	_	
91-2	21057-21061	area	_	
91-3	21062-21067	under	_	
91-4	21068-21073	curve	_	
91-5	21074-21077	was	_	
91-6	21078-21091	significantly	_	
91-7	21092-21098	higher	_	
91-8	21099-21103	than	_	
91-9	21104-21108	that	_	
91-10	21109-21112	can	_	
91-11	21113-21115	be	_	
91-12	21116-21124	achieved	_	
91-13	21125-21127	by	_	
91-14	21128-21134	chance	_	
91-15	21134-21135	,	_	
91-16	21136-21139	per	_	
91-17	21140-21151	permutation	_	
91-18	21152-21159	testing	_	
91-19	21159-21160	.	_	

#Text=Error bars indicate standard errors
#Text=To confirm that the detected network hyperconnectivity is a “trait” abnormality for psychosis, we further investigated the presence of such alteration in an independent sample with multi-paradigm fMRI data acquired from three clinical populations (SZ, BD, and ADHD) and healthy controls (Supplementary Table 3).
92-1	21161-21166	Error	_	
92-2	21167-21171	bars	_	
92-3	21172-21180	indicate	_	
92-4	21181-21189	standard	_	
92-5	21190-21196	errors	_	
92-6	21197-21199	To	_	
92-7	21200-21207	confirm	_	
92-8	21208-21212	that	_	
92-9	21213-21216	the	_	
92-10	21217-21225	detected	_	
92-11	21226-21233	network	_	
92-12	21234-21251	hyperconnectivity	_	
92-13	21252-21254	is	_	
92-14	21255-21256	a	_	
92-15	21257-21258	“	_	
92-16	21258-21263	trait	_	
92-17	21263-21264	”	_	
92-18	21265-21276	abnormality	_	
92-19	21277-21280	for	_	
92-20	21281-21290	psychosis	_	
92-21	21290-21291	,	_	
92-22	21292-21294	we	_	
92-23	21295-21302	further	_	
92-24	21303-21315	investigated	_	
92-25	21316-21319	the	_	
92-26	21320-21328	presence	_	
92-27	21329-21331	of	_	
92-28	21332-21336	such	_	
92-29	21337-21347	alteration	_	
92-30	21348-21350	in	_	
92-31	21351-21353	an	_	
92-32	21354-21365	independent	_	
92-33	21366-21372	sample	_	
92-34	21373-21377	with	_	
92-35	21378-21392	multi-paradigm	_	
92-36	21393-21397	fMRI	_	
92-37	21398-21402	data	_	
92-38	21403-21411	acquired	_	
92-39	21412-21416	from	_	
92-40	21417-21422	three	_	
92-41	21423-21431	clinical	_	
92-42	21432-21443	populations	_	
92-43	21444-21445	(	_	
92-44	21445-21447	SZ	_	
92-45	21447-21448	,	_	
92-46	21449-21451	BD	_	
92-47	21451-21452	,	_	
92-48	21453-21456	and	_	
92-49	21457-21461	ADHD	_	
92-50	21461-21462	)	_	
92-51	21463-21466	and	_	
92-52	21467-21474	healthy	_	
92-53	21475-21483	controls	_	
92-54	21484-21485	(	_	
92-55	21485-21498	Supplementary	_	
92-56	21499-21504	Table	_	
92-57	21504-21505	 	_	
92-58	21505-21506	3	_	
92-59	21506-21507	)	_	
92-60	21507-21508	.	_	

#Text=The subjects in the CNP sample completed some or all of the seven paradigms employed by the cohort: an eyes-open resting-state paradigm, a “balloon-analog” risk taking task, a spatial working memory task, an episodic memory encoding task, an episodic memory retrieval task, a “Go–No Go” stop signal task, and a “color-shape” task-switching task.
93-1	21509-21512	The	_	
93-2	21513-21521	subjects	_	
93-3	21522-21524	in	_	
93-4	21525-21528	the	_	
93-5	21529-21532	CNP	_	
93-6	21533-21539	sample	_	
93-7	21540-21549	completed	_	
93-8	21550-21554	some	_	
93-9	21555-21557	or	_	
93-10	21558-21561	all	_	
93-11	21562-21564	of	_	
93-12	21565-21568	the	_	
93-13	21569-21574	seven	_	
93-14	21575-21584	paradigms	_	
93-15	21585-21593	employed	_	
93-16	21594-21596	by	_	
93-17	21597-21600	the	_	
93-18	21601-21607	cohort	_	
93-19	21607-21608	:	_	
93-20	21609-21611	an	_	
93-21	21612-21621	eyes-open	_	
93-22	21622-21635	resting-state	_	
93-23	21636-21644	paradigm	_	
93-24	21644-21645	,	_	
93-25	21646-21647	a	_	
93-26	21648-21649	“	_	
93-27	21649-21663	balloon-analog	_	
93-28	21663-21664	”	_	
93-29	21665-21669	risk	_	
93-30	21670-21676	taking	_	
93-31	21677-21681	task	_	
93-32	21681-21682	,	_	
93-33	21683-21684	a	_	
93-34	21685-21692	spatial	_	
93-35	21693-21700	working	_	
93-36	21701-21707	memory	_	
93-37	21708-21712	task	_	
93-38	21712-21713	,	_	
93-39	21714-21716	an	_	
93-40	21717-21725	episodic	_	
93-41	21726-21732	memory	_	
93-42	21733-21741	encoding	_	
93-43	21742-21746	task	_	
93-44	21746-21747	,	_	
93-45	21748-21750	an	_	
93-46	21751-21759	episodic	_	
93-47	21760-21766	memory	_	
93-48	21767-21776	retrieval	_	
93-49	21777-21781	task	_	
93-50	21781-21782	,	_	
93-51	21783-21784	a	_	
93-52	21785-21786	“	_	
93-53	21786-21791	Go–No	_	
93-54	21792-21794	Go	_	
93-55	21794-21795	”	_	
93-56	21796-21800	stop	_	
93-57	21801-21807	signal	_	
93-58	21808-21812	task	_	
93-59	21812-21813	,	_	
93-60	21814-21817	and	_	
93-61	21818-21819	a	_	
93-62	21820-21821	“	_	
93-63	21821-21832	color-shape	_	
93-64	21832-21833	”	_	
93-65	21834-21848	task-switching	_	
93-66	21849-21853	task	_	
93-67	21853-21854	.	_	

#Text=Following the same procedures described above, we computed the first PC scores for the correlation matrices across all paradigms and extracted the values from the same network for each individual (Supplementary Fig 2).
94-1	21855-21864	Following	_	
94-2	21865-21868	the	_	
94-3	21869-21873	same	_	
94-4	21874-21884	procedures	_	
94-5	21885-21894	described	_	
94-6	21895-21900	above	_	
94-7	21900-21901	,	_	
94-8	21902-21904	we	_	
94-9	21905-21913	computed	_	
94-10	21914-21917	the	_	
94-11	21918-21923	first	_	
94-12	21924-21926	PC	_	
94-13	21927-21933	scores	_	
94-14	21934-21937	for	_	
94-15	21938-21941	the	_	
94-16	21942-21953	correlation	_	
94-17	21954-21962	matrices	_	
94-18	21963-21969	across	_	
94-19	21970-21973	all	_	
94-20	21974-21983	paradigms	_	
94-21	21984-21987	and	_	
94-22	21988-21997	extracted	_	
94-23	21998-22001	the	_	
94-24	22002-22008	values	_	
94-25	22009-22013	from	_	
94-26	22014-22017	the	_	
94-27	22018-22022	same	_	
94-28	22023-22030	network	_	
94-29	22031-22034	for	_	
94-30	22035-22039	each	_	
94-31	22040-22050	individual	_	
94-32	22050-22051	 	_	
94-33	22051-22052	(	_	
94-34	22052-22065	Supplementary	_	
94-35	22066-22069	Fig	_	
94-36	22070-22071	2	_	
94-37	22071-22072	)	_	
94-38	22072-22073	.	_	

#Text=As expected, we observed a significant group effect on the network cross-paradigm connectivity after controlling for age, sex, IQ, mean FD, and antipsychotic dosage (P = 0.025, one-way ANCOVA, Fig. 3a).
95-1	22074-22076	As	_	
95-2	22077-22085	expected	_	
95-3	22085-22086	,	_	
95-4	22087-22089	we	_	
95-5	22090-22098	observed	_	
95-6	22099-22100	a	_	
95-7	22101-22112	significant	_	
95-8	22113-22118	group	_	
95-9	22119-22125	effect	_	
95-10	22126-22128	on	_	
95-11	22129-22132	the	_	
95-12	22133-22140	network	_	
95-13	22141-22155	cross-paradigm	_	
95-14	22156-22168	connectivity	_	
95-15	22169-22174	after	_	
95-16	22175-22186	controlling	_	
95-17	22187-22190	for	_	
95-18	22191-22194	age	_	
95-19	22194-22195	,	_	
95-20	22196-22199	sex	_	
95-21	22199-22200	,	_	
95-22	22201-22203	IQ	_	
95-23	22203-22204	,	_	
95-24	22205-22209	mean	_	
95-25	22210-22212	FD	_	
95-26	22212-22213	,	_	
95-27	22214-22217	and	_	
95-28	22218-22231	antipsychotic	_	
95-29	22232-22238	dosage	_	
95-30	22239-22240	(	_	
95-31	22240-22241	P	_	
95-32	22242-22243	=	_	
95-33	22244-22249	0.025	_	
95-34	22249-22250	,	_	
95-35	22251-22258	one-way	_	
95-36	22259-22265	ANCOVA	_	
95-37	22265-22266	,	_	
95-38	22267-22270	Fig	_	
95-39	22270-22271	.	_	
95-40	22271-22272	 	_	
95-41	22272-22274	3a	_	
95-42	22274-22275	)	_	
95-43	22275-22276	.	_	

#Text=Specifically, this effect was driven by the differences between the SZ group and the HC group (PBonferroni = 0.024, post-hoc t-test) but not between the other groups (PBonferroni > 0.26, post-hoc t-test).
96-1	22277-22289	Specifically	_	
96-2	22289-22290	,	_	
96-3	22291-22295	this	_	
96-4	22296-22302	effect	_	
96-5	22303-22306	was	_	
96-6	22307-22313	driven	_	
96-7	22314-22316	by	_	
96-8	22317-22320	the	_	
96-9	22321-22332	differences	_	
96-10	22333-22340	between	_	
96-11	22341-22344	the	_	
96-12	22345-22347	SZ	_	
96-13	22348-22353	group	_	
96-14	22354-22357	and	_	
96-15	22358-22361	the	_	
96-16	22362-22364	HC	_	
96-17	22365-22370	group	_	
96-18	22371-22372	(	_	
96-19	22372-22383	PBonferroni	_	
96-20	22384-22385	=	_	
96-21	22386-22391	0.024	_	
96-22	22391-22392	,	_	
96-23	22393-22401	post-hoc	_	
96-24	22402-22408	t-test	_	
96-25	22408-22409	)	_	
96-26	22410-22413	but	_	
96-27	22414-22417	not	_	
96-28	22418-22425	between	_	
96-29	22426-22429	the	_	
96-30	22430-22435	other	_	
96-31	22436-22442	groups	_	
96-32	22443-22444	(	_	
96-33	22444-22455	PBonferroni	_	
96-34	22456-22457	>	_	
96-35	22458-22462	0.26	_	
96-36	22462-22463	,	_	
96-37	22464-22472	post-hoc	_	
96-38	22473-22479	t-test	_	
96-39	22479-22480	)	_	
96-40	22480-22481	.	_	

#Text=Moreover, there tended to be a gradient elevation of the degree of hyperconnectivity in the identified network with the increase of prevalence of psychotic symptoms in the populations (such that SZ > BD > ADHD > HC).
97-1	22482-22490	Moreover	_	
97-2	22490-22491	,	_	
97-3	22492-22497	there	_	
97-4	22498-22504	tended	_	
97-5	22505-22507	to	_	
97-6	22508-22510	be	_	
97-7	22511-22512	a	_	
97-8	22513-22521	gradient	_	
97-9	22522-22531	elevation	_	
97-10	22532-22534	of	_	
97-11	22535-22538	the	_	
97-12	22539-22545	degree	_	
97-13	22546-22548	of	_	
97-14	22549-22566	hyperconnectivity	_	
97-15	22567-22569	in	_	
97-16	22570-22573	the	_	
97-17	22574-22584	identified	_	
97-18	22585-22592	network	_	
97-19	22593-22597	with	_	
97-20	22598-22601	the	_	
97-21	22602-22610	increase	_	
97-22	22611-22613	of	_	
97-23	22614-22624	prevalence	_	
97-24	22625-22627	of	_	
97-25	22628-22637	psychotic	_	
97-26	22638-22646	symptoms	_	
97-27	22647-22649	in	_	
97-28	22650-22653	the	_	
97-29	22654-22665	populations	_	
97-30	22666-22667	(	_	
97-31	22667-22671	such	_	
97-32	22672-22676	that	_	
97-33	22677-22679	SZ	_	
97-34	22680-22681	>	_	
97-35	22682-22684	BD	_	
97-36	22685-22686	>	_	
97-37	22687-22691	ADHD	_	
97-38	22692-22693	>	_	
97-39	22694-22696	HC	_	
97-40	22696-22697	)	_	
97-41	22697-22698	.	_	

#Text=These findings suggest a psychosis-specific functional neural signature in patients, in particular those with SZ.
98-1	22699-22704	These	_	
98-2	22705-22713	findings	_	
98-3	22714-22721	suggest	_	
98-4	22722-22723	a	_	
98-5	22724-22742	psychosis-specific	_	
98-6	22743-22753	functional	_	
98-7	22754-22760	neural	_	
98-8	22761-22770	signature	_	
98-9	22771-22773	in	_	
98-10	22774-22782	patients	_	
98-11	22782-22783	,	_	
98-12	22784-22786	in	_	
98-13	22787-22797	particular	_	
98-14	22798-22803	those	_	
98-15	22804-22808	with	_	
98-16	22809-22811	SZ	_	
98-17	22811-22812	.	_	

#Text=To further verify the association between the network hyperconnectivity and the disorganization symptoms as identified in the NAPLS-2 sample, Spearman rank-order correlations were performed for the network cross-paradigm connectivity measures on each of the four subscales (hallucinations, delusions, bizarre behavior, thought disorder) of the Scale for the Assessment of Positive Symptoms (SAPS) in patients with SZ.
99-1	22813-22815	To	_	
99-2	22816-22823	further	_	
99-3	22824-22830	verify	_	
99-4	22831-22834	the	_	
99-5	22835-22846	association	_	
99-6	22847-22854	between	_	
99-7	22855-22858	the	_	
99-8	22859-22866	network	_	
99-9	22867-22884	hyperconnectivity	_	
99-10	22885-22888	and	_	
99-11	22889-22892	the	_	
99-12	22893-22908	disorganization	_	
99-13	22909-22917	symptoms	_	
99-14	22918-22920	as	_	
99-15	22921-22931	identified	_	
99-16	22932-22934	in	_	
99-17	22935-22938	the	_	
99-18	22939-22944	NAPLS	_	
99-19	22944-22945	-	_	
99-20	22945-22946	2	_	
99-21	22947-22953	sample	_	
99-22	22953-22954	,	_	
99-23	22955-22963	Spearman	_	
99-24	22964-22974	rank-order	_	
99-25	22975-22987	correlations	_	
99-26	22988-22992	were	_	
99-27	22993-23002	performed	_	
99-28	23003-23006	for	_	
99-29	23007-23010	the	_	
99-30	23011-23018	network	_	
99-31	23019-23033	cross-paradigm	_	
99-32	23034-23046	connectivity	_	
99-33	23047-23055	measures	_	
99-34	23056-23058	on	_	
99-35	23059-23063	each	_	
99-36	23064-23066	of	_	
99-37	23067-23070	the	_	
99-38	23071-23075	four	_	
99-39	23076-23085	subscales	_	
99-40	23086-23087	(	_	
99-41	23087-23101	hallucinations	_	
99-42	23101-23102	,	_	
99-43	23103-23112	delusions	_	
99-44	23112-23113	,	_	
99-45	23114-23121	bizarre	_	
99-46	23122-23130	behavior	_	
99-47	23130-23131	,	_	
99-48	23132-23139	thought	_	
99-49	23140-23148	disorder	_	
99-50	23148-23149	)	_	
99-51	23150-23152	of	_	
99-52	23153-23156	the	_	
99-53	23157-23162	Scale	_	
99-54	23163-23166	for	_	
99-55	23167-23170	the	_	
99-56	23171-23181	Assessment	_	
99-57	23182-23184	of	_	
99-58	23185-23193	Positive	_	
99-59	23194-23202	Symptoms	_	
99-60	23203-23204	(	_	
99-61	23204-23208	SAPS	_	
99-62	23208-23209	)	_	
99-63	23210-23212	in	_	
99-64	23213-23221	patients	_	
99-65	23222-23226	with	_	
99-66	23227-23229	SZ	_	
99-67	23229-23230	.	_	

#Text=Consistent with the finding in the NAPLS-2 sample, the result revealed a significant correlation between the network measure and the thought disorder subscale scores (R = 0.30, P = 0.035, Fig. 3b).
100-1	23231-23241	Consistent	_	
100-2	23242-23246	with	_	
100-3	23247-23250	the	_	
100-4	23251-23258	finding	_	
100-5	23259-23261	in	_	
100-6	23262-23265	the	_	
100-7	23266-23271	NAPLS	_	
100-8	23271-23272	-	_	
100-9	23272-23273	2	_	
100-10	23274-23280	sample	_	
100-11	23280-23281	,	_	
100-12	23282-23285	the	_	
100-13	23286-23292	result	_	
100-14	23293-23301	revealed	_	
100-15	23302-23303	a	_	
100-16	23304-23315	significant	_	
100-17	23316-23327	correlation	_	
100-18	23328-23335	between	_	
100-19	23336-23339	the	_	
100-20	23340-23347	network	_	
100-21	23348-23355	measure	_	
100-22	23356-23359	and	_	
100-23	23360-23363	the	_	
100-24	23364-23371	thought	_	
100-25	23372-23380	disorder	_	
100-26	23381-23389	subscale	_	
100-27	23390-23396	scores	_	
100-28	23397-23398	(	_	
100-29	23398-23399	R	_	
100-30	23400-23401	=	_	
100-31	23402-23406	0.30	_	
100-32	23406-23407	,	_	
100-33	23408-23409	P	_	
100-34	23410-23411	=	_	
100-35	23412-23417	0.035	_	
100-36	23417-23418	,	_	
100-37	23419-23422	Fig	_	
100-38	23422-23423	.	_	
100-39	23423-23424	 	_	
100-40	23424-23426	3b	_	
100-41	23426-23427	)	_	
100-42	23427-23428	.	_	

#Text=The correlations with other subscales did not reach statistical significance (P > 0.30), suggesting that the observed network alteration may be specifically related to disorganized thought and speech in patients.
101-1	23429-23432	The	_	
101-2	23433-23445	correlations	_	
101-3	23446-23450	with	_	
101-4	23451-23456	other	_	
101-5	23457-23466	subscales	_	
101-6	23467-23470	did	_	
101-7	23471-23474	not	_	
101-8	23475-23480	reach	_	
101-9	23481-23492	statistical	_	
101-10	23493-23505	significance	_	
101-11	23506-23507	(	_	
101-12	23507-23508	P	_	
101-13	23509-23510	>	_	
101-14	23511-23515	0.30	_	
101-15	23515-23516	)	_	
101-16	23516-23517	,	_	
101-17	23518-23528	suggesting	_	
101-18	23529-23533	that	_	
101-19	23534-23537	the	_	
101-20	23538-23546	observed	_	
101-21	23547-23554	network	_	
101-22	23555-23565	alteration	_	
101-23	23566-23569	may	_	
101-24	23570-23572	be	_	
101-25	23573-23585	specifically	_	
101-26	23586-23593	related	_	
101-27	23594-23596	to	_	
101-28	23597-23609	disorganized	_	
101-29	23610-23617	thought	_	
101-30	23618-23621	and	_	
101-31	23622-23628	speech	_	
101-32	23629-23631	in	_	
101-33	23632-23640	patients	_	
101-34	23640-23641	.	_	

#Text=Similar to the procedures used in the NAPLS-2 sample, we also confirmed the findings in a demographically matched subsample of the CNP cohort including 27 patients with SZ, 27 patients with BD, 27 patients with ADHD, and 27 HCs (Supplementary Table 4).
102-1	23642-23649	Similar	_	
102-2	23650-23652	to	_	
102-3	23653-23656	the	_	
102-4	23657-23667	procedures	_	
102-5	23668-23672	used	_	
102-6	23673-23675	in	_	
102-7	23676-23679	the	_	
102-8	23680-23685	NAPLS	_	
102-9	23685-23686	-	_	
102-10	23686-23687	2	_	
102-11	23688-23694	sample	_	
102-12	23694-23695	,	_	
102-13	23696-23698	we	_	
102-14	23699-23703	also	_	
102-15	23704-23713	confirmed	_	
102-16	23714-23717	the	_	
102-17	23718-23726	findings	_	
102-18	23727-23729	in	_	
102-19	23730-23731	a	_	
102-20	23732-23747	demographically	_	
102-21	23748-23755	matched	_	
102-22	23756-23765	subsample	_	
102-23	23766-23768	of	_	
102-24	23769-23772	the	_	
102-25	23773-23776	CNP	_	
102-26	23777-23783	cohort	_	
102-27	23784-23793	including	_	
102-28	23794-23796	27	_	
102-29	23797-23805	patients	_	
102-30	23806-23810	with	_	
102-31	23811-23813	SZ	_	
102-32	23813-23814	,	_	
102-33	23815-23817	27	_	
102-34	23818-23826	patients	_	
102-35	23827-23831	with	_	
102-36	23832-23834	BD	_	
102-37	23834-23835	,	_	
102-38	23836-23838	27	_	
102-39	23839-23847	patients	_	
102-40	23848-23852	with	_	
102-41	23853-23857	ADHD	_	
102-42	23857-23858	,	_	
102-43	23859-23862	and	_	
102-44	23863-23865	27	_	
102-45	23866-23869	HCs	_	
102-46	23870-23871	(	_	
102-47	23871-23884	Supplementary	_	
102-48	23885-23890	Table	_	
102-49	23890-23891	 	_	
102-50	23891-23892	4	_	
102-51	23892-23893	)	_	
102-52	23893-23894	.	_	

#Text=The same group effect was again identified (P = 0.016, one-way ANCOVA, Supplementary Fig 3B), which was again driven by the differences between the SZ group and the HC group (PBonferroni = 0.043, post-hoc t-test) but not between the other groups (PBonferroni > 0.06, post-hoc t-test).
103-1	23895-23898	The	_	
103-2	23899-23903	same	_	
103-3	23904-23909	group	_	
103-4	23910-23916	effect	_	
103-5	23917-23920	was	_	
103-6	23921-23926	again	_	
103-7	23927-23937	identified	_	
103-8	23938-23939	(	_	
103-9	23939-23940	P	_	
103-10	23941-23942	=	_	
103-11	23943-23948	0.016	_	
103-12	23948-23949	,	_	
103-13	23950-23957	one-way	_	
103-14	23958-23964	ANCOVA	_	
103-15	23964-23965	,	_	
103-16	23966-23979	Supplementary	_	
103-17	23980-23983	Fig	_	
103-18	23983-23984	 	_	
103-19	23984-23986	3B	_	
103-20	23986-23987	)	_	
103-21	23987-23988	,	_	
103-22	23989-23994	which	_	
103-23	23995-23998	was	_	
103-24	23999-24004	again	_	
103-25	24005-24011	driven	_	
103-26	24012-24014	by	_	
103-27	24015-24018	the	_	
103-28	24019-24030	differences	_	
103-29	24031-24038	between	_	
103-30	24039-24042	the	_	
103-31	24043-24045	SZ	_	
103-32	24046-24051	group	_	
103-33	24052-24055	and	_	
103-34	24056-24059	the	_	
103-35	24060-24062	HC	_	
103-36	24063-24068	group	_	
103-37	24069-24070	(	_	
103-38	24070-24081	PBonferroni	_	
103-39	24082-24083	=	_	
103-40	24084-24089	0.043	_	
103-41	24089-24090	,	_	
103-42	24091-24099	post-hoc	_	
103-43	24100-24106	t-test	_	
103-44	24106-24107	)	_	
103-45	24108-24111	but	_	
103-46	24112-24115	not	_	
103-47	24116-24123	between	_	
103-48	24124-24127	the	_	
103-49	24128-24133	other	_	
103-50	24134-24140	groups	_	
103-51	24141-24142	(	_	
103-52	24142-24153	PBonferroni	_	
103-53	24154-24155	>	_	
103-54	24156-24160	0.06	_	
103-55	24160-24161	,	_	
103-56	24162-24170	post-hoc	_	
103-57	24171-24177	t-test	_	
103-58	24177-24178	)	_	
103-59	24178-24179	.	_	

#Text=These findings suggest that the detected connectivity differences in the larger sample are unlikely to be a result of unmatched demographics between groups.
104-1	24180-24185	These	_	
104-2	24186-24194	findings	_	
104-3	24195-24202	suggest	_	
104-4	24203-24207	that	_	
104-5	24208-24211	the	_	
104-6	24212-24220	detected	_	
104-7	24221-24233	connectivity	_	
104-8	24234-24245	differences	_	
104-9	24246-24248	in	_	
104-10	24249-24252	the	_	
104-11	24253-24259	larger	_	
104-12	24260-24266	sample	_	
104-13	24267-24270	are	_	
104-14	24271-24279	unlikely	_	
104-15	24280-24282	to	_	
104-16	24283-24285	be	_	
104-17	24286-24287	a	_	
104-18	24288-24294	result	_	
104-19	24295-24297	of	_	
104-20	24298-24307	unmatched	_	
104-21	24308-24320	demographics	_	
104-22	24321-24328	between	_	
104-23	24329-24335	groups	_	
104-24	24335-24336	.	_	

#Text=Encouraged by these results, we further performed a receiver operating characteristic (ROC) curve analysis to test the ability of using the hyperconnectivity pattern discovered in the NAPLS-2 data to distinguish patients with SZ from the controls in the overall CNP sample.
105-1	24337-24347	Encouraged	_	
105-2	24348-24350	by	_	
105-3	24351-24356	these	_	
105-4	24357-24364	results	_	
105-5	24364-24365	,	_	
105-6	24366-24368	we	_	
105-7	24369-24376	further	_	
105-8	24377-24386	performed	_	
105-9	24387-24388	a	_	
105-10	24389-24397	receiver	_	
105-11	24398-24407	operating	_	
105-12	24408-24422	characteristic	_	
105-13	24423-24424	(	_	
105-14	24424-24427	ROC	_	
105-15	24427-24428	)	_	
105-16	24429-24434	curve	_	
105-17	24435-24443	analysis	_	
105-18	24444-24446	to	_	
105-19	24447-24451	test	_	
105-20	24452-24455	the	_	
105-21	24456-24463	ability	_	
105-22	24464-24466	of	_	
105-23	24467-24472	using	_	
105-24	24473-24476	the	_	
105-25	24477-24494	hyperconnectivity	_	
105-26	24495-24502	pattern	_	
105-27	24503-24513	discovered	_	
105-28	24514-24516	in	_	
105-29	24517-24520	the	_	
105-30	24521-24526	NAPLS	_	
105-31	24526-24527	-	_	
105-32	24527-24528	2	_	
105-33	24529-24533	data	_	
105-34	24534-24536	to	_	
105-35	24537-24548	distinguish	_	
105-36	24549-24557	patients	_	
105-37	24558-24562	with	_	
105-38	24563-24565	SZ	_	
105-39	24566-24570	from	_	
105-40	24571-24574	the	_	
105-41	24575-24583	controls	_	
105-42	24584-24586	in	_	
105-43	24587-24590	the	_	
105-44	24591-24598	overall	_	
105-45	24599-24602	CNP	_	
105-46	24603-24609	sample	_	
105-47	24609-24610	.	_	

#Text=Our analysis revealed an area under curve (AUC) of 0.64 (P = 0.003 from 10,000 permutations, Fig. 3c), further supporting a trait hyperconnectivity alteration that can potentially be used for psychosis prediction and characterization.
106-1	24611-24614	Our	_	
106-2	24615-24623	analysis	_	
106-3	24624-24632	revealed	_	
106-4	24633-24635	an	_	
106-5	24636-24640	area	_	
106-6	24641-24646	under	_	
106-7	24647-24652	curve	_	
106-8	24653-24654	(	_	
106-9	24654-24657	AUC	_	
106-10	24657-24658	)	_	
106-11	24659-24661	of	_	
106-12	24662-24666	0.64	_	
106-13	24667-24668	(	_	
106-14	24668-24669	P	_	
106-15	24670-24671	=	_	
106-16	24672-24677	0.003	_	
106-17	24678-24682	from	_	
106-18	24683-24689	10,000	_	
106-19	24690-24702	permutations	_	
106-20	24702-24703	,	_	
106-21	24704-24707	Fig	_	
106-22	24707-24708	.	_	
106-23	24708-24709	 	_	
106-24	24709-24711	3c	_	
106-25	24711-24712	)	_	
106-26	24712-24713	,	_	
106-27	24714-24721	further	_	
106-28	24722-24732	supporting	_	
106-29	24733-24734	a	_	
106-30	24735-24740	trait	_	
106-31	24741-24758	hyperconnectivity	_	
106-32	24759-24769	alteration	_	
106-33	24770-24774	that	_	
106-34	24775-24778	can	_	
106-35	24779-24790	potentially	_	
106-36	24791-24793	be	_	
106-37	24794-24798	used	_	
106-38	24799-24802	for	_	
106-39	24803-24812	psychosis	_	
106-40	24813-24823	prediction	_	
106-41	24824-24827	and	_	
106-42	24828-24844	characterization	_	
106-43	24844-24845	.	_	

#Text=Discussion
#Text=What are the fundamental brain functional alterations that lead to psychosis?
107-1	24846-24856	Discussion	_	
107-2	24857-24861	What	_	
107-3	24862-24865	are	_	
107-4	24866-24869	the	_	
107-5	24870-24881	fundamental	_	
107-6	24882-24887	brain	_	
107-7	24888-24898	functional	_	
107-8	24899-24910	alterations	_	
107-9	24911-24915	that	_	
107-10	24916-24920	lead	_	
107-11	24921-24923	to	_	
107-12	24924-24933	psychosis	_	
107-13	24933-24934	?	_	

#Text=Although prior work has converged on the hypothesis of multiple target regions in the cerebral cortex, subcortex, and cerebellum, direct evidence that binds these discrete observations into a unified framework is still lacking.
108-1	24935-24943	Although	_	
108-2	24944-24949	prior	_	
108-3	24950-24954	work	_	
108-4	24955-24958	has	_	
108-5	24959-24968	converged	_	
108-6	24969-24971	on	_	
108-7	24972-24975	the	_	
108-8	24976-24986	hypothesis	_	
108-9	24987-24989	of	_	
108-10	24990-24998	multiple	_	
108-11	24999-25005	target	_	
108-12	25006-25013	regions	_	
108-13	25014-25016	in	_	
108-14	25017-25020	the	_	
108-15	25021-25029	cerebral	_	
108-16	25030-25036	cortex	_	
108-17	25036-25037	,	_	
108-18	25038-25047	subcortex	_	
108-19	25047-25048	,	_	
108-20	25049-25052	and	_	
108-21	25053-25063	cerebellum	_	
108-22	25063-25064	,	_	
108-23	25065-25071	direct	_	
108-24	25072-25080	evidence	_	
108-25	25081-25085	that	_	
108-26	25086-25091	binds	_	
108-27	25092-25097	these	_	
108-28	25098-25106	discrete	_	
108-29	25107-25119	observations	_	
108-30	25120-25124	into	_	
108-31	25125-25126	a	_	
108-32	25127-25134	unified	_	
108-33	25135-25144	framework	_	
108-34	25145-25147	is	_	
108-35	25148-25153	still	_	
108-36	25154-25161	lacking	_	
108-37	25161-25162	.	_	

#Text=In this study, we combined PCA and NBS approaches to analyze data from two independent cohorts to show that cerebello–thalamo–cortical hyperconnectivity is a “trait” alteration that can be robustly detected across different fMRI paradigms in subjects with psychosis and with high vulnerability to psychosis.
109-1	25163-25165	In	_	
109-2	25166-25170	this	_	
109-3	25171-25176	study	_	
109-4	25176-25177	,	_	
109-5	25178-25180	we	_	
109-6	25181-25189	combined	_	
109-7	25190-25193	PCA	_	
109-8	25194-25197	and	_	
109-9	25198-25201	NBS	_	
109-10	25202-25212	approaches	_	
109-11	25213-25215	to	_	
109-12	25216-25223	analyze	_	
109-13	25224-25228	data	_	
109-14	25229-25233	from	_	
109-15	25234-25237	two	_	
109-16	25238-25249	independent	_	
109-17	25250-25257	cohorts	_	
109-18	25258-25260	to	_	
109-19	25261-25265	show	_	
109-20	25266-25270	that	_	
109-21	25271-25297	cerebello–thalamo–cortical	_	
109-22	25298-25315	hyperconnectivity	_	
109-23	25316-25318	is	_	
109-24	25319-25320	a	_	
109-25	25321-25322	“	_	
109-26	25322-25327	trait	_	
109-27	25327-25328	”	_	
109-28	25329-25339	alteration	_	
109-29	25340-25344	that	_	
109-30	25345-25348	can	_	
109-31	25349-25351	be	_	
109-32	25352-25360	robustly	_	
109-33	25361-25369	detected	_	
109-34	25370-25376	across	_	
109-35	25377-25386	different	_	
109-36	25387-25391	fMRI	_	
109-37	25392-25401	paradigms	_	
109-38	25402-25404	in	_	
109-39	25405-25413	subjects	_	
109-40	25414-25418	with	_	
109-41	25419-25428	psychosis	_	
109-42	25429-25432	and	_	
109-43	25433-25437	with	_	
109-44	25438-25442	high	_	
109-45	25443-25456	vulnerability	_	
109-46	25457-25459	to	_	
109-47	25460-25469	psychosis	_	
109-48	25469-25470	.	_	

#Text=These findings suggest a state-independent functional neural signature that precedes and potentially predicts psychotic disorders.
110-1	25471-25476	These	_	
110-2	25477-25485	findings	_	
110-3	25486-25493	suggest	_	
110-4	25494-25495	a	_	
110-5	25496-25513	state-independent	_	
110-6	25514-25524	functional	_	
110-7	25525-25531	neural	_	
110-8	25532-25541	signature	_	
110-9	25542-25546	that	_	
110-10	25547-25555	precedes	_	
110-11	25556-25559	and	_	
110-12	25560-25571	potentially	_	
110-13	25572-25580	predicts	_	
110-14	25581-25590	psychotic	_	
110-15	25591-25600	disorders	_	
110-16	25600-25601	.	_	

#Text=The results of our study extend existing knowledge in clinical neuroscience and offer some useful implications for psychosis research going forward.
111-1	25602-25605	The	_	
111-2	25606-25613	results	_	
111-3	25614-25616	of	_	
111-4	25617-25620	our	_	
111-5	25621-25626	study	_	
111-6	25627-25633	extend	_	
111-7	25634-25642	existing	_	
111-8	25643-25652	knowledge	_	
111-9	25653-25655	in	_	
111-10	25656-25664	clinical	_	
111-11	25665-25677	neuroscience	_	
111-12	25678-25681	and	_	
111-13	25682-25687	offer	_	
111-14	25688-25692	some	_	
111-15	25693-25699	useful	_	
111-16	25700-25712	implications	_	
111-17	25713-25716	for	_	
111-18	25717-25726	psychosis	_	
111-19	25727-25735	research	_	
111-20	25736-25741	going	_	
111-21	25742-25749	forward	_	
111-22	25749-25750	.	_	

#Text=First, our data provide the first empirical evidence that psychosis is associated with an intrinsic “trait-like” abnormality in functional brain architecture, which occurs before the onset of full illness.
112-1	25751-25756	First	_	
112-2	25756-25757	,	_	
112-3	25758-25761	our	_	
112-4	25762-25766	data	_	
112-5	25767-25774	provide	_	
112-6	25775-25778	the	_	
112-7	25779-25784	first	_	
112-8	25785-25794	empirical	_	
112-9	25795-25803	evidence	_	
112-10	25804-25808	that	_	
112-11	25809-25818	psychosis	_	
112-12	25819-25821	is	_	
112-13	25822-25832	associated	_	
112-14	25833-25837	with	_	
112-15	25838-25840	an	_	
112-16	25841-25850	intrinsic	_	
112-17	25851-25852	“	_	
112-18	25852-25862	trait-like	_	
112-19	25862-25863	”	_	
112-20	25864-25875	abnormality	_	
112-21	25876-25878	in	_	
112-22	25879-25889	functional	_	
112-23	25890-25895	brain	_	
112-24	25896-25908	architecture	_	
112-25	25908-25909	,	_	
112-26	25910-25915	which	_	
112-27	25916-25922	occurs	_	
112-28	25923-25929	before	_	
112-29	25930-25933	the	_	
112-30	25934-25939	onset	_	
112-31	25940-25942	of	_	
112-32	25943-25947	full	_	
112-33	25948-25955	illness	_	
112-34	25955-25956	.	_	

#Text=This “trait-like” abnormality involves dysconnectivity between multiple cerebral cortical regions, thalamus, and cerebellum.
113-1	25957-25961	This	_	
113-2	25962-25963	“	_	
113-3	25963-25973	trait-like	_	
113-4	25973-25974	”	_	
113-5	25975-25986	abnormality	_	
113-6	25987-25995	involves	_	
113-7	25996-26011	dysconnectivity	_	
113-8	26012-26019	between	_	
113-9	26020-26028	multiple	_	
113-10	26029-26037	cerebral	_	
113-11	26038-26046	cortical	_	
113-12	26047-26054	regions	_	
113-13	26054-26055	,	_	
113-14	26056-26064	thalamus	_	
113-15	26064-26065	,	_	
113-16	26066-26069	and	_	
113-17	26070-26080	cerebellum	_	
113-18	26080-26081	.	_	

#Text=The affected cortical regions correspond well to those that have been frequently reported as associated with SZ in the literature, such as the medial prefrontal cortex, dorsolateral prefrontal cortex, orbitofrontal cortex, medial temporal cortex, lateral temporal cortex, parietal cortex, and occipital cortex.
114-1	26082-26085	The	_	
114-2	26086-26094	affected	_	
114-3	26095-26103	cortical	_	
114-4	26104-26111	regions	_	
114-5	26112-26122	correspond	_	
114-6	26123-26127	well	_	
114-7	26128-26130	to	_	
114-8	26131-26136	those	_	
114-9	26137-26141	that	_	
114-10	26142-26146	have	_	
114-11	26147-26151	been	_	
114-12	26152-26162	frequently	_	
114-13	26163-26171	reported	_	
114-14	26172-26174	as	_	
114-15	26175-26185	associated	_	
114-16	26186-26190	with	_	
114-17	26191-26193	SZ	_	
114-18	26194-26196	in	_	
114-19	26197-26200	the	_	
114-20	26201-26211	literature	_	
114-21	26211-26212	,	_	
114-22	26213-26217	such	_	
114-23	26218-26220	as	_	
114-24	26221-26224	the	_	
114-25	26225-26231	medial	_	
114-26	26232-26242	prefrontal	_	
114-27	26243-26249	cortex	_	
114-28	26249-26250	,	_	
114-29	26251-26263	dorsolateral	_	
114-30	26264-26274	prefrontal	_	
114-31	26275-26281	cortex	_	
114-32	26281-26282	,	_	
114-33	26283-26296	orbitofrontal	_	
114-34	26297-26303	cortex	_	
114-35	26303-26304	,	_	
114-36	26305-26311	medial	_	
114-37	26312-26320	temporal	_	
114-38	26321-26327	cortex	_	
114-39	26327-26328	,	_	
114-40	26329-26336	lateral	_	
114-41	26337-26345	temporal	_	
114-42	26346-26352	cortex	_	
114-43	26352-26353	,	_	
114-44	26354-26362	parietal	_	
114-45	26363-26369	cortex	_	
114-46	26369-26370	,	_	
114-47	26371-26374	and	_	
114-48	26375-26384	occipital	_	
114-49	26385-26391	cortex	_	
114-50	26391-26392	.	_	

#Text=The associations of these regions with psychosis have been found both anatomically and functionally, including measurements such as cortical thickness, cortical volume, brain activation and connectivity during tasks and rest, and low-frequency brain oscillations, suggesting that the changes in these regions are robust and may be consistently present across multiple imaging modalities.
115-1	26393-26396	The	_	
115-2	26397-26409	associations	_	
115-3	26410-26412	of	_	
115-4	26413-26418	these	_	
115-5	26419-26426	regions	_	
115-6	26427-26431	with	_	
115-7	26432-26441	psychosis	_	
115-8	26442-26446	have	_	
115-9	26447-26451	been	_	
115-10	26452-26457	found	_	
115-11	26458-26462	both	_	
115-12	26463-26475	anatomically	_	
115-13	26476-26479	and	_	
115-14	26480-26492	functionally	_	
115-15	26492-26493	,	_	
115-16	26494-26503	including	_	
115-17	26504-26516	measurements	_	
115-18	26517-26521	such	_	
115-19	26522-26524	as	_	
115-20	26525-26533	cortical	_	
115-21	26534-26543	thickness	_	
115-22	26543-26544	,	_	
115-23	26545-26553	cortical	_	
115-24	26554-26560	volume	_	
115-25	26560-26561	,	_	
115-26	26562-26567	brain	_	
115-27	26568-26578	activation	_	
115-28	26579-26582	and	_	
115-29	26583-26595	connectivity	_	
115-30	26596-26602	during	_	
115-31	26603-26608	tasks	_	
115-32	26609-26612	and	_	
115-33	26613-26617	rest	_	
115-34	26617-26618	,	_	
115-35	26619-26622	and	_	
115-36	26623-26636	low-frequency	_	
115-37	26637-26642	brain	_	
115-38	26643-26655	oscillations	_	
115-39	26655-26656	,	_	
115-40	26657-26667	suggesting	_	
115-41	26668-26672	that	_	
115-42	26673-26676	the	_	
115-43	26677-26684	changes	_	
115-44	26685-26687	in	_	
115-45	26688-26693	these	_	
115-46	26694-26701	regions	_	
115-47	26702-26705	are	_	
115-48	26706-26712	robust	_	
115-49	26713-26716	and	_	
115-50	26717-26720	may	_	
115-51	26721-26723	be	_	
115-52	26724-26736	consistently	_	
115-53	26737-26744	present	_	
115-54	26745-26751	across	_	
115-55	26752-26760	multiple	_	
115-56	26761-26768	imaging	_	
115-57	26769-26779	modalities	_	
115-58	26779-26780	.	_	

#Text=Our study extends these previous results by showing the existence of a state-independent network anomaly, suggesting that circumscribed regional alterations reported previously may partly belong to a broader and intrinsic neural network change in psychosis.
116-1	26781-26784	Our	_	
116-2	26785-26790	study	_	
116-3	26791-26798	extends	_	
116-4	26799-26804	these	_	
116-5	26805-26813	previous	_	
116-6	26814-26821	results	_	
116-7	26822-26824	by	_	
116-8	26825-26832	showing	_	
116-9	26833-26836	the	_	
116-10	26837-26846	existence	_	
116-11	26847-26849	of	_	
116-12	26850-26851	a	_	
116-13	26852-26869	state-independent	_	
116-14	26870-26877	network	_	
116-15	26878-26885	anomaly	_	
116-16	26885-26886	,	_	
116-17	26887-26897	suggesting	_	
116-18	26898-26902	that	_	
116-19	26903-26916	circumscribed	_	
116-20	26917-26925	regional	_	
116-21	26926-26937	alterations	_	
116-22	26938-26946	reported	_	
116-23	26947-26957	previously	_	
116-24	26958-26961	may	_	
116-25	26962-26968	partly	_	
116-26	26969-26975	belong	_	
116-27	26976-26978	to	_	
116-28	26979-26980	a	_	
116-29	26981-26988	broader	_	
116-30	26989-26992	and	_	
116-31	26993-27002	intrinsic	_	
116-32	27003-27009	neural	_	
116-33	27010-27017	network	_	
116-34	27018-27024	change	_	
116-35	27025-27027	in	_	
116-36	27028-27037	psychosis	_	
116-37	27037-27038	.	_	

#Text=See Supplementary Discussion for further discussion of the relation of these findings to previous results.
117-1	27039-27042	See	_	
117-2	27043-27056	Supplementary	_	
117-3	27057-27067	Discussion	_	
117-4	27068-27071	for	_	
117-5	27072-27079	further	_	
117-6	27080-27090	discussion	_	
117-7	27091-27093	of	_	
117-8	27094-27097	the	_	
117-9	27098-27106	relation	_	
117-10	27107-27109	of	_	
117-11	27110-27115	these	_	
117-12	27116-27124	findings	_	
117-13	27125-27127	to	_	
117-14	27128-27136	previous	_	
117-15	27137-27144	results	_	
117-16	27144-27145	.	_	

#Text=From a systems neuroscience perspective, the nodes in the detected network belong to seven functional systems that are strongly associated with psychotic disorders.
118-1	27146-27150	From	_	
118-2	27151-27152	a	_	
118-3	27153-27160	systems	_	
118-4	27161-27173	neuroscience	_	
118-5	27174-27185	perspective	_	
118-6	27185-27186	,	_	
118-7	27187-27190	the	_	
118-8	27191-27196	nodes	_	
118-9	27197-27199	in	_	
118-10	27200-27203	the	_	
118-11	27204-27212	detected	_	
118-12	27213-27220	network	_	
118-13	27221-27227	belong	_	
118-14	27228-27230	to	_	
118-15	27231-27236	seven	_	
118-16	27237-27247	functional	_	
118-17	27248-27255	systems	_	
118-18	27256-27260	that	_	
118-19	27261-27264	are	_	
118-20	27265-27273	strongly	_	
118-21	27274-27284	associated	_	
118-22	27285-27289	with	_	
118-23	27290-27299	psychotic	_	
118-24	27300-27309	disorders	_	
118-25	27309-27310	.	_	

#Text=Specifically, the frontoparietal and attentional networks are critical cognitive control systems in humans and have been implicated in the cognitive deficits in patients with psychosis, particularly SZ.
119-1	27311-27323	Specifically	_	
119-2	27323-27324	,	_	
119-3	27325-27328	the	_	
119-4	27329-27343	frontoparietal	_	
119-5	27344-27347	and	_	
119-6	27348-27359	attentional	_	
119-7	27360-27368	networks	_	
119-8	27369-27372	are	_	
119-9	27373-27381	critical	_	
119-10	27382-27391	cognitive	_	
119-11	27392-27399	control	_	
119-12	27400-27407	systems	_	
119-13	27408-27410	in	_	
119-14	27411-27417	humans	_	
119-15	27418-27421	and	_	
119-16	27422-27426	have	_	
119-17	27427-27431	been	_	
119-18	27432-27442	implicated	_	
119-19	27443-27445	in	_	
119-20	27446-27449	the	_	
119-21	27450-27459	cognitive	_	
119-22	27460-27468	deficits	_	
119-23	27469-27471	in	_	
119-24	27472-27480	patients	_	
119-25	27481-27485	with	_	
119-26	27486-27495	psychosis	_	
119-27	27495-27496	,	_	
119-28	27497-27509	particularly	_	
119-29	27510-27512	SZ	_	
119-30	27512-27513	.	_	

#Text=The default-mode network is a brain system that is activated during rest but deactivated during attention-demanding tasks.
120-1	27514-27517	The	_	
120-2	27518-27530	default-mode	_	
120-3	27531-27538	network	_	
120-4	27539-27541	is	_	
120-5	27542-27543	a	_	
120-6	27544-27549	brain	_	
120-7	27550-27556	system	_	
120-8	27557-27561	that	_	
120-9	27562-27564	is	_	
120-10	27565-27574	activated	_	
120-11	27575-27581	during	_	
120-12	27582-27586	rest	_	
120-13	27587-27590	but	_	
120-14	27591-27602	deactivated	_	
120-15	27603-27609	during	_	
120-16	27610-27629	attention-demanding	_	
120-17	27630-27635	tasks	_	
120-18	27635-27636	.	_	

#Text=The failure to deactivate this network during active tasks and the exaggeration of connectivity in this network during resting state have been repeatedly reported in the psychosis state, which may relate to excessive internally focused thoughts and self-reference during rest and lack of sufficient suppression of these thoughts during task.
121-1	27637-27640	The	_	
121-2	27641-27648	failure	_	
121-3	27649-27651	to	_	
121-4	27652-27662	deactivate	_	
121-5	27663-27667	this	_	
121-6	27668-27675	network	_	
121-7	27676-27682	during	_	
121-8	27683-27689	active	_	
121-9	27690-27695	tasks	_	
121-10	27696-27699	and	_	
121-11	27700-27703	the	_	
121-12	27704-27716	exaggeration	_	
121-13	27717-27719	of	_	
121-14	27720-27732	connectivity	_	
121-15	27733-27735	in	_	
121-16	27736-27740	this	_	
121-17	27741-27748	network	_	
121-18	27749-27755	during	_	
121-19	27756-27763	resting	_	
121-20	27764-27769	state	_	
121-21	27770-27774	have	_	
121-22	27775-27779	been	_	
121-23	27780-27790	repeatedly	_	
121-24	27791-27799	reported	_	
121-25	27800-27802	in	_	
121-26	27803-27806	the	_	
121-27	27807-27816	psychosis	_	
121-28	27817-27822	state	_	
121-29	27822-27823	,	_	
121-30	27824-27829	which	_	
121-31	27830-27833	may	_	
121-32	27834-27840	relate	_	
121-33	27841-27843	to	_	
121-34	27844-27853	excessive	_	
121-35	27854-27864	internally	_	
121-36	27865-27872	focused	_	
121-37	27873-27881	thoughts	_	
121-38	27882-27885	and	_	
121-39	27886-27900	self-reference	_	
121-40	27901-27907	during	_	
121-41	27908-27912	rest	_	
121-42	27913-27916	and	_	
121-43	27917-27921	lack	_	
121-44	27922-27924	of	_	
121-45	27925-27935	sufficient	_	
121-46	27936-27947	suppression	_	
121-47	27948-27950	of	_	
121-48	27951-27956	these	_	
121-49	27957-27965	thoughts	_	
121-50	27966-27972	during	_	
121-51	27973-27977	task	_	
121-52	27977-27978	.	_	

#Text=The dysfunction in primary functional systems such as the visual and auditory networks may contribute to hallucination symptoms in psychotic disorders, and the altered connectivity between thalamus and the sensorimotor network may reflect a subcortical gating deficit which leads to abnormal subcortical sensory inputs to the cortex.
122-1	27979-27982	The	_	
122-2	27983-27994	dysfunction	_	
122-3	27995-27997	in	_	
122-4	27998-28005	primary	_	
122-5	28006-28016	functional	_	
122-6	28017-28024	systems	_	
122-7	28025-28029	such	_	
122-8	28030-28032	as	_	
122-9	28033-28036	the	_	
122-10	28037-28043	visual	_	
122-11	28044-28047	and	_	
122-12	28048-28056	auditory	_	
122-13	28057-28065	networks	_	
122-14	28066-28069	may	_	
122-15	28070-28080	contribute	_	
122-16	28081-28083	to	_	
122-17	28084-28097	hallucination	_	
122-18	28098-28106	symptoms	_	
122-19	28107-28109	in	_	
122-20	28110-28119	psychotic	_	
122-21	28120-28129	disorders	_	
122-22	28129-28130	,	_	
122-23	28131-28134	and	_	
122-24	28135-28138	the	_	
122-25	28139-28146	altered	_	
122-26	28147-28159	connectivity	_	
122-27	28160-28167	between	_	
122-28	28168-28176	thalamus	_	
122-29	28177-28180	and	_	
122-30	28181-28184	the	_	
122-31	28185-28197	sensorimotor	_	
122-32	28198-28205	network	_	
122-33	28206-28209	may	_	
122-34	28210-28217	reflect	_	
122-35	28218-28219	a	_	
122-36	28220-28231	subcortical	_	
122-37	28232-28238	gating	_	
122-38	28239-28246	deficit	_	
122-39	28247-28252	which	_	
122-40	28253-28258	leads	_	
122-41	28259-28261	to	_	
122-42	28262-28270	abnormal	_	
122-43	28271-28282	subcortical	_	
122-44	28283-28290	sensory	_	
122-45	28291-28297	inputs	_	
122-46	28298-28300	to	_	
122-47	28301-28304	the	_	
122-48	28305-28311	cortex	_	
122-49	28311-28312	.	_	

#Text=Together, the conjoint involvement of these systems in the identified network change suggests aberrant information integration or communication between multiple primary and higher-order systems as a core feature of psychosis.
123-1	28313-28321	Together	_	
123-2	28321-28322	,	_	
123-3	28323-28326	the	_	
123-4	28327-28335	conjoint	_	
123-5	28336-28347	involvement	_	
123-6	28348-28350	of	_	
123-7	28351-28356	these	_	
123-8	28357-28364	systems	_	
123-9	28365-28367	in	_	
123-10	28368-28371	the	_	
123-11	28372-28382	identified	_	
123-12	28383-28390	network	_	
123-13	28391-28397	change	_	
123-14	28398-28406	suggests	_	
123-15	28407-28415	aberrant	_	
123-16	28416-28427	information	_	
123-17	28428-28439	integration	_	
123-18	28440-28442	or	_	
123-19	28443-28456	communication	_	
123-20	28457-28464	between	_	
123-21	28465-28473	multiple	_	
123-22	28474-28481	primary	_	
123-23	28482-28485	and	_	
123-24	28486-28498	higher-order	_	
123-25	28499-28506	systems	_	
123-26	28507-28509	as	_	
123-27	28510-28511	a	_	
123-28	28512-28516	core	_	
123-29	28517-28524	feature	_	
123-30	28525-28527	of	_	
123-31	28528-28537	psychosis	_	
123-32	28537-28538	.	_	

#Text=The effects of each system may summate and/or interact with each other in creating risk for overt illness.
124-1	28539-28542	The	_	
124-2	28543-28550	effects	_	
124-3	28551-28553	of	_	
124-4	28554-28558	each	_	
124-5	28559-28565	system	_	
124-6	28566-28569	may	_	
124-7	28570-28577	summate	_	
124-8	28578-28581	and	_	
124-9	28581-28582	/	_	
124-10	28582-28584	or	_	
124-11	28585-28593	interact	_	
124-12	28594-28598	with	_	
124-13	28599-28603	each	_	
124-14	28604-28609	other	_	
124-15	28610-28612	in	_	
124-16	28613-28621	creating	_	
124-17	28622-28626	risk	_	
124-18	28627-28630	for	_	
124-19	28631-28636	overt	_	
124-20	28637-28644	illness	_	
124-21	28644-28645	.	_	

#Text=Our findings appear to be broadly consistent with the “cognitive dysmetria” theory of SZ.
125-1	28646-28649	Our	_	
125-2	28650-28658	findings	_	
125-3	28659-28665	appear	_	
125-4	28666-28668	to	_	
125-5	28669-28671	be	_	
125-6	28672-28679	broadly	_	
125-7	28680-28690	consistent	_	
125-8	28691-28695	with	_	
125-9	28696-28699	the	_	
125-10	28700-28701	“	_	
125-11	28701-28710	cognitive	_	
125-12	28711-28720	dysmetria	_	
125-13	28720-28721	”	_	
125-14	28722-28728	theory	_	
125-15	28729-28731	of	_	
125-16	28732-28734	SZ	_	
125-17	28734-28735	.	_	

#Text=Initially proposed by Nancy Andreasen and colleagues, this theory posits that patients with SZ are characterized by changes in a key neural circuit, namely, the cerebello–thalamo–cortical circuitry.
126-1	28736-28745	Initially	_	
126-2	28746-28754	proposed	_	
126-3	28755-28757	by	_	
126-4	28758-28763	Nancy	_	
126-5	28764-28773	Andreasen	_	
126-6	28774-28777	and	_	
126-7	28778-28788	colleagues	_	
126-8	28788-28789	,	_	
126-9	28790-28794	this	_	
126-10	28795-28801	theory	_	
126-11	28802-28808	posits	_	
126-12	28809-28813	that	_	
126-13	28814-28822	patients	_	
126-14	28823-28827	with	_	
126-15	28828-28830	SZ	_	
126-16	28831-28834	are	_	
126-17	28835-28848	characterized	_	
126-18	28849-28851	by	_	
126-19	28852-28859	changes	_	
126-20	28860-28862	in	_	
126-21	28863-28864	a	_	
126-22	28865-28868	key	_	
126-23	28869-28875	neural	_	
126-24	28876-28883	circuit	_	
126-25	28883-28884	,	_	
126-26	28885-28891	namely	_	
126-27	28891-28892	,	_	
126-28	28893-28896	the	_	
126-29	28897-28923	cerebello–thalamo–cortical	_	
126-30	28924-28933	circuitry	_	
126-31	28933-28934	.	_	

#Text=Dysfunction in this circuitry leads to an impairment in the synchrony or coordination of mental processes.
127-1	28935-28946	Dysfunction	_	
127-2	28947-28949	in	_	
127-3	28950-28954	this	_	
127-4	28955-28964	circuitry	_	
127-5	28965-28970	leads	_	
127-6	28971-28973	to	_	
127-7	28974-28976	an	_	
127-8	28977-28987	impairment	_	
127-9	28988-28990	in	_	
127-10	28991-28994	the	_	
127-11	28995-29004	synchrony	_	
127-12	29005-29007	or	_	
127-13	29008-29020	coordination	_	
127-14	29021-29023	of	_	
127-15	29024-29030	mental	_	
127-16	29031-29040	processes	_	
127-17	29040-29041	.	_	

#Text=This impaired mental coordination is considered as the fundamental deficit in SZ that further accounts for various clinical symptoms.
128-1	29042-29046	This	_	
128-2	29047-29055	impaired	_	
128-3	29056-29062	mental	_	
128-4	29063-29075	coordination	_	
128-5	29076-29078	is	_	
128-6	29079-29089	considered	_	
128-7	29090-29092	as	_	
128-8	29093-29096	the	_	
128-9	29097-29108	fundamental	_	
128-10	29109-29116	deficit	_	
128-11	29117-29119	in	_	
128-12	29120-29122	SZ	_	
128-13	29123-29127	that	_	
128-14	29128-29135	further	_	
128-15	29136-29144	accounts	_	
128-16	29145-29148	for	_	
128-17	29149-29156	various	_	
128-18	29157-29165	clinical	_	
128-19	29166-29174	symptoms	_	
128-20	29174-29175	.	_	

#Text=This theory is supported by prior neuroimaging studies.
129-1	29176-29180	This	_	
129-2	29181-29187	theory	_	
129-3	29188-29190	is	_	
129-4	29191-29200	supported	_	
129-5	29201-29203	by	_	
129-6	29204-29209	prior	_	
129-7	29210-29222	neuroimaging	_	
129-8	29223-29230	studies	_	
129-9	29230-29231	.	_	

#Text=For example, altered cerebellar and prefrontal activations have been reported during a wide range of cognitive tasks.
130-1	29232-29235	For	_	
130-2	29236-29243	example	_	
130-3	29243-29244	,	_	
130-4	29245-29252	altered	_	
130-5	29253-29263	cerebellar	_	
130-6	29264-29267	and	_	
130-7	29268-29278	prefrontal	_	
130-8	29279-29290	activations	_	
130-9	29291-29295	have	_	
130-10	29296-29300	been	_	
130-11	29301-29309	reported	_	
130-12	29310-29316	during	_	
130-13	29317-29318	a	_	
130-14	29319-29323	wide	_	
130-15	29324-29329	range	_	
130-16	29330-29332	of	_	
130-17	29333-29342	cognitive	_	
130-18	29343-29348	tasks	_	
130-19	29348-29349	.	_	

#Text=In addition, abnormal thalamic–cortical and cerebellar–cortical functional connectivity have been consistently observed in populations with psychosis, particularly SZ.
131-1	29350-29352	In	_	
131-2	29353-29361	addition	_	
131-3	29361-29362	,	_	
131-4	29363-29371	abnormal	_	
131-5	29372-29389	thalamic–cortical	_	
131-6	29390-29393	and	_	
131-7	29394-29413	cerebellar–cortical	_	
131-8	29414-29424	functional	_	
131-9	29425-29437	connectivity	_	
131-10	29438-29442	have	_	
131-11	29443-29447	been	_	
131-12	29448-29460	consistently	_	
131-13	29461-29469	observed	_	
131-14	29470-29472	in	_	
131-15	29473-29484	populations	_	
131-16	29485-29489	with	_	
131-17	29490-29499	psychosis	_	
131-18	29499-29500	,	_	
131-19	29501-29513	particularly	_	
131-20	29514-29516	SZ	_	
131-21	29516-29517	.	_	

#Text=These alterations can further be found before the onset of psychosis in subjects at high risk, suggesting a trait anomaly that possibly relates to vulnerability to psychotic disorders.
132-1	29518-29523	These	_	
132-2	29524-29535	alterations	_	
132-3	29536-29539	can	_	
132-4	29540-29547	further	_	
132-5	29548-29550	be	_	
132-6	29551-29556	found	_	
132-7	29557-29563	before	_	
132-8	29564-29567	the	_	
132-9	29568-29573	onset	_	
132-10	29574-29576	of	_	
132-11	29577-29586	psychosis	_	
132-12	29587-29589	in	_	
132-13	29590-29598	subjects	_	
132-14	29599-29601	at	_	
132-15	29602-29606	high	_	
132-16	29607-29611	risk	_	
132-17	29611-29612	,	_	
132-18	29613-29623	suggesting	_	
132-19	29624-29625	a	_	
132-20	29626-29631	trait	_	
132-21	29632-29639	anomaly	_	
132-22	29640-29644	that	_	
132-23	29645-29653	possibly	_	
132-24	29654-29661	relates	_	
132-25	29662-29664	to	_	
132-26	29665-29678	vulnerability	_	
132-27	29679-29681	to	_	
132-28	29682-29691	psychotic	_	
132-29	29692-29701	disorders	_	
132-30	29701-29702	.	_	

#Text=Apart from these functional findings, structural changes in thalamus, cerebellum, and prefrontal cortex are also evident in SZ and have been summarized in several meta- or mega-analysis studies.
133-1	29703-29708	Apart	_	
133-2	29709-29713	from	_	
133-3	29714-29719	these	_	
133-4	29720-29730	functional	_	
133-5	29731-29739	findings	_	
133-6	29739-29740	,	_	
133-7	29741-29751	structural	_	
133-8	29752-29759	changes	_	
133-9	29760-29762	in	_	
133-10	29763-29771	thalamus	_	
133-11	29771-29772	,	_	
133-12	29773-29783	cerebellum	_	
133-13	29783-29784	,	_	
133-14	29785-29788	and	_	
133-15	29789-29799	prefrontal	_	
133-16	29800-29806	cortex	_	
133-17	29807-29810	are	_	
133-18	29811-29815	also	_	
133-19	29816-29823	evident	_	
133-20	29824-29826	in	_	
133-21	29827-29829	SZ	_	
133-22	29830-29833	and	_	
133-23	29834-29838	have	_	
133-24	29839-29843	been	_	
133-25	29844-29854	summarized	_	
133-26	29855-29857	in	_	
133-27	29858-29865	several	_	
133-28	29866-29870	meta	_	
133-29	29870-29871	-	_	
133-30	29872-29874	or	_	
133-31	29875-29888	mega-analysis	_	
133-32	29889-29896	studies	_	
133-33	29896-29897	.	_	

#Text=Highly consistent with these prior findings, our research further demonstrates that the dysfunction of the cerebello–thalamo–cortical circuitry may be a fundamental state-independent neural trait that predicts and characterizes psychosis, thereby highlighting the role of this circuitry in the neuropathology and psychopathology of SZ.
134-1	29898-29904	Highly	_	
134-2	29905-29915	consistent	_	
134-3	29916-29920	with	_	
134-4	29921-29926	these	_	
134-5	29927-29932	prior	_	
134-6	29933-29941	findings	_	
134-7	29941-29942	,	_	
134-8	29943-29946	our	_	
134-9	29947-29955	research	_	
134-10	29956-29963	further	_	
134-11	29964-29976	demonstrates	_	
134-12	29977-29981	that	_	
134-13	29982-29985	the	_	
134-14	29986-29997	dysfunction	_	
134-15	29998-30000	of	_	
134-16	30001-30004	the	_	
134-17	30005-30031	cerebello–thalamo–cortical	_	
134-18	30032-30041	circuitry	_	
134-19	30042-30045	may	_	
134-20	30046-30048	be	_	
134-21	30049-30050	a	_	
134-22	30051-30062	fundamental	_	
134-23	30063-30080	state-independent	_	
134-24	30081-30087	neural	_	
134-25	30088-30093	trait	_	
134-26	30094-30098	that	_	
134-27	30099-30107	predicts	_	
134-28	30108-30111	and	_	
134-29	30112-30125	characterizes	_	
134-30	30126-30135	psychosis	_	
134-31	30135-30136	,	_	
134-32	30137-30144	thereby	_	
134-33	30145-30157	highlighting	_	
134-34	30158-30161	the	_	
134-35	30162-30166	role	_	
134-36	30167-30169	of	_	
134-37	30170-30174	this	_	
134-38	30175-30184	circuitry	_	
134-39	30185-30187	in	_	
134-40	30188-30191	the	_	
134-41	30192-30206	neuropathology	_	
134-42	30207-30210	and	_	
134-43	30211-30226	psychopathology	_	
134-44	30227-30229	of	_	
134-45	30230-30232	SZ	_	
134-46	30232-30233	.	_	

#Text=These findings overall may offer a unified framework to explain the complex and heterogeneous behavioral and cognitive phenotypes in psychotic disorders.
135-1	30234-30239	These	_	
135-2	30240-30248	findings	_	
135-3	30249-30256	overall	_	
135-4	30257-30260	may	_	
135-5	30261-30266	offer	_	
135-6	30267-30268	a	_	
135-7	30269-30276	unified	_	
135-8	30277-30286	framework	_	
135-9	30287-30289	to	_	
135-10	30290-30297	explain	_	
135-11	30298-30301	the	_	
135-12	30302-30309	complex	_	
135-13	30310-30313	and	_	
135-14	30314-30327	heterogeneous	_	
135-15	30328-30338	behavioral	_	
135-16	30339-30342	and	_	
135-17	30343-30352	cognitive	_	
135-18	30353-30363	phenotypes	_	
135-19	30364-30366	in	_	
135-20	30367-30376	psychotic	_	
135-21	30377-30386	disorders	_	
135-22	30386-30387	.	_	

#Text=The hyperconnectivity in the identified network is also broadly consistent with the “N-methyl-D-aspartate receptor (NMDAR) hypofunction” hypothesis of SZ.
136-1	30388-30391	The	_	
136-2	30392-30409	hyperconnectivity	_	
136-3	30410-30412	in	_	
136-4	30413-30416	the	_	
136-5	30417-30427	identified	_	
136-6	30428-30435	network	_	
136-7	30436-30438	is	_	
136-8	30439-30443	also	_	
136-9	30444-30451	broadly	_	
136-10	30452-30462	consistent	_	
136-11	30463-30467	with	_	
136-12	30468-30471	the	_	
136-13	30472-30473	“	_	
136-14	30473-30493	N-methyl-D-aspartate	_	
136-15	30494-30502	receptor	_	
136-16	30503-30504	(	_	
136-17	30504-30509	NMDAR	_	
136-18	30509-30510	)	_	
136-19	30511-30523	hypofunction	_	
136-20	30523-30524	”	_	
136-21	30525-30535	hypothesis	_	
136-22	30536-30538	of	_	
136-23	30539-30541	SZ	_	
136-24	30541-30542	.	_	

#Text=Reduced global NMDAR expression and activity have long been observed in patients with SZ, possibly due to underlying genetic and environmental risk factors.
137-1	30543-30550	Reduced	_	
137-2	30551-30557	global	_	
137-3	30558-30563	NMDAR	_	
137-4	30564-30574	expression	_	
137-5	30575-30578	and	_	
137-6	30579-30587	activity	_	
137-7	30588-30592	have	_	
137-8	30593-30597	long	_	
137-9	30598-30602	been	_	
137-10	30603-30611	observed	_	
137-11	30612-30614	in	_	
137-12	30615-30623	patients	_	
137-13	30624-30628	with	_	
137-14	30629-30631	SZ	_	
137-15	30631-30632	,	_	
137-16	30633-30641	possibly	_	
137-17	30642-30645	due	_	
137-18	30646-30648	to	_	
137-19	30649-30659	underlying	_	
137-20	30660-30667	genetic	_	
137-21	30668-30671	and	_	
137-22	30672-30685	environmental	_	
137-23	30686-30690	risk	_	
137-24	30691-30698	factors	_	
137-25	30698-30699	.	_	

#Text=These NMDAR deficits would downward regulate the function of cortical parvalbumin-containing γ-amino-butyric acid (GABA) interneurons, leading to reduced recurrent inhibition of the pyramidal glutamatergic neurons, which in turn, cause exaggerated cortical gamma oscillations and functional connectivity in patients.
138-1	30700-30705	These	_	
138-2	30706-30711	NMDAR	_	
138-3	30712-30720	deficits	_	
138-4	30721-30726	would	_	
138-5	30727-30735	downward	_	
138-6	30736-30744	regulate	_	
138-7	30745-30748	the	_	
138-8	30749-30757	function	_	
138-9	30758-30760	of	_	
138-10	30761-30769	cortical	_	
138-11	30770-30792	parvalbumin-containing	_	
138-12	30793-30808	γ-amino-butyric	_	
138-13	30809-30813	acid	_	
138-14	30814-30815	(	_	
138-15	30815-30819	GABA	_	
138-16	30819-30820	)	_	
138-17	30821-30833	interneurons	_	
138-18	30833-30834	,	_	
138-19	30835-30842	leading	_	
138-20	30843-30845	to	_	
138-21	30846-30853	reduced	_	
138-22	30854-30863	recurrent	_	
138-23	30864-30874	inhibition	_	
138-24	30875-30877	of	_	
138-25	30878-30881	the	_	
138-26	30882-30891	pyramidal	_	
138-27	30892-30905	glutamatergic	_	
138-28	30906-30913	neurons	_	
138-29	30913-30914	,	_	
138-30	30915-30920	which	_	
138-31	30921-30923	in	_	
138-32	30924-30928	turn	_	
138-33	30928-30929	,	_	
138-34	30930-30935	cause	_	
138-35	30936-30947	exaggerated	_	
138-36	30948-30956	cortical	_	
138-37	30957-30962	gamma	_	
138-38	30963-30975	oscillations	_	
138-39	30976-30979	and	_	
138-40	30980-30990	functional	_	
138-41	30991-31003	connectivity	_	
138-42	31004-31006	in	_	
138-43	31007-31015	patients	_	
138-44	31015-31016	.	_	

#Text=As a result, the hyperconnectivity in the cerebello–thalamo–cortical circuitry in our study may reflect a downstream phenomenon of NMDAR functional deficits, which occurs prior to the onset of psychosis and maintains during the full psychosis state.
139-1	31017-31019	As	_	
139-2	31020-31021	a	_	
139-3	31022-31028	result	_	
139-4	31028-31029	,	_	
139-5	31030-31033	the	_	
139-6	31034-31051	hyperconnectivity	_	
139-7	31052-31054	in	_	
139-8	31055-31058	the	_	
139-9	31059-31085	cerebello–thalamo–cortical	_	
139-10	31086-31095	circuitry	_	
139-11	31096-31098	in	_	
139-12	31099-31102	our	_	
139-13	31103-31108	study	_	
139-14	31109-31112	may	_	
139-15	31113-31120	reflect	_	
139-16	31121-31122	a	_	
139-17	31123-31133	downstream	_	
139-18	31134-31144	phenomenon	_	
139-19	31145-31147	of	_	
139-20	31148-31153	NMDAR	_	
139-21	31154-31164	functional	_	
139-22	31165-31173	deficits	_	
139-23	31173-31174	,	_	
139-24	31175-31180	which	_	
139-25	31181-31187	occurs	_	
139-26	31188-31193	prior	_	
139-27	31194-31196	to	_	
139-28	31197-31200	the	_	
139-29	31201-31206	onset	_	
139-30	31207-31209	of	_	
139-31	31210-31219	psychosis	_	
139-32	31220-31223	and	_	
139-33	31224-31233	maintains	_	
139-34	31234-31240	during	_	
139-35	31241-31244	the	_	
139-36	31245-31249	full	_	
139-37	31250-31259	psychosis	_	
139-38	31260-31265	state	_	
139-39	31265-31266	.	_	

#Text=Another interpretation, in line with the “cognitive dysmetria” theory, relates to the need for increased cognitive effort in SZ patients, as well as in subjects at CHR.
140-1	31267-31274	Another	_	
140-2	31275-31289	interpretation	_	
140-3	31289-31290	,	_	
140-4	31291-31293	in	_	
140-5	31294-31298	line	_	
140-6	31299-31303	with	_	
140-7	31304-31307	the	_	
140-8	31308-31309	“	_	
140-9	31309-31318	cognitive	_	
140-10	31319-31328	dysmetria	_	
140-11	31328-31329	”	_	
140-12	31330-31336	theory	_	
140-13	31336-31337	,	_	
140-14	31338-31345	relates	_	
140-15	31346-31348	to	_	
140-16	31349-31352	the	_	
140-17	31353-31357	need	_	
140-18	31358-31361	for	_	
140-19	31362-31371	increased	_	
140-20	31372-31381	cognitive	_	
140-21	31382-31388	effort	_	
140-22	31389-31391	in	_	
140-23	31392-31394	SZ	_	
140-24	31395-31403	patients	_	
140-25	31403-31404	,	_	
140-26	31405-31407	as	_	
140-27	31408-31412	well	_	
140-28	31413-31415	as	_	
140-29	31416-31418	in	_	
140-30	31419-31427	subjects	_	
140-31	31428-31430	at	_	
140-32	31431-31434	CHR	_	
140-33	31434-31435	.	_	

#Text=A large body of work has pointed to the role of cerebellum as a general “error detection and correction” center in the brain, which receives, integrates, and computes error information regarding both movement and thought from the cerebral cortex and provides adaptive feedback via the cerebello–thalamo–cortical circuitry.
141-1	31436-31437	A	_	
141-2	31438-31443	large	_	
141-3	31444-31448	body	_	
141-4	31449-31451	of	_	
141-5	31452-31456	work	_	
141-6	31457-31460	has	_	
141-7	31461-31468	pointed	_	
141-8	31469-31471	to	_	
141-9	31472-31475	the	_	
141-10	31476-31480	role	_	
141-11	31481-31483	of	_	
141-12	31484-31494	cerebellum	_	
141-13	31495-31497	as	_	
141-14	31498-31499	a	_	
141-15	31500-31507	general	_	
141-16	31508-31509	“	_	
141-17	31509-31514	error	_	
141-18	31515-31524	detection	_	
141-19	31525-31528	and	_	
141-20	31529-31539	correction	_	
141-21	31539-31540	”	_	
141-22	31541-31547	center	_	
141-23	31548-31550	in	_	
141-24	31551-31554	the	_	
141-25	31555-31560	brain	_	
141-26	31560-31561	,	_	
141-27	31562-31567	which	_	
141-28	31568-31576	receives	_	
141-29	31576-31577	,	_	
141-30	31578-31588	integrates	_	
141-31	31588-31589	,	_	
141-32	31590-31593	and	_	
141-33	31594-31602	computes	_	
141-34	31603-31608	error	_	
141-35	31609-31620	information	_	
141-36	31621-31630	regarding	_	
141-37	31631-31635	both	_	
141-38	31636-31644	movement	_	
141-39	31645-31648	and	_	
141-40	31649-31656	thought	_	
141-41	31657-31661	from	_	
141-42	31662-31665	the	_	
141-43	31666-31674	cerebral	_	
141-44	31675-31681	cortex	_	
141-45	31682-31685	and	_	
141-46	31686-31694	provides	_	
141-47	31695-31703	adaptive	_	
141-48	31704-31712	feedback	_	
141-49	31713-31716	via	_	
141-50	31717-31720	the	_	
141-51	31721-31747	cerebello–thalamo–cortical	_	
141-52	31748-31757	circuitry	_	
141-53	31757-31758	.	_	

#Text=In parallel with this notion, the hyperconnectivity in this circuitry may reflect a compensatory effect induced by excessive error input from the upstream cerebral cortex.
142-1	31759-31761	In	_	
142-2	31762-31770	parallel	_	
142-3	31771-31775	with	_	
142-4	31776-31780	this	_	
142-5	31781-31787	notion	_	
142-6	31787-31788	,	_	
142-7	31789-31792	the	_	
142-8	31793-31810	hyperconnectivity	_	
142-9	31811-31813	in	_	
142-10	31814-31818	this	_	
142-11	31819-31828	circuitry	_	
142-12	31829-31832	may	_	
142-13	31833-31840	reflect	_	
142-14	31841-31842	a	_	
142-15	31843-31855	compensatory	_	
142-16	31856-31862	effect	_	
142-17	31863-31870	induced	_	
142-18	31871-31873	by	_	
142-19	31874-31883	excessive	_	
142-20	31884-31889	error	_	
142-21	31890-31895	input	_	
142-22	31896-31900	from	_	
142-23	31901-31904	the	_	
142-24	31905-31913	upstream	_	
142-25	31914-31922	cerebral	_	
142-26	31923-31929	cortex	_	
142-27	31929-31930	.	_	

#Text=In other words, individuals with psychosis and at high risk may require more effort in error processing in order to coordinate their behaviors and thoughts.
143-1	31931-31933	In	_	
143-2	31934-31939	other	_	
143-3	31940-31945	words	_	
143-4	31945-31946	,	_	
143-5	31947-31958	individuals	_	
143-6	31959-31963	with	_	
143-7	31964-31973	psychosis	_	
143-8	31974-31977	and	_	
143-9	31978-31980	at	_	
143-10	31981-31985	high	_	
143-11	31986-31990	risk	_	
143-12	31991-31994	may	_	
143-13	31995-32002	require	_	
143-14	32003-32007	more	_	
143-15	32008-32014	effort	_	
143-16	32015-32017	in	_	
143-17	32018-32023	error	_	
143-18	32024-32034	processing	_	
143-19	32035-32037	in	_	
143-20	32038-32043	order	_	
143-21	32044-32046	to	_	
143-22	32047-32057	coordinate	_	
143-23	32058-32063	their	_	
143-24	32064-32073	behaviors	_	
143-25	32074-32077	and	_	
143-26	32078-32086	thoughts	_	
143-27	32086-32087	.	_	

#Text=Our study has some limitations to note.
144-1	32088-32091	Our	_	
144-2	32092-32097	study	_	
144-3	32098-32101	has	_	
144-4	32102-32106	some	_	
144-5	32107-32118	limitations	_	
144-6	32119-32121	to	_	
144-7	32122-32126	note	_	
144-8	32126-32127	.	_	

#Text=First, the results reported here were based on the PCA analysis of the original connectivity matrices across multiple paradigms, which essentially extracted the individual-specific connectivity characteristics in brain organization.
145-1	32128-32133	First	_	
145-2	32133-32134	,	_	
145-3	32135-32138	the	_	
145-4	32139-32146	results	_	
145-5	32147-32155	reported	_	
145-6	32156-32160	here	_	
145-7	32161-32165	were	_	
145-8	32166-32171	based	_	
145-9	32172-32174	on	_	
145-10	32175-32178	the	_	
145-11	32179-32182	PCA	_	
145-12	32183-32191	analysis	_	
145-13	32192-32194	of	_	
145-14	32195-32198	the	_	
145-15	32199-32207	original	_	
145-16	32208-32220	connectivity	_	
145-17	32221-32229	matrices	_	
145-18	32230-32236	across	_	
145-19	32237-32245	multiple	_	
145-20	32246-32255	paradigms	_	
145-21	32255-32256	,	_	
145-22	32257-32262	which	_	
145-23	32263-32274	essentially	_	
145-24	32275-32284	extracted	_	
145-25	32285-32288	the	_	
145-26	32289-32308	individual-specific	_	
145-27	32309-32321	connectivity	_	
145-28	32322-32337	characteristics	_	
145-29	32338-32340	in	_	
145-30	32341-32346	brain	_	
145-31	32347-32359	organization	_	
145-32	32359-32360	.	_	

#Text=These individual-specific connectivity characteristics, although largely attributed to biological and (patho)physiological differences, may also be affected by other factors such as demographics, head motion, and medication.
146-1	32361-32366	These	_	
146-2	32367-32386	individual-specific	_	
146-3	32387-32399	connectivity	_	
146-4	32400-32415	characteristics	_	
146-5	32415-32416	,	_	
146-6	32417-32425	although	_	
146-7	32426-32433	largely	_	
146-8	32434-32444	attributed	_	
146-9	32445-32447	to	_	
146-10	32448-32458	biological	_	
146-11	32459-32462	and	_	
146-12	32463-32464	(	_	
146-13	32464-32469	patho	_	
146-14	32469-32470	)	_	
146-15	32470-32483	physiological	_	
146-16	32484-32495	differences	_	
146-17	32495-32496	,	_	
146-18	32497-32500	may	_	
146-19	32501-32505	also	_	
146-20	32506-32508	be	_	
146-21	32509-32517	affected	_	
146-22	32518-32520	by	_	
146-23	32521-32526	other	_	
146-24	32527-32534	factors	_	
146-25	32535-32539	such	_	
146-26	32540-32542	as	_	
146-27	32543-32555	demographics	_	
146-28	32555-32556	,	_	
146-29	32557-32561	head	_	
146-30	32562-32568	motion	_	
146-31	32568-32569	,	_	
146-32	32570-32573	and	_	
146-33	32574-32584	medication	_	
146-34	32584-32585	.	_	

#Text=Although we sought to control these factors by directly modeling these variables in our analyses and by verifying results in subsamples matched on these features, we cannot fully exclude the possibility that our findings may to certain degree be influenced by other factors that we have not measured.
147-1	32586-32594	Although	_	
147-2	32595-32597	we	_	
147-3	32598-32604	sought	_	
147-4	32605-32607	to	_	
147-5	32608-32615	control	_	
147-6	32616-32621	these	_	
147-7	32622-32629	factors	_	
147-8	32630-32632	by	_	
147-9	32633-32641	directly	_	
147-10	32642-32650	modeling	_	
147-11	32651-32656	these	_	
147-12	32657-32666	variables	_	
147-13	32667-32669	in	_	
147-14	32670-32673	our	_	
147-15	32674-32682	analyses	_	
147-16	32683-32686	and	_	
147-17	32687-32689	by	_	
147-18	32690-32699	verifying	_	
147-19	32700-32707	results	_	
147-20	32708-32710	in	_	
147-21	32711-32721	subsamples	_	
147-22	32722-32729	matched	_	
147-23	32730-32732	on	_	
147-24	32733-32738	these	_	
147-25	32739-32747	features	_	
147-26	32747-32748	,	_	
147-27	32749-32751	we	_	
147-28	32752-32758	cannot	_	
147-29	32759-32764	fully	_	
147-30	32765-32772	exclude	_	
147-31	32773-32776	the	_	
147-32	32777-32788	possibility	_	
147-33	32789-32793	that	_	
147-34	32794-32797	our	_	
147-35	32798-32806	findings	_	
147-36	32807-32810	may	_	
147-37	32811-32813	to	_	
147-38	32814-32821	certain	_	
147-39	32822-32828	degree	_	
147-40	32829-32831	be	_	
147-41	32832-32842	influenced	_	
147-42	32843-32845	by	_	
147-43	32846-32851	other	_	
147-44	32852-32859	factors	_	
147-45	32860-32864	that	_	
147-46	32865-32867	we	_	
147-47	32868-32872	have	_	
147-48	32873-32876	not	_	
147-49	32877-32885	measured	_	
147-50	32885-32886	.	_	

#Text=Second, despite the fact that our study was performed on one of the largest psychosis CHR fMRI sample to date, the number of converters in our NAPLS-2 sample was relatively small.
148-1	32887-32893	Second	_	
148-2	32893-32894	,	_	
148-3	32895-32902	despite	_	
148-4	32903-32906	the	_	
148-5	32907-32911	fact	_	
148-6	32912-32916	that	_	
148-7	32917-32920	our	_	
148-8	32921-32926	study	_	
148-9	32927-32930	was	_	
148-10	32931-32940	performed	_	
148-11	32941-32943	on	_	
148-12	32944-32947	one	_	
148-13	32948-32950	of	_	
148-14	32951-32954	the	_	
148-15	32955-32962	largest	_	
148-16	32963-32972	psychosis	_	
148-17	32973-32976	CHR	_	
148-18	32977-32981	fMRI	_	
148-19	32982-32988	sample	_	
148-20	32989-32991	to	_	
148-21	32992-32996	date	_	
148-22	32996-32997	,	_	
148-23	32998-33001	the	_	
148-24	33002-33008	number	_	
148-25	33009-33011	of	_	
148-26	33012-33022	converters	_	
148-27	33023-33025	in	_	
148-28	33026-33029	our	_	
148-29	33030-33035	NAPLS	_	
148-30	33035-33036	-	_	
148-31	33036-33037	2	_	
148-32	33038-33044	sample	_	
148-33	33045-33048	was	_	
148-34	33049-33059	relatively	_	
148-35	33060-33065	small	_	
148-36	33065-33066	.	_	

#Text=Therefore, future replications are encouraged in larger cohorts with more data available for converters.
149-1	33067-33076	Therefore	_	
149-2	33076-33077	,	_	
149-3	33078-33084	future	_	
149-4	33085-33097	replications	_	
149-5	33098-33101	are	_	
149-6	33102-33112	encouraged	_	
149-7	33113-33115	in	_	
149-8	33116-33122	larger	_	
149-9	33123-33130	cohorts	_	
149-10	33131-33135	with	_	
149-11	33136-33140	more	_	
149-12	33141-33145	data	_	
149-13	33146-33155	available	_	
149-14	33156-33159	for	_	
149-15	33160-33170	converters	_	
149-16	33170-33171	.	_	

#Text=Third, all patients recruited in the CNP cohort were chronic patients.
150-1	33172-33177	Third	_	
150-2	33177-33178	,	_	
150-3	33179-33182	all	_	
150-4	33183-33191	patients	_	
150-5	33192-33201	recruited	_	
150-6	33202-33204	in	_	
150-7	33205-33208	the	_	
150-8	33209-33212	CNP	_	
150-9	33213-33219	cohort	_	
150-10	33220-33224	were	_	
150-11	33225-33232	chronic	_	
150-12	33233-33241	patients	_	
150-13	33241-33242	.	_	

#Text=As a result, the detected connectivity differences between groups may also partly reflect differences in disease chronicity, treatment, comorbidity, among others.
151-1	33243-33245	As	_	
151-2	33246-33247	a	_	
151-3	33248-33254	result	_	
151-4	33254-33255	,	_	
151-5	33256-33259	the	_	
151-6	33260-33268	detected	_	
151-7	33269-33281	connectivity	_	
151-8	33282-33293	differences	_	
151-9	33294-33301	between	_	
151-10	33302-33308	groups	_	
151-11	33309-33312	may	_	
151-12	33313-33317	also	_	
151-13	33318-33324	partly	_	
151-14	33325-33332	reflect	_	
151-15	33333-33344	differences	_	
151-16	33345-33347	in	_	
151-17	33348-33355	disease	_	
151-18	33356-33366	chronicity	_	
151-19	33366-33367	,	_	
151-20	33368-33377	treatment	_	
151-21	33377-33378	,	_	
151-22	33379-33390	comorbidity	_	
151-23	33390-33391	,	_	
151-24	33392-33397	among	_	
151-25	33398-33404	others	_	
151-26	33404-33405	.	_	

#Text=Due to the lack of sufficient clinical data in the CNP sample, these factors cannot be isolated and thus may to certain degree contribute to the current findings.
152-1	33406-33409	Due	_	
152-2	33410-33412	to	_	
152-3	33413-33416	the	_	
152-4	33417-33421	lack	_	
152-5	33422-33424	of	_	
152-6	33425-33435	sufficient	_	
152-7	33436-33444	clinical	_	
152-8	33445-33449	data	_	
152-9	33450-33452	in	_	
152-10	33453-33456	the	_	
152-11	33457-33460	CNP	_	
152-12	33461-33467	sample	_	
152-13	33467-33468	,	_	
152-14	33469-33474	these	_	
152-15	33475-33482	factors	_	
152-16	33483-33489	cannot	_	
152-17	33490-33492	be	_	
152-18	33493-33501	isolated	_	
152-19	33502-33505	and	_	
152-20	33506-33510	thus	_	
152-21	33511-33514	may	_	
152-22	33515-33517	to	_	
152-23	33518-33525	certain	_	
152-24	33526-33532	degree	_	
152-25	33533-33543	contribute	_	
152-26	33544-33546	to	_	
152-27	33547-33550	the	_	
152-28	33551-33558	current	_	
152-29	33559-33567	findings	_	
152-30	33567-33568	.	_	

#Text=To sum up, using multi-paradigm fMRI data from two independent cohorts, our study provides the first evidence for cerebello–thalamo–cortical hyperconnectivity as a state-independent neural trait for psychosis prediction and characterization.
153-1	33569-33571	To	_	
153-2	33572-33575	sum	_	
153-3	33576-33578	up	_	
153-4	33578-33579	,	_	
153-5	33580-33585	using	_	
153-6	33586-33600	multi-paradigm	_	
153-7	33601-33605	fMRI	_	
153-8	33606-33610	data	_	
153-9	33611-33615	from	_	
153-10	33616-33619	two	_	
153-11	33620-33631	independent	_	
153-12	33632-33639	cohorts	_	
153-13	33639-33640	,	_	
153-14	33641-33644	our	_	
153-15	33645-33650	study	_	
153-16	33651-33659	provides	_	
153-17	33660-33663	the	_	
153-18	33664-33669	first	_	
153-19	33670-33678	evidence	_	
153-20	33679-33682	for	_	
153-21	33683-33709	cerebello–thalamo–cortical	_	
153-22	33710-33727	hyperconnectivity	_	
153-23	33728-33730	as	_	
153-24	33731-33732	a	_	
153-25	33733-33750	state-independent	_	
153-26	33751-33757	neural	_	
153-27	33758-33763	trait	_	
153-28	33764-33767	for	_	
153-29	33768-33777	psychosis	_	
153-30	33778-33788	prediction	_	
153-31	33789-33792	and	_	
153-32	33793-33809	characterization	_	
153-33	33809-33810	.	_	

#Text=The results revealed in the study converge with established theories of SZ focusing on coordination and timing of cognitive and motor systems as well as excitation–inhibition balance, and may potentially help to advance a more unified framework for understanding of the neuropathology of psychosis.
154-1	33811-33814	The	_	
154-2	33815-33822	results	_	
154-3	33823-33831	revealed	_	
154-4	33832-33834	in	_	
154-5	33835-33838	the	_	
154-6	33839-33844	study	_	
154-7	33845-33853	converge	_	
154-8	33854-33858	with	_	
154-9	33859-33870	established	_	
154-10	33871-33879	theories	_	
154-11	33880-33882	of	_	
154-12	33883-33885	SZ	_	
154-13	33886-33894	focusing	_	
154-14	33895-33897	on	_	
154-15	33898-33910	coordination	_	
154-16	33911-33914	and	_	
154-17	33915-33921	timing	_	
154-18	33922-33924	of	_	
154-19	33925-33934	cognitive	_	
154-20	33935-33938	and	_	
154-21	33939-33944	motor	_	
154-22	33945-33952	systems	_	
154-23	33953-33955	as	_	
154-24	33956-33960	well	_	
154-25	33961-33963	as	_	
154-26	33964-33985	excitation–inhibition	_	
154-27	33986-33993	balance	_	
154-28	33993-33994	,	_	
154-29	33995-33998	and	_	
154-30	33999-34002	may	_	
154-31	34003-34014	potentially	_	
154-32	34015-34019	help	_	
154-33	34020-34022	to	_	
154-34	34023-34030	advance	_	
154-35	34031-34032	a	_	
154-36	34033-34037	more	_	
154-37	34038-34045	unified	_	
154-38	34046-34055	framework	_	
154-39	34056-34059	for	_	
154-40	34060-34073	understanding	_	
154-41	34074-34076	of	_	
154-42	34077-34080	the	_	
154-43	34081-34095	neuropathology	_	
154-44	34096-34098	of	_	
154-45	34099-34108	psychosis	_	
154-46	34108-34109	.	_	

#Text=Future research is encouraged to replicate these findings and to investigate the nuanced role of this circuitry in relation to cognitive, symptomatic, and other features of psychotic illness.
155-1	34110-34116	Future	_	
155-2	34117-34125	research	_	
155-3	34126-34128	is	_	
155-4	34129-34139	encouraged	_	
155-5	34140-34142	to	_	
155-6	34143-34152	replicate	_	
155-7	34153-34158	these	_	
155-8	34159-34167	findings	_	
155-9	34168-34171	and	_	
155-10	34172-34174	to	_	
155-11	34175-34186	investigate	_	
155-12	34187-34190	the	_	
155-13	34191-34198	nuanced	_	
155-14	34199-34203	role	_	
155-15	34204-34206	of	_	
155-16	34207-34211	this	_	
155-17	34212-34221	circuitry	_	
155-18	34222-34224	in	_	
155-19	34225-34233	relation	_	
155-20	34234-34236	to	_	
155-21	34237-34246	cognitive	_	
155-22	34246-34247	,	_	
155-23	34248-34259	symptomatic	_	
155-24	34259-34260	,	_	
155-25	34261-34264	and	_	
155-26	34265-34270	other	_	
155-27	34271-34279	features	_	
155-28	34280-34282	of	_	
155-29	34283-34292	psychotic	_	
155-30	34293-34300	illness	_	
155-31	34300-34301	.	_	

#Text=Methods
#Text=Subjects
#Text=The NAPLS-2 sample consisted of 182 subjects at CHR for psychosis (including 19 subjects who converted to psychosis during follow-up (CHR-C) and 163 subjects who did not convert (CHR-NC)) and 120 healthy controls (HC) as part of the NAPLS-2 project recruited from eight study sites across the United States and Canada.
156-1	34302-34309	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
156-2	34310-34318	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-3	34319-34322	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-4	34323-34328	NAPLS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-5	34328-34329	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-6	34329-34330	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-7	34331-34337	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-8	34338-34347	consisted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-9	34348-34350	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-10	34351-34354	182	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-11	34355-34363	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-12	34364-34366	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-13	34367-34370	CHR	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#HighRisk[3]	
156-14	34371-34374	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-15	34375-34384	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#PsychoticDisorder[4]	
156-16	34385-34386	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-17	34386-34395	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-18	34396-34398	19	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-19	34399-34407	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-20	34408-34411	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-21	34412-34421	converted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-22	34422-34424	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-23	34425-34434	psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-24	34435-34441	during	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-25	34442-34451	follow-up	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-26	34452-34453	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-27	34453-34458	CHR-C	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-28	34458-34459	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-29	34460-34463	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-30	34464-34467	163	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-31	34468-34476	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-32	34477-34480	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-33	34481-34484	did	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-34	34485-34488	not	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-35	34489-34496	convert	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-36	34497-34498	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-37	34498-34504	CHR-NC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-38	34504-34505	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-39	34505-34506	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-40	34507-34510	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-41	34511-34514	120	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-42	34515-34522	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
156-43	34523-34531	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
156-44	34532-34533	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
156-45	34533-34535	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
156-46	34535-34536	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[5]	
156-47	34537-34539	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-48	34540-34544	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-49	34545-34547	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-50	34548-34551	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-51	34552-34557	NAPLS	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-52	34557-34558	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-53	34558-34559	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-54	34560-34567	project	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-55	34568-34577	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-56	34578-34582	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-57	34583-34588	eight	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-58	34589-34594	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-59	34595-34600	sites	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-60	34601-34607	across	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-61	34608-34611	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-62	34612-34618	United	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-63	34619-34625	States	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-64	34626-34629	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-65	34630-34636	Canada	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
156-66	34636-34637	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=All included subjects completed a battery of fMRI scans with five different paradigms (resting state, working memory, episodic memory encoding, episodic memory retrieval, emotional face processing) at the initial recruitment point.
157-1	34638-34641	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-2	34642-34650	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-3	34651-34659	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-4	34660-34669	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-5	34670-34671	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-6	34672-34679	battery	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-7	34680-34682	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-8	34683-34687	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]|http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging[7]	
157-9	34688-34693	scans	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-10	34694-34698	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-11	34699-34703	five	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-12	34704-34713	different	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-13	34714-34723	paradigms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-14	34724-34725	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-15	34725-34732	resting	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-16	34733-34738	state	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-17	34738-34739	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-18	34740-34747	working	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-19	34748-34754	memory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-20	34754-34755	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-21	34756-34764	episodic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-22	34765-34771	memory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-23	34772-34780	encoding	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-24	34780-34781	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-25	34782-34790	episodic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-26	34791-34797	memory	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-27	34798-34807	retrieval	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-28	34807-34808	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-29	34809-34818	emotional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-30	34819-34823	face	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-31	34824-34834	processing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-32	34834-34835	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-33	34836-34838	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-34	34839-34842	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-35	34843-34850	initial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-36	34851-34862	recruitment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-37	34863-34868	point	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	
157-38	34868-34869	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[6]	

#Text=The participants provided written informed consent for the study.
158-1	34870-34873	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-2	34874-34886	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-3	34887-34895	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-4	34896-34903	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-5	34904-34912	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-6	34913-34920	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-7	34921-34924	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-8	34925-34928	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-9	34929-34934	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
158-10	34934-34935	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=The protocol and consent forms were approved by the institutional review boards at each site.
159-1	34936-34939	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-2	34940-34948	protocol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-3	34949-34952	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-4	34953-34960	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-5	34961-34966	forms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-6	34967-34971	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-7	34972-34980	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-8	34981-34983	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-9	34984-34987	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-10	34988-35001	institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-11	35002-35008	review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-12	35009-35015	boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-13	35016-35018	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-14	35019-35023	each	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-15	35024-35028	site	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	
159-16	35028-35029	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[9]	

#Text=The CNP sample was drawn from a publicly available dataset (UCLA CNP study, https://openfmri.org/dataset/ds000030/).
160-1	35030-35033	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-2	35034-35037	CNP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-3	35038-35044	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-4	35045-35048	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-5	35049-35054	drawn	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-6	35055-35059	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-7	35060-35061	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-8	35062-35070	publicly	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-9	35071-35080	available	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-10	35081-35088	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-11	35089-35090	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-12	35090-35094	UCLA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-13	35095-35098	CNP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-14	35099-35104	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-15	35104-35105	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-16	35106-35111	https	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-17	35111-35112	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-18	35112-35113	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-19	35113-35114	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-20	35114-35126	openfmri.org	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-21	35126-35127	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-22	35127-35134	dataset	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-23	35134-35135	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-24	35135-35143	ds000030	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-25	35143-35144	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-26	35144-35145	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	
160-27	35145-35146	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]	

#Text=The final sample used in this study included 50 patients with SZ, 49 patients with BD, 40 patients with ADHD, and 123 HCs.
161-1	35147-35150	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-2	35151-35156	final	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-3	35157-35163	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-4	35164-35168	used	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-5	35169-35171	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-6	35172-35176	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-7	35177-35182	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-8	35183-35191	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-9	35192-35194	50	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-10	35195-35203	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-11	35204-35208	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-12	35209-35211	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[12]	
161-13	35211-35212	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-14	35213-35215	49	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-15	35216-35224	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-16	35225-35229	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-17	35230-35232	BD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#BipolarDisorder[13]	
161-18	35232-35233	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-19	35234-35236	40	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-20	35237-35245	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-21	35246-35250	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-22	35251-35255	ADHD	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#AttentionDeficitHyperactivityDisorder[14]	
161-23	35255-35256	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-24	35257-35260	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-25	35261-35264	123	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
161-26	35265-35268	HCs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[15]	
161-27	35268-35269	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=The included participants underwent some or all of the seven paradigms employed in the cohort (resting state, risk taking, working memory, episodic memory encoding, episodic memory retrieval, stop signal, task switching).
162-1	35270-35273	The	_	
162-2	35274-35282	included	_	
162-3	35283-35295	participants	_	
162-4	35296-35305	underwent	_	
162-5	35306-35310	some	_	
162-6	35311-35313	or	_	
162-7	35314-35317	all	_	
162-8	35318-35320	of	_	
162-9	35321-35324	the	_	
162-10	35325-35330	seven	_	
162-11	35331-35340	paradigms	_	
162-12	35341-35349	employed	_	
162-13	35350-35352	in	_	
162-14	35353-35356	the	_	
162-15	35357-35363	cohort	_	
162-16	35364-35365	(	_	
162-17	35365-35372	resting	_	
162-18	35373-35378	state	_	
162-19	35378-35379	,	_	
162-20	35380-35384	risk	_	
162-21	35385-35391	taking	_	
162-22	35391-35392	,	_	
162-23	35393-35400	working	_	
162-24	35401-35407	memory	_	
162-25	35407-35408	,	_	
162-26	35409-35417	episodic	_	
162-27	35418-35424	memory	_	
162-28	35425-35433	encoding	_	
162-29	35433-35434	,	_	
162-30	35435-35443	episodic	_	
162-31	35444-35450	memory	_	
162-32	35451-35460	retrieval	_	
162-33	35460-35461	,	_	
162-34	35462-35466	stop	_	
162-35	35467-35473	signal	_	
162-36	35473-35474	,	_	
162-37	35475-35479	task	_	
162-38	35480-35489	switching	_	
162-39	35489-35490	)	_	
162-40	35490-35491	.	_	

#Text=Subjects provided written informed consent following procedures approved by the Institutional Review Boards at UCLA and the Los Angeles County Department of Mental Health.
163-1	35492-35500	Subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-2	35501-35509	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-3	35510-35517	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-4	35518-35526	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-5	35527-35534	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-6	35535-35544	following	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-7	35545-35555	procedures	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-8	35556-35564	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-9	35565-35567	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-10	35568-35571	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-11	35572-35585	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-12	35586-35592	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-13	35593-35599	Boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-14	35600-35602	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-15	35603-35607	UCLA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-16	35608-35611	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-17	35612-35615	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-18	35616-35619	Los	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-19	35620-35627	Angeles	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-20	35628-35634	County	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-21	35635-35645	Department	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-22	35646-35648	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-23	35649-35655	Mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-24	35656-35662	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
163-25	35662-35663	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	

#Text=Details on both samples are provided in Supplementary Methods.
164-1	35664-35671	Details	_	
164-2	35672-35674	on	_	
164-3	35675-35679	both	_	
164-4	35680-35687	samples	_	
164-5	35688-35691	are	_	
164-6	35692-35700	provided	_	
164-7	35701-35703	in	_	
164-8	35704-35717	Supplementary	_	
164-9	35718-35725	Methods	_	
164-10	35725-35726	.	_	

#Text=Common data processing for both samples
#Text=Both samples followed the same preprocessing pipelines using the Statistical Parametric Mapping software (SPM12, [http://www.fil.ion.ucl.ac.uk/spm/software/spm12/]).
165-1	35727-35733	Common	_	
165-2	35734-35738	data	_	
165-3	35739-35749	processing	_	
165-4	35750-35753	for	_	
165-5	35754-35758	both	_	
165-6	35759-35766	samples	_	
165-7	35767-35771	Both	_	
165-8	35772-35779	samples	_	
165-9	35780-35788	followed	_	
165-10	35789-35792	the	_	
165-11	35793-35797	same	_	
165-12	35798-35811	preprocessing	_	
165-13	35812-35821	pipelines	_	
165-14	35822-35827	using	_	
165-15	35828-35831	the	_	
165-16	35832-35843	Statistical	_	
165-17	35844-35854	Parametric	_	
165-18	35855-35862	Mapping	_	
165-19	35863-35871	software	_	
165-20	35872-35873	(	_	
165-21	35873-35878	SPM12	_	
165-22	35878-35879	,	_	
165-23	35880-35881	[	_	
165-24	35881-35885	http	_	
165-25	35885-35886	:	_	
165-26	35886-35887	/	_	
165-27	35887-35888	/	_	
165-28	35888-35909	www.fil.ion.ucl.ac.uk	_	
165-29	35909-35910	/	_	
165-30	35910-35913	spm	_	
165-31	35913-35914	/	_	
165-32	35914-35922	software	_	
165-33	35922-35923	/	_	
165-34	35923-35928	spm12	_	
165-35	35928-35929	/	_	
165-36	35929-35930	]	_	
165-37	35930-35931	)	_	
165-38	35931-35932	.	_	

#Text=After preprocessing, we extracted the mean time series from each of the 270 nodes in the extended Power atlas as previously defined.
166-1	35933-35938	After	_	
166-2	35939-35952	preprocessing	_	
166-3	35952-35953	,	_	
166-4	35954-35956	we	_	
166-5	35957-35966	extracted	_	
166-6	35967-35970	the	_	
166-7	35971-35975	mean	_	
166-8	35976-35980	time	_	
166-9	35981-35987	series	_	
166-10	35988-35992	from	_	
166-11	35993-35997	each	_	
166-12	35998-36000	of	_	
166-13	36001-36004	the	_	
166-14	36005-36008	270	_	
166-15	36009-36014	nodes	_	
166-16	36015-36017	in	_	
166-17	36018-36021	the	_	
166-18	36022-36030	extended	_	
166-19	36031-36036	Power	_	
166-20	36037-36042	atlas	_	
166-21	36043-36045	as	_	
166-22	36046-36056	previously	_	
166-23	36057-36064	defined	_	
166-24	36064-36065	.	_	

#Text=The extracted time series were further corrected for mean effects of task-evoked coactivations, white matter (WM) and cerebrospinal (CSF) signals, 24 head motion parameters (6 translation and rotation parameters, their first derivatives, and the square of these 12 parameters), and frame-wise displacement (FD), and then temporally filtered (rest data: band-pass 0.008-0.1 Hz; task data: high-pass 0.008 Hz).
167-1	36066-36069	The	_	
167-2	36070-36079	extracted	_	
167-3	36080-36084	time	_	
167-4	36085-36091	series	_	
167-5	36092-36096	were	_	
167-6	36097-36104	further	_	
167-7	36105-36114	corrected	_	
167-8	36115-36118	for	_	
167-9	36119-36123	mean	_	
167-10	36124-36131	effects	_	
167-11	36132-36134	of	_	
167-12	36135-36146	task-evoked	_	
167-13	36147-36160	coactivations	_	
167-14	36160-36161	,	_	
167-15	36162-36167	white	_	
167-16	36168-36174	matter	_	
167-17	36175-36176	(	_	
167-18	36176-36178	WM	_	
167-19	36178-36179	)	_	
167-20	36180-36183	and	_	
167-21	36184-36197	cerebrospinal	_	
167-22	36198-36199	(	_	
167-23	36199-36202	CSF	_	
167-24	36202-36203	)	_	
167-25	36204-36211	signals	_	
167-26	36211-36212	,	_	
167-27	36213-36215	24	_	
167-28	36216-36220	head	_	
167-29	36221-36227	motion	_	
167-30	36228-36238	parameters	_	
167-31	36239-36240	(	_	
167-32	36240-36241	6	_	
167-33	36242-36253	translation	_	
167-34	36254-36257	and	_	
167-35	36258-36266	rotation	_	
167-36	36267-36277	parameters	_	
167-37	36277-36278	,	_	
167-38	36279-36284	their	_	
167-39	36285-36290	first	_	
167-40	36291-36302	derivatives	_	
167-41	36302-36303	,	_	
167-42	36304-36307	and	_	
167-43	36308-36311	the	_	
167-44	36312-36318	square	_	
167-45	36319-36321	of	_	
167-46	36322-36327	these	_	
167-47	36328-36330	12	_	
167-48	36331-36341	parameters	_	
167-49	36341-36342	)	_	
167-50	36342-36343	,	_	
167-51	36344-36347	and	_	
167-52	36348-36358	frame-wise	_	
167-53	36359-36371	displacement	_	
167-54	36372-36373	(	_	
167-55	36373-36375	FD	_	
167-56	36375-36376	)	_	
167-57	36376-36377	,	_	
167-58	36378-36381	and	_	
167-59	36382-36386	then	_	
167-60	36387-36397	temporally	_	
167-61	36398-36406	filtered	_	
167-62	36407-36408	(	_	
167-63	36408-36412	rest	_	
167-64	36413-36417	data	_	
167-65	36417-36418	:	_	
167-66	36419-36428	band-pass	_	
167-67	36429-36434	0.008	_	
167-68	36434-36435	-	_	
167-69	36435-36438	0.1	_	
167-70	36439-36441	Hz	_	
167-71	36441-36442	;	_	
167-72	36443-36447	task	_	
167-73	36448-36452	data	_	
167-74	36452-36453	:	_	
167-75	36454-36463	high-pass	_	
167-76	36464-36469	0.008	_	
167-77	36470-36472	Hz	_	
167-78	36472-36473	)	_	
167-79	36473-36474	.	_	

#Text=Pairwise correlations were performed between the noise-corrected, filtered time series of each of the 270 nodes, yielding a 270 × 270 connectivity matrix for each subject during each paradigm.
168-1	36475-36483	Pairwise	_	
168-2	36484-36496	correlations	_	
168-3	36497-36501	were	_	
168-4	36502-36511	performed	_	
168-5	36512-36519	between	_	
168-6	36520-36523	the	_	
168-7	36524-36539	noise-corrected	_	
168-8	36539-36540	,	_	
168-9	36541-36549	filtered	_	
168-10	36550-36554	time	_	
168-11	36555-36561	series	_	
168-12	36562-36564	of	_	
168-13	36565-36569	each	_	
168-14	36570-36572	of	_	
168-15	36573-36576	the	_	
168-16	36577-36580	270	_	
168-17	36581-36586	nodes	_	
168-18	36586-36587	,	_	
168-19	36588-36596	yielding	_	
168-20	36597-36598	a	_	
168-21	36599-36602	270	_	
168-22	36603-36604	×	_	
168-23	36605-36608	270	_	
168-24	36609-36621	connectivity	_	
168-25	36622-36628	matrix	_	
168-26	36629-36632	for	_	
168-27	36633-36637	each	_	
168-28	36638-36645	subject	_	
168-29	36646-36652	during	_	
168-30	36653-36657	each	_	
168-31	36658-36666	paradigm	_	
168-32	36666-36667	.	_	

#Text=To generate a subject-specific “trait” matrix that can explain the majority of variance across paradigms, the first PC scores were extracted from the connectivity matrices across all paradigms for each individual.
169-1	36668-36670	To	_	
169-2	36671-36679	generate	_	
169-3	36680-36681	a	_	
169-4	36682-36698	subject-specific	_	
169-5	36699-36700	“	_	
169-6	36700-36705	trait	_	
169-7	36705-36706	”	_	
169-8	36707-36713	matrix	_	
169-9	36714-36718	that	_	
169-10	36719-36722	can	_	
169-11	36723-36730	explain	_	
169-12	36731-36734	the	_	
169-13	36735-36743	majority	_	
169-14	36744-36746	of	_	
169-15	36747-36755	variance	_	
169-16	36756-36762	across	_	
169-17	36763-36772	paradigms	_	
169-18	36772-36773	,	_	
169-19	36774-36777	the	_	
169-20	36778-36783	first	_	
169-21	36784-36786	PC	_	
169-22	36787-36793	scores	_	
169-23	36794-36798	were	_	
169-24	36799-36808	extracted	_	
169-25	36809-36813	from	_	
169-26	36814-36817	the	_	
169-27	36818-36830	connectivity	_	
169-28	36831-36839	matrices	_	
169-29	36840-36846	across	_	
169-30	36847-36850	all	_	
169-31	36851-36860	paradigms	_	
169-32	36861-36864	for	_	
169-33	36865-36869	each	_	
169-34	36870-36880	individual	_	
169-35	36880-36881	.	_	

#Text=Details on data processing can be found in Supplementary Methods.
170-1	36882-36889	Details	_	
170-2	36890-36892	on	_	
170-3	36893-36897	data	_	
170-4	36898-36908	processing	_	
170-5	36909-36912	can	_	
170-6	36913-36915	be	_	
170-7	36916-36921	found	_	
170-8	36922-36924	in	_	
170-9	36925-36938	Supplementary	_	
170-10	36939-36946	Methods	_	
170-11	36946-36947	.	_	

#Text=Network discovery in the NAPLS-2 sample
#Text=We used NBS (NBS, [https://sites.google.com/site/bctnet/comparison/nbs]) to probe connectivity differences in the extracted first PC matrices between the three outcome groups in the NAPLS-2 sample following previous publications.
171-1	36948-36955	Network	_	
171-2	36956-36965	discovery	_	
171-3	36966-36968	in	_	
171-4	36969-36972	the	_	
171-5	36973-36978	NAPLS	_	
171-6	36978-36979	-	_	
171-7	36979-36980	2	_	
171-8	36981-36987	sample	_	
171-9	36988-36990	We	_	
171-10	36991-36995	used	_	
171-11	36996-36999	NBS	_	
171-12	37000-37001	(	_	
171-13	37001-37004	NBS	_	
171-14	37004-37005	,	_	
171-15	37006-37007	[	_	
171-16	37007-37012	https	_	
171-17	37012-37013	:	_	
171-18	37013-37014	/	_	
171-19	37014-37015	/	_	
171-20	37015-37031	sites.google.com	_	
171-21	37031-37032	/	_	
171-22	37032-37036	site	_	
171-23	37036-37037	/	_	
171-24	37037-37043	bctnet	_	
171-25	37043-37044	/	_	
171-26	37044-37054	comparison	_	
171-27	37054-37055	/	_	
171-28	37055-37058	nbs	_	
171-29	37058-37059	]	_	
171-30	37059-37060	)	_	
171-31	37061-37063	to	_	
171-32	37064-37069	probe	_	
171-33	37070-37082	connectivity	_	
171-34	37083-37094	differences	_	
171-35	37095-37097	in	_	
171-36	37098-37101	the	_	
171-37	37102-37111	extracted	_	
171-38	37112-37117	first	_	
171-39	37118-37120	PC	_	
171-40	37121-37129	matrices	_	
171-41	37130-37137	between	_	
171-42	37138-37141	the	_	
171-43	37142-37147	three	_	
171-44	37148-37155	outcome	_	
171-45	37156-37162	groups	_	
171-46	37163-37165	in	_	
171-47	37166-37169	the	_	
171-48	37170-37175	NAPLS	_	
171-49	37175-37176	-	_	
171-50	37176-37177	2	_	
171-51	37178-37184	sample	_	
171-52	37185-37194	following	_	
171-53	37195-37203	previous	_	
171-54	37204-37216	publications	_	
171-55	37216-37217	.	_	

#Text=Age, sex, IQ, site, and mean FD across all paradigms and antipsychotic dosage were included in the model as nuisance regressors to strictly control for potential confounding effects related to subjects’ demographic, head motion, and/or medication status.
172-1	37218-37221	Age	_	
172-2	37221-37222	,	_	
172-3	37223-37226	sex	_	
172-4	37226-37227	,	_	
172-5	37228-37230	IQ	_	
172-6	37230-37231	,	_	
172-7	37232-37236	site	_	
172-8	37236-37237	,	_	
172-9	37238-37241	and	_	
172-10	37242-37246	mean	_	
172-11	37247-37249	FD	_	
172-12	37250-37256	across	_	
172-13	37257-37260	all	_	
172-14	37261-37270	paradigms	_	
172-15	37271-37274	and	_	
172-16	37275-37288	antipsychotic	_	
172-17	37289-37295	dosage	_	
172-18	37296-37300	were	_	
172-19	37301-37309	included	_	
172-20	37310-37312	in	_	
172-21	37313-37316	the	_	
172-22	37317-37322	model	_	
172-23	37323-37325	as	_	
172-24	37326-37334	nuisance	_	
172-25	37335-37345	regressors	_	
172-26	37346-37348	to	_	
172-27	37349-37357	strictly	_	
172-28	37358-37365	control	_	
172-29	37366-37369	for	_	
172-30	37370-37379	potential	_	
172-31	37380-37391	confounding	_	
172-32	37392-37399	effects	_	
172-33	37400-37407	related	_	
172-34	37408-37410	to	_	
172-35	37411-37419	subjects	_	
172-36	37419-37420	’	_	
172-37	37421-37432	demographic	_	
172-38	37432-37433	,	_	
172-39	37434-37438	head	_	
172-40	37439-37445	motion	_	
172-41	37445-37446	,	_	
172-42	37447-37450	and	_	
172-43	37450-37451	/	_	
172-44	37451-37453	or	_	
172-45	37454-37464	medication	_	
172-46	37465-37471	status	_	
172-47	37471-37472	.	_	

#Text=The significance of results was determined by 10,000 permutation testing.
173-1	37473-37476	The	_	
173-2	37477-37489	significance	_	
173-3	37490-37492	of	_	
173-4	37493-37500	results	_	
173-5	37501-37504	was	_	
173-6	37505-37515	determined	_	
173-7	37516-37518	by	_	
173-8	37519-37525	10,000	_	
173-9	37526-37537	permutation	_	
173-10	37538-37545	testing	_	
173-11	37545-37546	.	_	

#Text=For further verification purposes, the mean values of the identified network in the PC matrices were extracted for each individual and tested in an unmedicated, matched subsample using an analysis of covariance (ANCOVA) model including the same nuisance variables described above as covariates.
174-1	37547-37550	For	_	
174-2	37551-37558	further	_	
174-3	37559-37571	verification	_	
174-4	37572-37580	purposes	_	
174-5	37580-37581	,	_	
174-6	37582-37585	the	_	
174-7	37586-37590	mean	_	
174-8	37591-37597	values	_	
174-9	37598-37600	of	_	
174-10	37601-37604	the	_	
174-11	37605-37615	identified	_	
174-12	37616-37623	network	_	
174-13	37624-37626	in	_	
174-14	37627-37630	the	_	
174-15	37631-37633	PC	_	
174-16	37634-37642	matrices	_	
174-17	37643-37647	were	_	
174-18	37648-37657	extracted	_	
174-19	37658-37661	for	_	
174-20	37662-37666	each	_	
174-21	37667-37677	individual	_	
174-22	37678-37681	and	_	
174-23	37682-37688	tested	_	
174-24	37689-37691	in	_	
174-25	37692-37694	an	_	
174-26	37695-37706	unmedicated	_	
174-27	37706-37707	,	_	
174-28	37708-37715	matched	_	
174-29	37716-37725	subsample	_	
174-30	37726-37731	using	_	
174-31	37732-37734	an	_	
174-32	37735-37743	analysis	_	
174-33	37744-37746	of	_	
174-34	37747-37757	covariance	_	
174-35	37758-37759	(	_	
174-36	37759-37765	ANCOVA	_	
174-37	37765-37766	)	_	
174-38	37767-37772	model	_	
174-39	37773-37782	including	_	
174-40	37783-37786	the	_	
174-41	37787-37791	same	_	
174-42	37792-37800	nuisance	_	
174-43	37801-37810	variables	_	
174-44	37811-37820	described	_	
174-45	37821-37826	above	_	
174-46	37827-37829	as	_	
174-47	37830-37840	covariates	_	
174-48	37840-37841	.	_	

#Text=To test potential associations with structural data, subjects’ high-resolution T1-weighted images were processed using the standard pipeline in the FreeSurfer software ([https://surfer.nmr.mgh.harvard.edu/]).
175-1	37842-37844	To	_	
175-2	37845-37849	test	_	
175-3	37850-37859	potential	_	
175-4	37860-37872	associations	_	
175-5	37873-37877	with	_	
175-6	37878-37888	structural	_	
175-7	37889-37893	data	_	
175-8	37893-37894	,	_	
175-9	37895-37903	subjects	_	
175-10	37903-37904	’	_	
175-11	37905-37920	high-resolution	_	
175-12	37921-37923	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[17]	
175-13	37923-37924	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[17]	
175-14	37924-37932	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[17]	
175-15	37933-37939	images	_	
175-16	37940-37944	were	_	
175-17	37945-37954	processed	_	
175-18	37955-37960	using	_	
175-19	37961-37964	the	_	
175-20	37965-37973	standard	_	
175-21	37974-37982	pipeline	_	
175-22	37983-37985	in	_	
175-23	37986-37989	the	_	
175-24	37990-38000	FreeSurfer	_	
175-25	38001-38009	software	_	
175-26	38010-38011	(	_	
175-27	38011-38012	[	_	
175-28	38012-38017	https	_	
175-29	38017-38018	:	_	
175-30	38018-38019	/	_	
175-31	38019-38020	/	_	
175-32	38020-38046	surfer.nmr.mgh.harvard.edu	_	
175-33	38046-38047	/	_	
175-34	38047-38048	]	_	
175-35	38048-38049	)	_	
175-36	38049-38050	.	_	

#Text=The gray matter volumes of the regions in the identified network were subsequently extracted and Pearson correlations were performed between these gray matter volumes and the mean values of the network in the PC matrices.
176-1	38051-38054	The	_	
176-2	38055-38059	gray	_	
176-3	38060-38066	matter	_	
176-4	38067-38074	volumes	_	
176-5	38075-38077	of	_	
176-6	38078-38081	the	_	
176-7	38082-38089	regions	_	
176-8	38090-38092	in	_	
176-9	38093-38096	the	_	
176-10	38097-38107	identified	_	
176-11	38108-38115	network	_	
176-12	38116-38120	were	_	
176-13	38121-38133	subsequently	_	
176-14	38134-38143	extracted	_	
176-15	38144-38147	and	_	
176-16	38148-38155	Pearson	_	
176-17	38156-38168	correlations	_	
176-18	38169-38173	were	_	
176-19	38174-38183	performed	_	
176-20	38184-38191	between	_	
176-21	38192-38197	these	_	
176-22	38198-38202	gray	_	
176-23	38203-38209	matter	_	
176-24	38210-38217	volumes	_	
176-25	38218-38221	and	_	
176-26	38222-38225	the	_	
176-27	38226-38230	mean	_	
176-28	38231-38237	values	_	
176-29	38238-38240	of	_	
176-30	38241-38244	the	_	
176-31	38245-38252	network	_	
176-32	38253-38255	in	_	
176-33	38256-38259	the	_	
176-34	38260-38262	PC	_	
176-35	38263-38271	matrices	_	
176-36	38271-38272	.	_	

#Text=Statistical significance was determined at P < 0.05 after family-wise error (FWE) correction.
177-1	38273-38284	Statistical	_	
177-2	38285-38297	significance	_	
177-3	38298-38301	was	_	
177-4	38302-38312	determined	_	
177-5	38313-38315	at	_	
177-6	38316-38317	P	_	
177-7	38318-38319	<	_	
177-8	38320-38324	0.05	_	
177-9	38325-38330	after	_	
177-10	38331-38342	family-wise	_	
177-11	38343-38348	error	_	
177-12	38349-38350	(	_	
177-13	38350-38353	FWE	_	
177-14	38353-38354	)	_	
177-15	38355-38365	correction	_	
177-16	38365-38366	.	_	

#Text=See Supplementary Methods for details on these analyses.
178-1	38367-38370	See	_	
178-2	38371-38384	Supplementary	_	
178-3	38385-38392	Methods	_	
178-4	38393-38396	for	_	
178-5	38397-38404	details	_	
178-6	38405-38407	on	_	
178-7	38408-38413	these	_	
178-8	38414-38422	analyses	_	
178-9	38422-38423	.	_	

#Text=Network verification in the CNP sample
#Text=Following the same procedure as described above, the mean values of the identified network in the PC matrices were extracted for each individual in the CNP sample.
179-1	38424-38431	Network	_	
179-2	38432-38444	verification	_	
179-3	38445-38447	in	_	
179-4	38448-38451	the	_	
179-5	38452-38455	CNP	_	
179-6	38456-38462	sample	_	
179-7	38463-38472	Following	_	
179-8	38473-38476	the	_	
179-9	38477-38481	same	_	
179-10	38482-38491	procedure	_	
179-11	38492-38494	as	_	
179-12	38495-38504	described	_	
179-13	38505-38510	above	_	
179-14	38510-38511	,	_	
179-15	38512-38515	the	_	
179-16	38516-38520	mean	_	
179-17	38521-38527	values	_	
179-18	38528-38530	of	_	
179-19	38531-38534	the	_	
179-20	38535-38545	identified	_	
179-21	38546-38553	network	_	
179-22	38554-38556	in	_	
179-23	38557-38560	the	_	
179-24	38561-38563	PC	_	
179-25	38564-38572	matrices	_	
179-26	38573-38577	were	_	
179-27	38578-38587	extracted	_	
179-28	38588-38591	for	_	
179-29	38592-38596	each	_	
179-30	38597-38607	individual	_	
179-31	38608-38610	in	_	
179-32	38611-38614	the	_	
179-33	38615-38618	CNP	_	
179-34	38619-38625	sample	_	
179-35	38625-38626	.	_	

#Text=Group effects on the identified network were examined using an ANCOVA model with age, sex, IQ, and mean FD across all paradigms and antipsychotic dosage as covariates.
180-1	38627-38632	Group	_	
180-2	38633-38640	effects	_	
180-3	38641-38643	on	_	
180-4	38644-38647	the	_	
180-5	38648-38658	identified	_	
180-6	38659-38666	network	_	
180-7	38667-38671	were	_	
180-8	38672-38680	examined	_	
180-9	38681-38686	using	_	
180-10	38687-38689	an	_	
180-11	38690-38696	ANCOVA	_	
180-12	38697-38702	model	_	
180-13	38703-38707	with	_	
180-14	38708-38711	age	_	
180-15	38711-38712	,	_	
180-16	38713-38716	sex	_	
180-17	38716-38717	,	_	
180-18	38718-38720	IQ	_	
180-19	38720-38721	,	_	
180-20	38722-38725	and	_	
180-21	38726-38730	mean	_	
180-22	38731-38733	FD	_	
180-23	38734-38740	across	_	
180-24	38741-38744	all	_	
180-25	38745-38754	paradigms	_	
180-26	38755-38758	and	_	
180-27	38759-38772	antipsychotic	_	
180-28	38773-38779	dosage	_	
180-29	38780-38782	as	_	
180-30	38783-38793	covariates	_	
180-31	38793-38794	.	_	

#Text=The same model was also used for the subsample analysis.
181-1	38795-38798	The	_	
181-2	38799-38803	same	_	
181-3	38804-38809	model	_	
181-4	38810-38813	was	_	
181-5	38814-38818	also	_	
181-6	38819-38823	used	_	
181-7	38824-38827	for	_	
181-8	38828-38831	the	_	
181-9	38832-38841	subsample	_	
181-10	38842-38850	analysis	_	
181-11	38850-38851	.	_	

#Text=Details are provided in Supplementary Methods.
182-1	38852-38859	Details	_	
182-2	38860-38863	are	_	
182-3	38864-38872	provided	_	
182-4	38873-38875	in	_	
182-5	38876-38889	Supplementary	_	
182-6	38890-38897	Methods	_	
182-7	38897-38898	.	_	

#Text=Code availability
#Text=Data were processed using publicly available software (SPM12, [http://www.fil.ion.ucl.ac.uk/spm/software/spm12/]; NBS toolbox, [https://sites.google.com/site/bctnet/comparison/nbs]; and Freesurfer, [https://surfer.nmr.mgh.harvard.edu/]).
183-1	38899-38903	Code	_	
183-2	38904-38916	availability	_	
183-3	38917-38921	Data	_	
183-4	38922-38926	were	_	
183-5	38927-38936	processed	_	
183-6	38937-38942	using	_	
183-7	38943-38951	publicly	_	
183-8	38952-38961	available	_	
183-9	38962-38970	software	_	
183-10	38971-38972	(	_	
183-11	38972-38977	SPM12	_	
183-12	38977-38978	,	_	
183-13	38979-38980	[	_	
183-14	38980-38984	http	_	
183-15	38984-38985	:	_	
183-16	38985-38986	/	_	
183-17	38986-38987	/	_	
183-18	38987-39008	www.fil.ion.ucl.ac.uk	_	
183-19	39008-39009	/	_	
183-20	39009-39012	spm	_	
183-21	39012-39013	/	_	
183-22	39013-39021	software	_	
183-23	39021-39022	/	_	
183-24	39022-39027	spm12	_	
183-25	39027-39028	/	_	
183-26	39028-39029	]	_	
183-27	39029-39030	;	_	
183-28	39031-39034	NBS	_	
183-29	39035-39042	toolbox	_	
183-30	39042-39043	,	_	
183-31	39044-39045	[	_	
183-32	39045-39050	https	_	
183-33	39050-39051	:	_	
183-34	39051-39052	/	_	
183-35	39052-39053	/	_	
183-36	39053-39069	sites.google.com	_	
183-37	39069-39070	/	_	
183-38	39070-39074	site	_	
183-39	39074-39075	/	_	
183-40	39075-39081	bctnet	_	
183-41	39081-39082	/	_	
183-42	39082-39092	comparison	_	
183-43	39092-39093	/	_	
183-44	39093-39096	nbs	_	
183-45	39096-39097	]	_	
183-46	39097-39098	;	_	
183-47	39099-39102	and	_	
183-48	39103-39113	Freesurfer	_	
183-49	39113-39114	,	_	
183-50	39115-39116	[	_	
183-51	39116-39121	https	_	
183-52	39121-39122	:	_	
183-53	39122-39123	/	_	
183-54	39123-39124	/	_	
183-55	39124-39150	surfer.nmr.mgh.harvard.edu	_	
183-56	39150-39151	/	_	
183-57	39151-39152	]	_	
183-58	39152-39153	)	_	
183-59	39153-39154	.	_	

#Text=The PCA analysis was performed using Matlab inbuilt function pca.
184-1	39155-39158	The	_	
184-2	39159-39162	PCA	_	
184-3	39163-39171	analysis	_	
184-4	39172-39175	was	_	
184-5	39176-39185	performed	_	
184-6	39186-39191	using	_	
184-7	39192-39198	Matlab	_	
184-8	39199-39206	inbuilt	_	
184-9	39207-39215	function	_	
184-10	39216-39219	pca	_	
184-11	39219-39220	.	_	

#Text=Electronic supplementary material
#Text=Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
185-1	39221-39231	Electronic	_	
185-2	39232-39245	supplementary	_	
185-3	39246-39254	material	_	
185-4	39255-39266	Publisher's	_	
185-5	39267-39271	note	_	
185-6	39271-39272	:	_	
185-7	39273-39281	Springer	_	
185-8	39282-39288	Nature	_	
185-9	39289-39296	remains	_	
185-10	39297-39304	neutral	_	
185-11	39305-39309	with	_	
185-12	39310-39316	regard	_	
185-13	39317-39319	to	_	
185-14	39320-39334	jurisdictional	_	
185-15	39335-39341	claims	_	
185-16	39342-39344	in	_	
185-17	39345-39354	published	_	
185-18	39355-39359	maps	_	
185-19	39360-39363	and	_	
185-20	39364-39377	institutional	_	
185-21	39378-39390	affiliations	_	
185-22	39390-39391	.	_	

#Text=Electronic supplementary material
#Text=Supplementary Information accompanies this paper at 10.1038/s41467-018-06350-7.
186-1	39392-39402	Electronic	_	
186-2	39403-39416	supplementary	_	
186-3	39417-39425	material	_	
186-4	39426-39439	Supplementary	_	
186-5	39440-39451	Information	_	
186-6	39452-39463	accompanies	_	
186-7	39464-39468	this	_	
186-8	39469-39474	paper	_	
186-9	39475-39477	at	_	
186-10	39478-39485	10.1038	_	
186-11	39485-39486	/	_	
186-12	39486-39492	s41467	_	
186-13	39492-39493	-	_	
186-14	39493-39496	018	_	
186-15	39496-39497	-	_	
186-16	39497-39502	06350	_	
186-17	39502-39503	-	_	
186-18	39503-39504	7	_	
186-19	39504-39505	.	_	

#Text=Author contributions
#Text=H.C. and T.D.C. conceptualized the study; C.E.B., J.A., K.S.C., B.A.C., D.H.M., T.H.M., D.O.P., L.J.S., M.T.T., E.F.W., S.W.W., and T.D.C. designed and organized the whole NAPLS consortium; S.C.M., C.E.B., J.A., K.S.C., B.A.C., D.H.M., T.H.M., D.O.P., L.J.S., M.T.T., E.F.W., S.W.W., T.D.C., B.G., H.M., R.E.C., A.B., H.T., T.G.M.E., and S.H. collected the data; H.C., O.Y.C., Y.C., J.K.F., S.C.M., D.G.G., and A.A. analyzed the data; and H.C. and T.D.C. drafted the paper with comments from all authors.
187-1	39506-39512	Author	_	
187-2	39513-39526	contributions	_	
187-3	39527-39530	H.C	_	
187-4	39530-39531	.	_	
187-5	39532-39535	and	_	
187-6	39536-39541	T.D.C	_	
187-7	39541-39542	.	_	
187-8	39543-39557	conceptualized	_	
187-9	39558-39561	the	_	
187-10	39562-39567	study	_	
187-11	39567-39568	;	_	
187-12	39569-39574	C.E.B	_	
187-13	39574-39575	.	_	
187-14	39575-39576	,	_	
187-15	39577-39580	J.A	_	
187-16	39580-39581	.	_	
187-17	39581-39582	,	_	
187-18	39583-39588	K.S.C	_	
187-19	39588-39589	.	_	
187-20	39589-39590	,	_	
187-21	39591-39596	B.A.C	_	
187-22	39596-39597	.	_	
187-23	39597-39598	,	_	
187-24	39599-39604	D.H.M	_	
187-25	39604-39605	.	_	
187-26	39605-39606	,	_	
187-27	39607-39612	T.H.M	_	
187-28	39612-39613	.	_	
187-29	39613-39614	,	_	
187-30	39615-39620	D.O.P	_	
187-31	39620-39621	.	_	
187-32	39621-39622	,	_	
187-33	39623-39628	L.J.S	_	
187-34	39628-39629	.	_	
187-35	39629-39630	,	_	
187-36	39631-39636	M.T.T	_	
187-37	39636-39637	.	_	
187-38	39637-39638	,	_	
187-39	39639-39644	E.F.W	_	
187-40	39644-39645	.	_	
187-41	39645-39646	,	_	
187-42	39647-39652	S.W.W	_	
187-43	39652-39653	.	_	
187-44	39653-39654	,	_	
187-45	39655-39658	and	_	
187-46	39659-39664	T.D.C	_	
187-47	39664-39665	.	_	
187-48	39666-39674	designed	_	
187-49	39675-39678	and	_	
187-50	39679-39688	organized	_	
187-51	39689-39692	the	_	
187-52	39693-39698	whole	_	
187-53	39699-39704	NAPLS	_	
187-54	39705-39715	consortium	_	
187-55	39715-39716	;	_	
187-56	39717-39722	S.C.M	_	
187-57	39722-39723	.	_	
187-58	39723-39724	,	_	
187-59	39725-39730	C.E.B	_	
187-60	39730-39731	.	_	
187-61	39731-39732	,	_	
187-62	39733-39736	J.A	_	
187-63	39736-39737	.	_	
187-64	39737-39738	,	_	
187-65	39739-39744	K.S.C	_	
187-66	39744-39745	.	_	
187-67	39745-39746	,	_	
187-68	39747-39752	B.A.C	_	
187-69	39752-39753	.	_	
187-70	39753-39754	,	_	
187-71	39755-39760	D.H.M	_	
187-72	39760-39761	.	_	
187-73	39761-39762	,	_	
187-74	39763-39768	T.H.M	_	
187-75	39768-39769	.	_	
187-76	39769-39770	,	_	
187-77	39771-39776	D.O.P	_	
187-78	39776-39777	.	_	
187-79	39777-39778	,	_	
187-80	39779-39784	L.J.S	_	
187-81	39784-39785	.	_	
187-82	39785-39786	,	_	
187-83	39787-39792	M.T.T	_	
187-84	39792-39793	.	_	
187-85	39793-39794	,	_	
187-86	39795-39800	E.F.W	_	
187-87	39800-39801	.	_	
187-88	39801-39802	,	_	
187-89	39803-39808	S.W.W	_	
187-90	39808-39809	.	_	
187-91	39809-39810	,	_	
187-92	39811-39816	T.D.C	_	
187-93	39816-39817	.	_	
187-94	39817-39818	,	_	
187-95	39819-39822	B.G	_	
187-96	39822-39823	.	_	
187-97	39823-39824	,	_	
187-98	39825-39828	H.M	_	
187-99	39828-39829	.	_	
187-100	39829-39830	,	_	
187-101	39831-39836	R.E.C	_	
187-102	39836-39837	.	_	
187-103	39837-39838	,	_	
187-104	39839-39842	A.B	_	
187-105	39842-39843	.	_	
187-106	39843-39844	,	_	
187-107	39845-39848	H.T	_	
187-108	39848-39849	.	_	
187-109	39849-39850	,	_	
187-110	39851-39858	T.G.M.E	_	
187-111	39858-39859	.	_	
187-112	39859-39860	,	_	
187-113	39861-39864	and	_	
187-114	39865-39868	S.H	_	
187-115	39868-39869	.	_	
187-116	39870-39879	collected	_	
187-117	39880-39883	the	_	
187-118	39884-39888	data	_	
187-119	39888-39889	;	_	
187-120	39890-39893	H.C	_	
187-121	39893-39894	.	_	
187-122	39894-39895	,	_	
187-123	39896-39901	O.Y.C	_	
187-124	39901-39902	.	_	
187-125	39902-39903	,	_	
187-126	39904-39907	Y.C	_	
187-127	39907-39908	.	_	
187-128	39908-39909	,	_	
187-129	39910-39915	J.K.F	_	
187-130	39915-39916	.	_	
187-131	39916-39917	,	_	
187-132	39918-39923	S.C.M	_	
187-133	39923-39924	.	_	
187-134	39924-39925	,	_	
187-135	39926-39931	D.G.G	_	
187-136	39931-39932	.	_	
187-137	39932-39933	,	_	
187-138	39934-39937	and	_	
187-139	39938-39941	A.A	_	
187-140	39941-39942	.	_	
187-141	39943-39951	analyzed	_	
187-142	39952-39955	the	_	
187-143	39956-39960	data	_	
187-144	39960-39961	;	_	
187-145	39962-39965	and	_	
187-146	39966-39969	H.C	_	
187-147	39969-39970	.	_	
187-148	39971-39974	and	_	
187-149	39975-39980	T.D.C	_	
187-150	39980-39981	.	_	
187-151	39982-39989	drafted	_	
187-152	39990-39993	the	_	
187-153	39994-39999	paper	_	
187-154	40000-40004	with	_	
187-155	40005-40013	comments	_	
187-156	40014-40018	from	_	
187-157	40019-40022	all	_	
187-158	40023-40030	authors	_	
187-159	40030-40031	.	_	

#Text=Data availability
#Text=The CNP data are publicly available at https://www.legacy.openfmri.org/dataset/ds000030/.
188-1	40032-40036	Data	_	
188-2	40037-40049	availability	_	
188-3	40050-40053	The	_	
188-4	40054-40057	CNP	_	
188-5	40058-40062	data	_	
188-6	40063-40066	are	_	
188-7	40067-40075	publicly	_	
188-8	40076-40085	available	_	
188-9	40086-40088	at	_	
188-10	40089-40094	https	_	
188-11	40094-40095	:	_	
188-12	40095-40096	/	_	
188-13	40096-40097	/	_	
188-14	40097-40120	www.legacy.openfmri.org	_	
188-15	40120-40121	/	_	
188-16	40121-40128	dataset	_	
188-17	40128-40129	/	_	
188-18	40129-40137	ds000030	_	
188-19	40137-40138	/	_	
188-20	40138-40139	.	_	

#Text=The NAPLS-2 data are available from corresponding authors upon request.
189-1	40140-40143	The	_	
189-2	40144-40149	NAPLS	_	
189-3	40149-40150	-	_	
189-4	40150-40151	2	_	
189-5	40152-40156	data	_	
189-6	40157-40160	are	_	
189-7	40161-40170	available	_	
189-8	40171-40175	from	_	
189-9	40176-40189	corresponding	_	
189-10	40190-40197	authors	_	
189-11	40198-40202	upon	_	
189-12	40203-40210	request	_	
189-13	40210-40211	.	_	

#Text=Competing interests
#Text=T.D.C. has served as a consultant for Boehringer–Ingelheim Pharmaceuticals and Lundbeck A/S.
190-1	40212-40221	Competing	_	
190-2	40222-40231	interests	_	
190-3	40232-40237	T.D.C	_	
190-4	40237-40238	.	_	
190-5	40239-40242	has	_	
190-6	40243-40249	served	_	
190-7	40250-40252	as	_	
190-8	40253-40254	a	_	
190-9	40255-40265	consultant	_	
190-10	40266-40269	for	_	
190-11	40270-40290	Boehringer–Ingelheim	_	
190-12	40291-40306	Pharmaceuticals	_	
190-13	40307-40310	and	_	
190-14	40311-40319	Lundbeck	_	
190-15	40320-40321	A	_	
190-16	40321-40322	/	_	
190-17	40322-40323	S	_	
190-18	40323-40324	.	_	

#Text=The remaining authors declare no competing interests.
191-1	40325-40328	The	_	
191-2	40329-40338	remaining	_	
191-3	40339-40346	authors	_	
191-4	40347-40354	declare	_	
191-5	40355-40357	no	_	
191-6	40358-40367	competing	_	
191-7	40368-40377	interests	_	
191-8	40377-40378	.	_	

#Text=References
#Text=Functional connectivity measures as schizophrenia intermediate phenotypes: advances, limitations, and future directions
#Text=Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk
#Text=Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis
#Text=Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis
#Text=Spatial working memory in individuals at high risk for psychosis: longitudinal fMRI study
#Text=Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study
#Text=Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis
#Text=Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals
#Text=Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
#Text=Increased neural response related to neutral faces in individuals at risk for psychosis
#Text=Altered functional subnetwork during emotional face processing: a potential intermediate phenotype for schizophrenia
#Text=Cerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity
#Text=Fryer S.
192-1	40379-40389	References	_	
192-2	40390-40400	Functional	_	
192-3	40401-40413	connectivity	_	
192-4	40414-40422	measures	_	
192-5	40423-40425	as	_	
192-6	40426-40439	schizophrenia	_	
192-7	40440-40452	intermediate	_	
192-8	40453-40463	phenotypes	_	
192-9	40463-40464	:	_	
192-10	40465-40473	advances	_	
192-11	40473-40474	,	_	
192-12	40475-40486	limitations	_	
192-13	40486-40487	,	_	
192-14	40488-40491	and	_	
192-15	40492-40498	future	_	
192-16	40499-40509	directions	_	
192-17	40510-40521	Association	_	
192-18	40522-40524	of	_	
192-19	40525-40533	thalamic	_	
192-20	40534-40549	dysconnectivity	_	
192-21	40550-40553	and	_	
192-22	40554-40564	conversion	_	
192-23	40565-40567	to	_	
192-24	40568-40577	psychosis	_	
192-25	40578-40580	in	_	
192-26	40581-40586	youth	_	
192-27	40587-40590	and	_	
192-28	40591-40596	young	_	
192-29	40597-40603	adults	_	
192-30	40604-40606	at	_	
192-31	40607-40615	elevated	_	
192-32	40616-40624	clinical	_	
192-33	40625-40629	risk	_	
192-34	40630-40637	Altered	_	
192-35	40638-40646	striatal	_	
192-36	40647-40657	functional	_	
192-37	40658-40670	connectivity	_	
192-38	40671-40673	in	_	
192-39	40674-40682	subjects	_	
192-40	40683-40687	with	_	
192-41	40688-40690	an	_	
192-42	40691-40698	at-risk	_	
192-43	40699-40705	mental	_	
192-44	40706-40711	state	_	
192-45	40712-40715	for	_	
192-46	40716-40725	psychosis	_	
192-47	40726-40752	Cerebello-thalamo-cortical	_	
192-48	40753-40761	networks	_	
192-49	40762-40769	predict	_	
192-50	40770-40778	positive	_	
192-51	40779-40786	symptom	_	
192-52	40787-40798	progression	_	
192-53	40799-40801	in	_	
192-54	40802-40813	individuals	_	
192-55	40814-40816	at	_	
192-56	40817-40827	ultra-high	_	
192-57	40828-40832	risk	_	
192-58	40833-40836	for	_	
192-59	40837-40846	psychosis	_	
192-60	40847-40854	Spatial	_	
192-61	40855-40862	working	_	
192-62	40863-40869	memory	_	
192-63	40870-40872	in	_	
192-64	40873-40884	individuals	_	
192-65	40885-40887	at	_	
192-66	40888-40892	high	_	
192-67	40893-40897	risk	_	
192-68	40898-40901	for	_	
192-69	40902-40911	psychosis	_	
192-70	40911-40912	:	_	
192-71	40913-40925	longitudinal	_	
192-72	40926-40930	fMRI	_	
192-73	40931-40936	study	_	
192-74	40937-40944	Altered	_	
192-75	40945-40950	brain	_	
192-76	40951-40959	function	_	
192-77	40960-40968	directly	_	
192-78	40969-40976	related	_	
192-79	40977-40979	to	_	
192-80	40980-40990	structural	_	
192-81	40991-41004	abnormalities	_	
192-82	41005-41007	in	_	
192-83	41008-41014	people	_	
192-84	41015-41017	at	_	
192-85	41018-41023	ultra	_	
192-86	41024-41028	high	_	
192-87	41029-41033	risk	_	
192-88	41034-41036	of	_	
192-89	41037-41046	psychosis	_	
192-90	41046-41047	:	_	
192-91	41048-41060	longitudinal	_	
192-92	41061-41069	VBM-fMRI	_	
192-93	41070-41075	study	_	
192-94	41076-41083	Altered	_	
192-95	41084-41094	prefrontal	_	
192-96	41095-41098	and	_	
192-97	41099-41110	hippocampal	_	
192-98	41111-41119	function	_	
192-99	41120-41126	during	_	
192-100	41127-41133	verbal	_	
192-101	41134-41142	encoding	_	
192-102	41143-41146	and	_	
192-103	41147-41158	recognition	_	
192-104	41159-41161	in	_	
192-105	41162-41168	people	_	
192-106	41169-41173	with	_	
192-107	41174-41183	prodromal	_	
192-108	41184-41192	symptoms	_	
192-109	41193-41195	of	_	
192-110	41196-41205	psychosis	_	
192-111	41206-41216	Transition	_	
192-112	41217-41219	to	_	
192-113	41220-41229	psychosis	_	
192-114	41230-41240	associated	_	
192-115	41241-41245	with	_	
192-116	41246-41256	prefrontal	_	
192-117	41257-41260	and	_	
192-118	41261-41272	subcortical	_	
192-119	41273-41284	dysfunction	_	
192-120	41285-41287	in	_	
192-121	41288-41293	ultra	_	
192-122	41294-41303	high-risk	_	
192-123	41304-41315	individuals	_	
192-124	41316-41324	Abnormal	_	
192-125	41325-41335	prefrontal	_	
192-126	41336-41346	activation	_	
192-127	41347-41355	directly	_	
192-128	41356-41363	related	_	
192-129	41364-41366	to	_	
192-130	41367-41379	pre-synaptic	_	
192-131	41380-41388	striatal	_	
192-132	41389-41397	dopamine	_	
192-133	41398-41409	dysfunction	_	
192-134	41410-41412	in	_	
192-135	41413-41419	people	_	
192-136	41420-41422	at	_	
192-137	41423-41431	clinical	_	
192-138	41432-41436	high	_	
192-139	41437-41441	risk	_	
192-140	41442-41445	for	_	
192-141	41446-41455	psychosis	_	
192-142	41456-41465	Increased	_	
192-143	41466-41472	neural	_	
192-144	41473-41481	response	_	
192-145	41482-41489	related	_	
192-146	41490-41492	to	_	
192-147	41493-41500	neutral	_	
192-148	41501-41506	faces	_	
192-149	41507-41509	in	_	
192-150	41510-41521	individuals	_	
192-151	41522-41524	at	_	
192-152	41525-41529	risk	_	
192-153	41530-41533	for	_	
192-154	41534-41543	psychosis	_	
192-155	41544-41551	Altered	_	
192-156	41552-41562	functional	_	
192-157	41563-41573	subnetwork	_	
192-158	41574-41580	during	_	
192-159	41581-41590	emotional	_	
192-160	41591-41595	face	_	
192-161	41596-41606	processing	_	
192-162	41606-41607	:	_	
192-163	41608-41609	a	_	
192-164	41610-41619	potential	_	
192-165	41620-41632	intermediate	_	
192-166	41633-41642	phenotype	_	
192-167	41643-41646	for	_	
192-168	41647-41660	schizophrenia	_	
192-169	41661-41671	Cerebellar	_	
192-170	41672-41680	networks	_	
192-171	41681-41683	in	_	
192-172	41684-41695	individuals	_	
192-173	41696-41698	at	_	
192-174	41699-41704	ultra	_	
192-175	41705-41714	high-risk	_	
192-176	41715-41717	of	_	
192-177	41718-41727	psychosis	_	
192-178	41727-41728	:	_	
192-179	41729-41735	impact	_	
192-180	41736-41738	on	_	
192-181	41739-41747	postural	_	
192-182	41748-41752	sway	_	
192-183	41753-41756	and	_	
192-184	41757-41764	symptom	_	
192-185	41765-41773	severity	_	
192-186	41774-41779	Fryer	_	
192-187	41780-41781	S	_	
192-188	41781-41782	.	_	

#Text=L. et al.
193-1	41783-41784	L	_	
193-2	41784-41785	.	_	
193-3	41786-41788	et	_	
193-4	41789-41791	al	_	
193-5	41791-41792	.	_	

#Text=Should i stay or should i go?
194-1	41793-41799	Should	_	
194-2	41800-41801	i	_	
194-3	41802-41806	stay	_	
194-4	41807-41809	or	_	
194-5	41810-41816	should	_	
194-6	41817-41818	i	_	
194-7	41819-41821	go	_	
194-8	41821-41822	?	_	

#Text=FMRI study of response inhibition in early illness schizophrenia and risk for psychosis.
195-1	41823-41827	FMRI	_	
195-2	41828-41833	study	_	
195-3	41834-41836	of	_	
195-4	41837-41845	response	_	
195-5	41846-41856	inhibition	_	
195-6	41857-41859	in	_	
195-7	41860-41865	early	_	
195-8	41866-41873	illness	_	
195-9	41874-41887	schizophrenia	_	
195-10	41888-41891	and	_	
195-11	41892-41896	risk	_	
195-12	41897-41900	for	_	
195-13	41901-41910	psychosis	_	
195-14	41910-41911	.	_	

#Text=Schizophr Bull (2018) 10.1093/schbul/sbx198 [Epub ahead of print].
196-1	41912-41921	Schizophr	_	
196-2	41922-41926	Bull	_	
196-3	41927-41928	(	_	
196-4	41928-41932	2018	_	
196-5	41932-41933	)	_	
196-6	41934-41941	10.1093	_	
196-7	41941-41942	/	_	
196-8	41942-41948	schbul	_	
196-9	41948-41949	/	_	
196-10	41949-41955	sbx198	_	
196-11	41956-41957	[	_	
196-12	41957-41961	Epub	_	
196-13	41962-41967	ahead	_	
196-14	41968-41970	of	_	
196-15	41971-41976	print	_	
196-16	41976-41977	]	_	
196-17	41977-41978	.	_	

#Text=Exploring neural dysfunction in ‘clinical high risk’ for psychosis: a quantitative review of fMRI studies
#Text=American Psychiatric Association.
197-1	41979-41988	Exploring	_	
197-2	41989-41995	neural	_	
197-3	41996-42007	dysfunction	_	
197-4	42008-42010	in	_	
197-5	42011-42012	‘	_	
197-6	42012-42020	clinical	_	
197-7	42021-42025	high	_	
197-8	42026-42030	risk	_	
197-9	42030-42031	’	_	
197-10	42032-42035	for	_	
197-11	42036-42045	psychosis	_	
197-12	42045-42046	:	_	
197-13	42047-42048	a	_	
197-14	42049-42061	quantitative	_	
197-15	42062-42068	review	_	
197-16	42069-42071	of	_	
197-17	42072-42076	fMRI	_	
197-18	42077-42084	studies	_	
197-19	42085-42093	American	_	
197-20	42094-42105	Psychiatric	_	
197-21	42106-42117	Association	_	
197-22	42117-42118	.	_	

#Text=Diagnostic and statistical manual of mental disorders (DSM-5®).
198-1	42119-42129	Diagnostic	_	
198-2	42130-42133	and	_	
198-3	42134-42145	statistical	_	
198-4	42146-42152	manual	_	
198-5	42153-42155	of	_	
198-6	42156-42162	mental	_	
198-7	42163-42172	disorders	_	
198-8	42173-42174	(	_	
198-9	42174-42177	DSM	_	
198-10	42177-42178	-	_	
198-11	42178-42179	5	_	
198-12	42179-42180	®	_	
198-13	42180-42181	)	_	
198-14	42181-42182	.	_	

#Text=(American Psychiatric Pub, Washington, DC 2013).
199-1	42183-42184	(	_	
199-2	42184-42192	American	_	
199-3	42193-42204	Psychiatric	_	
199-4	42205-42208	Pub	_	
199-5	42208-42209	,	_	
199-6	42210-42220	Washington	_	
199-7	42220-42221	,	_	
199-8	42222-42224	DC	_	
199-9	42225-42229	2013	_	
199-10	42229-42230	)	_	
199-11	42230-42231	.	_	

#Text=Intrinsic and task-evoked network architectures of the human brain
#Text=Reconfigurable task-dependent functional coupling modes cluster around a core functional architecture
#Text=State and trait components of functional connectivity: individual differences vary with mental state
#Text=Neuroimaging predictors of transition to psychosis—a systematic review and meta-analysis
#Text=North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment
#Text=How schizophrenia develops: cognitive and brain mechanisms underlying onset of psychosis
#Text=A phenome-wide examination of neural and cognitive function
#Text=Functional network organization of the human brain
#Text=The 5-HTTLPR polymorphism affects network-based functional connectivity in the visual-limbic system in healthy adults.
200-1	42232-42241	Intrinsic	_	
200-2	42242-42245	and	_	
200-3	42246-42257	task-evoked	_	
200-4	42258-42265	network	_	
200-5	42266-42279	architectures	_	
200-6	42280-42282	of	_	
200-7	42283-42286	the	_	
200-8	42287-42292	human	_	
200-9	42293-42298	brain	_	
200-10	42299-42313	Reconfigurable	_	
200-11	42314-42328	task-dependent	_	
200-12	42329-42339	functional	_	
200-13	42340-42348	coupling	_	
200-14	42349-42354	modes	_	
200-15	42355-42362	cluster	_	
200-16	42363-42369	around	_	
200-17	42370-42371	a	_	
200-18	42372-42376	core	_	
200-19	42377-42387	functional	_	
200-20	42388-42400	architecture	_	
200-21	42401-42406	State	_	
200-22	42407-42410	and	_	
200-23	42411-42416	trait	_	
200-24	42417-42427	components	_	
200-25	42428-42430	of	_	
200-26	42431-42441	functional	_	
200-27	42442-42454	connectivity	_	
200-28	42454-42455	:	_	
200-29	42456-42466	individual	_	
200-30	42467-42478	differences	_	
200-31	42479-42483	vary	_	
200-32	42484-42488	with	_	
200-33	42489-42495	mental	_	
200-34	42496-42501	state	_	
200-35	42502-42514	Neuroimaging	_	
200-36	42515-42525	predictors	_	
200-37	42526-42528	of	_	
200-38	42529-42539	transition	_	
200-39	42540-42542	to	_	
200-40	42543-42554	psychosis—a	_	
200-41	42555-42565	systematic	_	
200-42	42566-42572	review	_	
200-43	42573-42576	and	_	
200-44	42577-42590	meta-analysis	_	
200-45	42591-42596	North	_	
200-46	42597-42605	American	_	
200-47	42606-42614	Prodrome	_	
200-48	42615-42627	Longitudinal	_	
200-49	42628-42633	Study	_	
200-50	42634-42635	(	_	
200-51	42635-42640	NAPLS	_	
200-52	42641-42642	2	_	
200-53	42642-42643	)	_	
200-54	42643-42644	:	_	
200-55	42645-42653	overview	_	
200-56	42654-42657	and	_	
200-57	42658-42669	recruitment	_	
200-58	42670-42673	How	_	
200-59	42674-42687	schizophrenia	_	
200-60	42688-42696	develops	_	
200-61	42696-42697	:	_	
200-62	42698-42707	cognitive	_	
200-63	42708-42711	and	_	
200-64	42712-42717	brain	_	
200-65	42718-42728	mechanisms	_	
200-66	42729-42739	underlying	_	
200-67	42740-42745	onset	_	
200-68	42746-42748	of	_	
200-69	42749-42758	psychosis	_	
200-70	42759-42760	A	_	
200-71	42761-42773	phenome-wide	_	
200-72	42774-42785	examination	_	
200-73	42786-42788	of	_	
200-74	42789-42795	neural	_	
200-75	42796-42799	and	_	
200-76	42800-42809	cognitive	_	
200-77	42810-42818	function	_	
200-78	42819-42829	Functional	_	
200-79	42830-42837	network	_	
200-80	42838-42850	organization	_	
200-81	42851-42853	of	_	
200-82	42854-42857	the	_	
200-83	42858-42863	human	_	
200-84	42864-42869	brain	_	
200-85	42870-42873	The	_	
200-86	42874-42875	5	_	
200-87	42875-42876	-	_	
200-88	42876-42882	HTTLPR	_	
200-89	42883-42895	polymorphism	_	
200-90	42896-42903	affects	_	
200-91	42904-42917	network-based	_	
200-92	42918-42928	functional	_	
200-93	42929-42941	connectivity	_	
200-94	42942-42944	in	_	
200-95	42945-42948	the	_	
200-96	42949-42962	visual-limbic	_	
200-97	42963-42969	system	_	
200-98	42970-42972	in	_	
200-99	42973-42980	healthy	_	
200-100	42981-42987	adults	_	
200-101	42987-42988	.	_	

#Text=Cao H. et al.
201-1	42989-42992	Cao	_	
201-2	42993-42994	H	_	
201-3	42994-42995	.	_	
201-4	42996-42998	et	_	
201-5	42999-43001	al	_	
201-6	43001-43002	.	_	

#Text=Toward leveraging human connectomic data in large consortia: generalizability of fmri-based brain graphs across sites, sessions, and paradigms.
202-1	43003-43009	Toward	_	
202-2	43010-43020	leveraging	_	
202-3	43021-43026	human	_	
202-4	43027-43038	connectomic	_	
202-5	43039-43043	data	_	
202-6	43044-43046	in	_	
202-7	43047-43052	large	_	
202-8	43053-43062	consortia	_	
202-9	43062-43063	:	_	
202-10	43064-43080	generalizability	_	
202-11	43081-43083	of	_	
202-12	43084-43094	fmri-based	_	
202-13	43095-43100	brain	_	
202-14	43101-43107	graphs	_	
202-15	43108-43114	across	_	
202-16	43115-43120	sites	_	
202-17	43120-43121	,	_	
202-18	43122-43130	sessions	_	
202-19	43130-43131	,	_	
202-20	43132-43135	and	_	
202-21	43136-43145	paradigms	_	
202-22	43145-43146	.	_	

#Text=Cereb Cortex (2018) 10.1093/cercor/bhy032 [Epub ahead of print].
203-1	43147-43152	Cereb	_	
203-2	43153-43159	Cortex	_	
203-3	43160-43161	(	_	
203-4	43161-43165	2018	_	
203-5	43165-43166	)	_	
203-6	43167-43174	10.1093	_	
203-7	43174-43175	/	_	
203-8	43175-43181	cercor	_	
203-9	43181-43182	/	_	
203-10	43182-43188	bhy032	_	
203-11	43189-43190	[	_	
203-12	43190-43194	Epub	_	
203-13	43195-43200	ahead	_	
203-14	43201-43203	of	_	
203-15	43204-43209	print	_	
203-16	43209-43210	]	_	
203-17	43210-43211	.	_	

#Text=Network-based statistic: identifying differences in brain networks
#Text=McGlashan T.
204-1	43212-43225	Network-based	_	
204-2	43226-43235	statistic	_	
204-3	43235-43236	:	_	
204-4	43237-43248	identifying	_	
204-5	43249-43260	differences	_	
204-6	43261-43263	in	_	
204-7	43264-43269	brain	_	
204-8	43270-43278	networks	_	
204-9	43279-43288	McGlashan	_	
204-10	43289-43290	T	_	
204-11	43290-43291	.	_	

#Text=H., Miller T.
205-1	43292-43293	H	_	
205-2	43293-43294	.	_	
205-3	43294-43295	,	_	
205-4	43296-43302	Miller	_	
205-5	43303-43304	T	_	
205-6	43304-43305	.	_	

#Text=J., Woods S.
206-1	43306-43307	J	_	
206-2	43307-43308	.	_	
206-3	43308-43309	,	_	
206-4	43310-43315	Woods	_	
206-5	43316-43317	S	_	
206-6	43317-43318	.	_	

#Text=W., Hoffman R.
207-1	43319-43320	W	_	
207-2	43320-43321	.	_	
207-3	43321-43322	,	_	
207-4	43323-43330	Hoffman	_	
207-5	43331-43332	R	_	
207-6	43332-43333	.	_	

#Text=E.. & Davidson L..
208-1	43334-43335	E	_	
208-2	43335-43336	.	_	
208-3	43336-43337	.	_	
208-4	43338-43339	&	_	
208-5	43340-43348	Davidson	_	
208-6	43349-43350	L	_	
208-7	43350-43351	.	_	
208-8	43351-43352	.	_	

#Text=(eds Miller, T.
209-1	43353-43354	(	_	
209-2	43354-43357	eds	_	
209-3	43358-43364	Miller	_	
209-4	43364-43365	,	_	
209-5	43366-43367	T	_	
209-6	43367-43368	.	_	

#Text=Mednick, S.
210-1	43369-43376	Mednick	_	
210-2	43376-43377	,	_	
210-3	43378-43379	S	_	
210-4	43379-43380	.	_	

#Text=A.
211-1	43381-43382	A	_	
211-2	43382-43383	.	_	

#Text=McGlashan, T.
212-1	43384-43393	McGlashan	_	
212-2	43393-43394	,	_	
212-3	43395-43396	T	_	
212-4	43396-43397	.	_	

#Text=H.
213-1	43398-43399	H	_	
213-2	43399-43400	.	_	

#Text=Libiger, J.
214-1	43401-43408	Libiger	_	
214-2	43408-43409	,	_	
214-3	43410-43411	J	_	
214-4	43411-43412	.	_	

#Text=Johannessen, J.
215-1	43413-43424	Johannessen	_	
215-2	43424-43425	,	_	
215-3	43426-43427	J	_	
215-4	43427-43428	.	_	

#Text=O.)
216-1	43429-43430	O	_	
216-2	43430-43431	.	_	
216-3	43431-43432	)	_	

#Text=Instrument for the Assessment of Prodromal Symptoms and States.
217-1	43433-43443	Instrument	_	
217-2	43444-43447	for	_	
217-3	43448-43451	the	_	
217-4	43452-43462	Assessment	_	
217-5	43463-43465	of	_	
217-6	43466-43475	Prodromal	_	
217-7	43476-43484	Symptoms	_	
217-8	43485-43488	and	_	
217-9	43489-43495	States	_	
217-10	43495-43496	.	_	

#Text=Early Intervention in Psychotic Disorders. 91, Springer: Dordrecht, 2001) 135–149. .
218-1	43497-43502	Early	_	
218-2	43503-43515	Intervention	_	
218-3	43516-43518	in	_	
218-4	43519-43528	Psychotic	_	
218-5	43529-43538	Disorders	_	
218-6	43538-43539	.	_	
218-7	43540-43542	91	_	
218-8	43542-43543	,	_	
218-9	43544-43552	Springer	_	
218-10	43552-43553	:	_	
218-11	43554-43563	Dordrecht	_	
218-12	43563-43564	,	_	
218-13	43565-43569	2001	_	
218-14	43569-43570	)	_	
218-15	43571-43574	135	_	
218-16	43574-43575	–	_	
218-17	43575-43578	149	_	
218-18	43578-43579	.	_	
218-19	43580-43581	.	_	

#Text=Andreasen N.
219-1	43582-43591	Andreasen	_	
219-2	43592-43593	N	_	
219-3	43593-43594	.	_	

#Text=C., Scale for the Assessment of Positive Symptoms (SAPS).
220-1	43595-43596	C	_	
220-2	43596-43597	.	_	
220-3	43597-43598	,	_	
220-4	43599-43604	Scale	_	
220-5	43605-43608	for	_	
220-6	43609-43612	the	_	
220-7	43613-43623	Assessment	_	
220-8	43624-43626	of	_	
220-9	43627-43635	Positive	_	
220-10	43636-43644	Symptoms	_	
220-11	43645-43646	(	_	
220-12	43646-43650	SAPS	_	
220-13	43650-43651	)	_	
220-14	43651-43652	.	_	

#Text=(University of Iowa, Iowa, 1984).
221-1	43653-43654	(	_	
221-2	43654-43664	University	_	
221-3	43665-43667	of	_	
221-4	43668-43672	Iowa	_	
221-5	43672-43673	,	_	
221-6	43674-43678	Iowa	_	
221-7	43678-43679	,	_	
221-8	43680-43684	1984	_	
221-9	43684-43685	)	_	
221-10	43685-43686	.	_	

#Text=Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk
#Text=Connectome-wide network analysis of youth with Psychosis-Spectrum symptoms
#Text=Reduced amplitude of low-frequency brain oscillations in the psychosis risk syndrome and early illness schizophrenia
#Text=Multi-task connectivity reveals flexible hubs for adaptive task control
#Text=Control of goal-directed and stimulus-driven attention in the brain
#Text=Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder
#Text=Dysfunction of large-scale brain networks in schizophrenia: a meta-analysis of resting-state functional connectivity
#Text=The brain’s default network: anatomy, function, and relevance to disease
#Text=Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network?
222-1	43687-43698	Progressive	_	
222-2	43699-43708	reduction	_	
222-3	43709-43711	in	_	
222-4	43712-43720	cortical	_	
222-5	43721-43730	thickness	_	
222-6	43731-43733	as	_	
222-7	43734-43743	psychosis	_	
222-8	43744-43752	develops	_	
222-9	43752-43753	:	_	
222-10	43754-43755	a	_	
222-11	43756-43765	multisite	_	
222-12	43766-43778	longitudinal	_	
222-13	43779-43791	neuroimaging	_	
222-14	43792-43797	study	_	
222-15	43798-43800	of	_	
222-16	43801-43806	youth	_	
222-17	43807-43809	at	_	
222-18	43810-43818	elevated	_	
222-19	43819-43827	clinical	_	
222-20	43828-43832	risk	_	
222-21	43833-43848	Connectome-wide	_	
222-22	43849-43856	network	_	
222-23	43857-43865	analysis	_	
222-24	43866-43868	of	_	
222-25	43869-43874	youth	_	
222-26	43875-43879	with	_	
222-27	43880-43898	Psychosis-Spectrum	_	
222-28	43899-43907	symptoms	_	
222-29	43908-43915	Reduced	_	
222-30	43916-43925	amplitude	_	
222-31	43926-43928	of	_	
222-32	43929-43942	low-frequency	_	
222-33	43943-43948	brain	_	
222-34	43949-43961	oscillations	_	
222-35	43962-43964	in	_	
222-36	43965-43968	the	_	
222-37	43969-43978	psychosis	_	
222-38	43979-43983	risk	_	
222-39	43984-43992	syndrome	_	
222-40	43993-43996	and	_	
222-41	43997-44002	early	_	
222-42	44003-44010	illness	_	
222-43	44011-44024	schizophrenia	_	
222-44	44025-44035	Multi-task	_	
222-45	44036-44048	connectivity	_	
222-46	44049-44056	reveals	_	
222-47	44057-44065	flexible	_	
222-48	44066-44070	hubs	_	
222-49	44071-44074	for	_	
222-50	44075-44083	adaptive	_	
222-51	44084-44088	task	_	
222-52	44089-44096	control	_	
222-53	44097-44104	Control	_	
222-54	44105-44107	of	_	
222-55	44108-44121	goal-directed	_	
222-56	44122-44125	and	_	
222-57	44126-44141	stimulus-driven	_	
222-58	44142-44151	attention	_	
222-59	44152-44154	in	_	
222-60	44155-44158	the	_	
222-61	44159-44164	brain	_	
222-62	44165-44175	Disruption	_	
222-63	44176-44178	of	_	
222-64	44179-44187	cortical	_	
222-65	44188-44199	association	_	
222-66	44200-44208	networks	_	
222-67	44209-44211	in	_	
222-68	44212-44225	schizophrenia	_	
222-69	44226-44229	and	_	
222-70	44230-44239	psychotic	_	
222-71	44240-44247	bipolar	_	
222-72	44248-44256	disorder	_	
222-73	44257-44268	Dysfunction	_	
222-74	44269-44271	of	_	
222-75	44272-44283	large-scale	_	
222-76	44284-44289	brain	_	
222-77	44290-44298	networks	_	
222-78	44299-44301	in	_	
222-79	44302-44315	schizophrenia	_	
222-80	44315-44316	:	_	
222-81	44317-44318	a	_	
222-82	44319-44332	meta-analysis	_	
222-83	44333-44335	of	_	
222-84	44336-44349	resting-state	_	
222-85	44350-44360	functional	_	
222-86	44361-44373	connectivity	_	
222-87	44374-44377	The	_	
222-88	44378-44383	brain	_	
222-89	44383-44384	’	_	
222-90	44384-44385	s	_	
222-91	44386-44393	default	_	
222-92	44394-44401	network	_	
222-93	44401-44402	:	_	
222-94	44403-44410	anatomy	_	
222-95	44410-44411	,	_	
222-96	44412-44420	function	_	
222-97	44420-44421	,	_	
222-98	44422-44425	and	_	
222-99	44426-44435	relevance	_	
222-100	44436-44438	to	_	
222-101	44439-44446	disease	_	
222-102	44447-44454	Failure	_	
222-103	44455-44457	to	_	
222-104	44458-44468	deactivate	_	
222-105	44469-44471	in	_	
222-106	44472-44475	the	_	
222-107	44476-44486	prefrontal	_	
222-108	44487-44493	cortex	_	
222-109	44494-44496	in	_	
222-110	44497-44510	schizophrenia	_	
222-111	44510-44511	:	_	
222-112	44512-44523	dysfunction	_	
222-113	44524-44526	of	_	
222-114	44527-44530	the	_	
222-115	44531-44538	default	_	
222-116	44539-44543	mode	_	
222-117	44544-44551	network	_	
222-118	44551-44552	?	_	

#Text=Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
#Text=Default mode network activity and connectivity in psychopathology
#Text=The neural mechanisms of hallucinations: a quantitative meta-analysis of neuroimaging studies
#Text=Disturbed brain activity in resting-state networks of patients with first-episode schizophrenia with auditory verbal hallucinations: A Cross-sectional Functional MR Imaging Study
#Text=Spontaneous activity patterns in primary visual cortex predispose to visual hallucinations
#Text=Thalamocortical dysconnectivity in schizophrenia
#Text=Mapping thalamocortical functional connectivity in chronic and early stages of psychotic disorders
#Text=Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry
#Text=Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness
#Text=“Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?
223-1	44553-44566	Hyperactivity	_	
223-2	44567-44570	and	_	
223-3	44571-44588	hyperconnectivity	_	
223-4	44589-44591	of	_	
223-5	44592-44595	the	_	
223-6	44596-44603	default	_	
223-7	44604-44611	network	_	
223-8	44612-44614	in	_	
223-9	44615-44628	schizophrenia	_	
223-10	44629-44632	and	_	
223-11	44633-44635	in	_	
223-12	44636-44648	first-degree	_	
223-13	44649-44658	relatives	_	
223-14	44659-44661	of	_	
223-15	44662-44669	persons	_	
223-16	44670-44674	with	_	
223-17	44675-44688	schizophrenia	_	
223-18	44689-44696	Default	_	
223-19	44697-44701	mode	_	
223-20	44702-44709	network	_	
223-21	44710-44718	activity	_	
223-22	44719-44722	and	_	
223-23	44723-44735	connectivity	_	
223-24	44736-44738	in	_	
223-25	44739-44754	psychopathology	_	
223-26	44755-44758	The	_	
223-27	44759-44765	neural	_	
223-28	44766-44776	mechanisms	_	
223-29	44777-44779	of	_	
223-30	44780-44794	hallucinations	_	
223-31	44794-44795	:	_	
223-32	44796-44797	a	_	
223-33	44798-44810	quantitative	_	
223-34	44811-44824	meta-analysis	_	
223-35	44825-44827	of	_	
223-36	44828-44840	neuroimaging	_	
223-37	44841-44848	studies	_	
223-38	44849-44858	Disturbed	_	
223-39	44859-44864	brain	_	
223-40	44865-44873	activity	_	
223-41	44874-44876	in	_	
223-42	44877-44890	resting-state	_	
223-43	44891-44899	networks	_	
223-44	44900-44902	of	_	
223-45	44903-44911	patients	_	
223-46	44912-44916	with	_	
223-47	44917-44930	first-episode	_	
223-48	44931-44944	schizophrenia	_	
223-49	44945-44949	with	_	
223-50	44950-44958	auditory	_	
223-51	44959-44965	verbal	_	
223-52	44966-44980	hallucinations	_	
223-53	44980-44981	:	_	
223-54	44982-44983	A	_	
223-55	44984-44999	Cross-sectional	_	
223-56	45000-45010	Functional	_	
223-57	45011-45013	MR	_	
223-58	45014-45021	Imaging	_	
223-59	45022-45027	Study	_	
223-60	45028-45039	Spontaneous	_	
223-61	45040-45048	activity	_	
223-62	45049-45057	patterns	_	
223-63	45058-45060	in	_	
223-64	45061-45068	primary	_	
223-65	45069-45075	visual	_	
223-66	45076-45082	cortex	_	
223-67	45083-45093	predispose	_	
223-68	45094-45096	to	_	
223-69	45097-45103	visual	_	
223-70	45104-45118	hallucinations	_	
223-71	45119-45134	Thalamocortical	_	
223-72	45135-45150	dysconnectivity	_	
223-73	45151-45153	in	_	
223-74	45154-45167	schizophrenia	_	
223-75	45168-45175	Mapping	_	
223-76	45176-45191	thalamocortical	_	
223-77	45192-45202	functional	_	
223-78	45203-45215	connectivity	_	
223-79	45216-45218	in	_	
223-80	45219-45226	chronic	_	
223-81	45227-45230	and	_	
223-82	45231-45236	early	_	
223-83	45237-45243	stages	_	
223-84	45244-45246	of	_	
223-85	45247-45256	psychotic	_	
223-86	45257-45266	disorders	_	
223-87	45267-45278	Voxel-based	_	
223-88	45278-45279	,	_	
223-89	45280-45290	brain-wide	_	
223-90	45291-45302	association	_	
223-91	45303-45308	study	_	
223-92	45309-45311	of	_	
223-93	45312-45320	aberrant	_	
223-94	45321-45331	functional	_	
223-95	45332-45344	connectivity	_	
223-96	45345-45347	in	_	
223-97	45348-45361	schizophrenia	_	
223-98	45362-45372	implicates	_	
223-99	45373-45388	thalamocortical	_	
223-100	45389-45398	circuitry	_	
223-101	45399-45413	Characterizing	_	
223-102	45414-45430	thalamo-cortical	_	
223-103	45431-45443	disturbances	_	
223-104	45444-45446	in	_	
223-105	45447-45460	schizophrenia	_	
223-106	45461-45464	and	_	
223-107	45465-45472	bipolar	_	
223-108	45473-45480	illness	_	
223-109	45481-45482	“	_	
223-110	45482-45491	Cognitive	_	
223-111	45492-45501	dysmetria	_	
223-112	45501-45502	”	_	
223-113	45503-45505	as	_	
223-114	45506-45508	an	_	
223-115	45509-45520	integrative	_	
223-116	45521-45527	theory	_	
223-117	45528-45530	of	_	
223-118	45531-45544	schizophrenia	_	
223-119	45544-45545	:	_	
223-120	45546-45547	a	_	
223-121	45548-45559	dysfunction	_	
223-122	45560-45562	in	_	
223-123	45563-45594	cortical-subcortical-cerebellar	_	
223-124	45595-45604	circuitry	_	
223-125	45604-45605	?	_	

#Text=Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry
#Text=Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms
#Text=Dysfunctional cortico-cerebellar circuits cause ‘cognitive dysmetria’ in schizophrenia
#Text=Recalling word lists reveals “cognitive dysmetria” in schizophrenia: a positron emission tomography study
#Text=The incidence and nature of cerebellar findings in schizophrenia: a quantitative review of fMRI literature
#Text=Altered resting-state functional connectivity of the cerebellum in schizophrenia
#Text=Disruptive changes of cerebellar functional connectivity with the default mode network in schizophrenia
#Text=Increased cerebellar functional connectivity with the default-mode network in unaffected siblings of schizophrenia patients at rest
#Text=Thalamic abnormalities in schizophrenia visualized through magnetic-resonance image averaging
#Text=Brain volumes in schizophrenia: a meta-analysis in over 18,000 subjects
#Text=Patterns of gray matter abnormalities in schizophrenia based on an international mega-analysis
#Text=Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls
#Text=NMDA receptor and schizophrenia: a brief history
#Text=Glutamate and dopamine in schizophrenia: an update for the 21st century
#Text=Schizophrenia as a disorder of developmentally reduced synaptic connectivity
#Text=First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
#Text=Biological insights from 108 schizophrenia-associated genetic loci
#Text=Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
#Text=The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia
#Text=NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia
#Text=The role of the cerebellum in schizophrenia
#Text=The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging
#Text=The cerebellar cognitive affective syndrome
224-1	45606-45619	Schizophrenia	_	
224-2	45620-45623	and	_	
224-3	45624-45633	cognitive	_	
224-4	45634-45643	dysmetria	_	
224-5	45643-45644	:	_	
224-6	45645-45646	a	_	
224-7	45647-45664	positron-emission	_	
224-8	45665-45675	tomography	_	
224-9	45676-45681	study	_	
224-10	45682-45684	of	_	
224-11	45685-45698	dysfunctional	_	
224-12	45699-45729	prefrontal-thalamic-cerebellar	_	
224-13	45730-45739	circuitry	_	
224-14	45740-45748	Defining	_	
224-15	45749-45752	the	_	
224-16	45753-45762	phenotype	_	
224-17	45763-45765	of	_	
224-18	45766-45779	schizophrenia	_	
224-19	45779-45780	:	_	
224-20	45781-45790	cognitive	_	
224-21	45791-45800	dysmetria	_	
224-22	45801-45804	and	_	
224-23	45805-45808	its	_	
224-24	45809-45815	neural	_	
224-25	45816-45826	mechanisms	_	
224-26	45827-45840	Dysfunctional	_	
224-27	45841-45859	cortico-cerebellar	_	
224-28	45860-45868	circuits	_	
224-29	45869-45874	cause	_	
224-30	45875-45876	‘	_	
224-31	45876-45885	cognitive	_	
224-32	45886-45895	dysmetria	_	
224-33	45895-45896	’	_	
224-34	45897-45899	in	_	
224-35	45900-45913	schizophrenia	_	
224-36	45914-45923	Recalling	_	
224-37	45924-45928	word	_	
224-38	45929-45934	lists	_	
224-39	45935-45942	reveals	_	
224-40	45943-45944	“	_	
224-41	45944-45953	cognitive	_	
224-42	45954-45963	dysmetria	_	
224-43	45963-45964	”	_	
224-44	45965-45967	in	_	
224-45	45968-45981	schizophrenia	_	
224-46	45981-45982	:	_	
224-47	45983-45984	a	_	
224-48	45985-45993	positron	_	
224-49	45994-46002	emission	_	
224-50	46003-46013	tomography	_	
224-51	46014-46019	study	_	
224-52	46020-46023	The	_	
224-53	46024-46033	incidence	_	
224-54	46034-46037	and	_	
224-55	46038-46044	nature	_	
224-56	46045-46047	of	_	
224-57	46048-46058	cerebellar	_	
224-58	46059-46067	findings	_	
224-59	46068-46070	in	_	
224-60	46071-46084	schizophrenia	_	
224-61	46084-46085	:	_	
224-62	46086-46087	a	_	
224-63	46088-46100	quantitative	_	
224-64	46101-46107	review	_	
224-65	46108-46110	of	_	
224-66	46111-46115	fMRI	_	
224-67	46116-46126	literature	_	
224-68	46127-46134	Altered	_	
224-69	46135-46148	resting-state	_	
224-70	46149-46159	functional	_	
224-71	46160-46172	connectivity	_	
224-72	46173-46175	of	_	
224-73	46176-46179	the	_	
224-74	46180-46190	cerebellum	_	
224-75	46191-46193	in	_	
224-76	46194-46207	schizophrenia	_	
224-77	46208-46218	Disruptive	_	
224-78	46219-46226	changes	_	
224-79	46227-46229	of	_	
224-80	46230-46240	cerebellar	_	
224-81	46241-46251	functional	_	
224-82	46252-46264	connectivity	_	
224-83	46265-46269	with	_	
224-84	46270-46273	the	_	
224-85	46274-46281	default	_	
224-86	46282-46286	mode	_	
224-87	46287-46294	network	_	
224-88	46295-46297	in	_	
224-89	46298-46311	schizophrenia	_	
224-90	46312-46321	Increased	_	
224-91	46322-46332	cerebellar	_	
224-92	46333-46343	functional	_	
224-93	46344-46356	connectivity	_	
224-94	46357-46361	with	_	
224-95	46362-46365	the	_	
224-96	46366-46378	default-mode	_	
224-97	46379-46386	network	_	
224-98	46387-46389	in	_	
224-99	46390-46400	unaffected	_	
224-100	46401-46409	siblings	_	
224-101	46410-46412	of	_	
224-102	46413-46426	schizophrenia	_	
224-103	46427-46435	patients	_	
224-104	46436-46438	at	_	
224-105	46439-46443	rest	_	
224-106	46444-46452	Thalamic	_	
224-107	46453-46466	abnormalities	_	
224-108	46467-46469	in	_	
224-109	46470-46483	schizophrenia	_	
224-110	46484-46494	visualized	_	
224-111	46495-46502	through	_	
224-112	46503-46521	magnetic-resonance	_	
224-113	46522-46527	image	_	
224-114	46528-46537	averaging	_	
224-115	46538-46543	Brain	_	
224-116	46544-46551	volumes	_	
224-117	46552-46554	in	_	
224-118	46555-46568	schizophrenia	_	
224-119	46568-46569	:	_	
224-120	46570-46571	a	_	
224-121	46572-46585	meta-analysis	_	
224-122	46586-46588	in	_	
224-123	46589-46593	over	_	
224-124	46594-46600	18,000	_	
224-125	46601-46609	subjects	_	
224-126	46610-46618	Patterns	_	
224-127	46619-46621	of	_	
224-128	46622-46626	gray	_	
224-129	46627-46633	matter	_	
224-130	46634-46647	abnormalities	_	
224-131	46648-46650	in	_	
224-132	46651-46664	schizophrenia	_	
224-133	46665-46670	based	_	
224-134	46671-46673	on	_	
224-135	46674-46676	an	_	
224-136	46677-46690	international	_	
224-137	46691-46704	mega-analysis	_	
224-138	46705-46715	Cerebellar	_	
224-139	46716-46722	volume	_	
224-140	46723-46726	and	_	
224-141	46727-46744	cerebellocerebral	_	
224-142	46745-46755	structural	_	
224-143	46756-46766	covariance	_	
224-144	46767-46769	in	_	
224-145	46770-46783	schizophrenia	_	
224-146	46783-46784	:	_	
224-147	46785-46786	a	_	
224-148	46787-46796	multisite	_	
224-149	46797-46810	mega-analysis	_	
224-150	46811-46813	of	_	
224-151	46814-46817	983	_	
224-152	46818-46826	patients	_	
224-153	46827-46830	and	_	
224-154	46831-46835	1349	_	
224-155	46836-46843	healthy	_	
224-156	46844-46852	controls	_	
224-157	46853-46857	NMDA	_	
224-158	46858-46866	receptor	_	
224-159	46867-46870	and	_	
224-160	46871-46884	schizophrenia	_	
224-161	46884-46885	:	_	
224-162	46886-46887	a	_	
224-163	46888-46893	brief	_	
224-164	46894-46901	history	_	
224-165	46902-46911	Glutamate	_	
224-166	46912-46915	and	_	
224-167	46916-46924	dopamine	_	
224-168	46925-46927	in	_	
224-169	46928-46941	schizophrenia	_	
224-170	46941-46942	:	_	
224-171	46943-46945	an	_	
224-172	46946-46952	update	_	
224-173	46953-46956	for	_	
224-174	46957-46960	the	_	
224-175	46961-46965	21st	_	
224-176	46966-46973	century	_	
224-177	46974-46987	Schizophrenia	_	
224-178	46988-46990	as	_	
224-179	46991-46992	a	_	
224-180	46993-47001	disorder	_	
224-181	47002-47004	of	_	
224-182	47005-47020	developmentally	_	
224-183	47021-47028	reduced	_	
224-184	47029-47037	synaptic	_	
224-185	47038-47050	connectivity	_	
224-186	47051-47056	First	_	
224-187	47057-47059	in	_	
224-188	47060-47064	vivo	_	
224-189	47065-47073	evidence	_	
224-190	47074-47076	of	_	
224-191	47077-47079	an	_	
224-192	47080-47084	NMDA	_	
224-193	47085-47093	receptor	_	
224-194	47094-47101	deficit	_	
224-195	47102-47104	in	_	
224-196	47105-47120	medication-free	_	
224-197	47121-47134	schizophrenic	_	
224-198	47135-47143	patients	_	
224-199	47144-47154	Biological	_	
224-200	47155-47163	insights	_	
224-201	47164-47168	from	_	
224-202	47169-47172	108	_	
224-203	47173-47197	schizophrenia-associated	_	
224-204	47198-47205	genetic	_	
224-205	47206-47210	loci	_	
224-206	47211-47218	Linking	_	
224-207	47219-47229	early-life	_	
224-208	47230-47235	NMDAR	_	
224-209	47236-47248	hypofunction	_	
224-210	47249-47252	and	_	
224-211	47253-47262	oxidative	_	
224-212	47263-47269	stress	_	
224-213	47270-47272	in	_	
224-214	47273-47286	schizophrenia	_	
224-215	47287-47299	pathogenesis	_	
224-216	47300-47303	The	_	
224-217	47304-47310	impact	_	
224-218	47311-47313	of	_	
224-219	47314-47318	NMDA	_	
224-220	47319-47327	receptor	_	
224-221	47328-47340	hypofunction	_	
224-222	47341-47343	on	_	
224-223	47344-47353	GABAergic	_	
224-224	47354-47361	neurons	_	
224-225	47362-47364	in	_	
224-226	47365-47368	the	_	
224-227	47369-47384	pathophysiology	_	
224-228	47385-47387	of	_	
224-229	47388-47401	schizophrenia	_	
224-230	47402-47406	NMDA	_	
224-231	47407-47415	receptor	_	
224-232	47416-47428	hypofunction	_	
224-233	47428-47429	,	_	
224-234	47430-47450	parvalbumin-positive	_	
224-235	47451-47458	neurons	_	
224-236	47458-47459	,	_	
224-237	47460-47463	and	_	
224-238	47464-47472	cortical	_	
224-239	47473-47478	gamma	_	
224-240	47479-47491	oscillations	_	
224-241	47492-47494	in	_	
224-242	47495-47508	schizophrenia	_	
224-243	47509-47512	The	_	
224-244	47513-47517	role	_	
224-245	47518-47520	of	_	
224-246	47521-47524	the	_	
224-247	47525-47535	cerebellum	_	
224-248	47536-47538	in	_	
224-249	47539-47552	schizophrenia	_	
224-250	47553-47556	The	_	
224-251	47557-47567	cerebellum	_	
224-252	47568-47571	and	_	
224-253	47572-47581	cognitive	_	
224-254	47582-47590	function	_	
224-255	47590-47591	:	_	
224-256	47592-47594	25	_	
224-257	47595-47600	years	_	
224-258	47601-47603	of	_	
224-259	47604-47611	insight	_	
224-260	47612-47616	from	_	
224-261	47617-47624	anatomy	_	
224-262	47625-47628	and	_	
224-263	47629-47641	neuroimaging	_	
224-264	47642-47645	The	_	
224-265	47646-47656	cerebellar	_	
224-266	47657-47666	cognitive	_	
224-267	47667-47676	affective	_	
224-268	47677-47685	syndrome	_	
